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GENERAL INTRODUCTION  
 
 Injury to the brain and spinal cord has devastating consequences because adult 
neurons in the central nervous system (CNS) do not regenerate. Traumatic CNS injuries are a 
significant clinical problem and have life-changing consequences for patients. There are 
130.000 new cases of spinal cord injury (SCI) per year worldwide and currently affects more 
than 2.5 million people (International Spinal Research Trust). Spinal cord injury often results 
in loss of essential bodily functions including sexual function, bladder control, and motor and 
sensory function. SCI mainly occurs among young adults and generates a psychological 
burden for both the patients and their caregivers. Furthermore, SCI is a substantial economic 
problem, as the UK national cost was estimated at one billion pounds per year. With these 
facts in mind, there is currently enormous interest in developing treatments for patients who 
are living with SCI. 
 There are many factors that contribute to the failure of axon regeneration in the CNS. 
Generally speaking, the problem of axon regeneration can be subdivided in at least two 
aspects: 1) the growth-repulsive environment surrounding the injured axon and 2) the low 
intrinsic regeneration potential of adult CNS neurons. 
 SCI initiates drastic molecular and cellular changes at the site of insult.  The 
primary injury is the direct mechanical trauma to the neurons, glia and blood vessels in the 
spinal cord. The ruptured vascular system contributes to ischemia-induced cell death and 
entry of inflammatory and other cells to the site of injury (reviewed in Oudega,  2012). Scar 
tissue is formed within a few days after an injury and consists of edema, and includes many 
cells types and an orchestra of molecules. Astrocytes react to the injury by forming a dense 
net within the scar and secrete a variety of molecules including chondroitin sulfate 
proteoglycans (CSPGs) including aggrecan (reviewed in Silver & Miller,  2004; Gervasi, 
Kwok, & Fawcett,  2008). Fibroblasts, derived from connective tissue, also enter the site of 
injury and produce axon repulsive molecules such as class III semaphorins (reviewed in 
Mecollari, Nieuwenhuis, & Verhaagen,  2014). On top of that, Wallerian degeneration occurs 
and myelin debris accumulates in the scar and along the denervated nerve tracts. Several of 
the myelin-derived molecules, including Nogo-A, MAG and OMgp, are known to be 
repulsive for axon regeneration (reviewed in Schweigreiter & Bandtlow,  2006; Alizadeh, 
Dyck, & Karimi-Abdolrezaee,  2015; Boghdadi, Teo, & Bourne,  2017). Thus, the scar tissue 
holds multiple molecular components that hinder axonal regeneration. Yet, there are also 
studies suggesting that certain components of the scar are regeneration-supportive, such as 
laminins, thrombospondin-1 and certain CSPGs (Tyzack et al.,  2014; Anderson et al.,  2016). 
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 Mechanisms within neurons also restrict axonal regeneration in the adult CNS. First of 
all, the primary injury causes apoptosis of many CNS neurons at the injury site. Only the 
surviving neurons have the possibility to promote axonal regeneration. However, many CNS 
neurons survive the injury, in particular the neurons of the large descending and ascending 
tracts of the spinal cord. Successful axon regeneration requires the formation of a growth cone 
and synthesis of cytoskeleton and regeneration-associated proteins to extend and lengthen the 
injured axon (reviewed in Liu et al.,  2011; Bradke, Fawcett, & Spira,  2012). However, adult 
CNS neurons are unsuccessful to activate regeneration-associated genes (reviewed in van 
Kesteren et al.,  2011; Fagoe, van Heest, & Verhaagen,  2014). The mechanism how the axon 
regeneration response declines during maturation is unknown. Our laboratory has the 
hypothesis that (epi-) genetic changes and selective polarized transport that occurs during 
neuronal polarization contribute to the decline in the axonal regeneration response of CNS 
neurons (reviewed in Nieuwenhuis & Eva,  2018). Developing neurons have a high dendritic 
and axonal growth capacity, while matured CNS neurons develop an axon initial segment, 
propagate action potentials, form spines and synapses and importantly have a low capacity for 
axonal growth. Some of the evidence that highlight the decline in the intrinsic axonal 
regeneration response in adult CNS neurons is briefly reviewed below.  
 Neurons of adult motor tracts that fail to regenerate lack regeneration-associated 
receptors in their axon. Integrins are cell-surface receptors that are important for axonal 
growth in embryonic CNS tissue, but are excluded from the axonal compartment of 
corticospinal tract and cerebellum in adulthood, and are also not upregulated after injury 
(Pinkstaff et al.,  1999; Andrews et al.,  2009). The cell-surface receptor TrkB is also not 
found in the axons of the adult corticospinal tract, nor upregulated after injury (Yan et al.,  
1997; Liebl et al.,  2001; Lu, Blesch, & Tuszynski,  2001). Insulin-like growth factor 
receptors are also important during development of the corticospinal tract (Arlotta et al.,  
2005; Ozdinler & Macklis,  2006), but are not found in the axon when matured (Hollis et al.,  
2009a). The absence of growth-promoting receptors that interact with the environment of the 
CNS is one mechanism that contributes to axon regeneration failure.   
 Studies that aimed to re-introduce regeneration-associated receptors in the 
corticospinal tract were unsuccessful to get the receptors transported in the axonal 
compartment. Adeno-associated viral vector mediated delivery of integrins (Andrews et al., 
2016), TrkB (Hollis et al.,  2009b), and IGFR-1 (Hollis et al.,  2009a) in the corticospinal 
tract resulted in localisation of the receptors in the somatodendritic compartment of the 
neuron in the cortex, but not in the axon in the spinal cord. This suggests that the adult 
corticospinal tract has mechanisms in place that prevent growth-promoting receptors to enter 
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the axon. The axon initial segment is an important component of selective polarised transport 
in multipolar neurons (reviewed in Rasband,  2010). The mechanisms how the AIS regulates 
axonal transport is not completely understood, but it is a known barrier for the axonal 
transport of many proteins including integrins (Bi et al.,  2001; Hedstrom, Ogawa, & 
Rasband,  2008; Sobotzik et al.,  2009; Franssen et al.,  2015). In addition, changes in the 
axonal transport machinery contribute to exclusion of regeneration-associated receptors. 
Rab11 is a small-GTPases that marks endosomes containing integrins, TrkB, and IGFR-1 
(reviewed in Nieuwenhuis & Eva,  2018). Rab11-positive recycling endosomes are largely 
excluded from axons in adult cortical neurons (Sheehan et al.,  1996; Koseki et al.,  2017). 
This is most likely the consequence of a steep-upregulation of GTP exchange factors (GEFs), 
such as EFA6 and ARNO (Sakagami et al.,  2006; Bi et al.,  2001; Franssen et al.,  2015; Eva 
et al.,  2017), which direct these endosomes away from the axon. Modifications in actin and 
microtubules also contribute to selective polarised transport in cortical neurons (Franssen et 
al.,  2015).   
 An age-dependent decline in axonal regeneration is observed in cultured cortical 
neurons (Koseki et al.,  2017) and in the corticospinal tract in vivo (Geoffroy et al.,  2016). 
Multiple intrinsic mechanisms, in which some are depended on upstream axonal receptor 
signalling, which are beneficial for axonal regeneration are down-regulated during 
maturation. For instance, there is a decline of phosphoinositide 3-kinases in cortical neurons 
in vitro and in vivo (Eickholt et al.,  2007; Koseki et al.,  2017). There is also a decline in the 
number of activated ribosomal proteins in CNS neurons in line with maturation in vivo (Park 
et al.,  2008; Liu et al.,  2010). An age-associated decline in cyclic adenosine monophosphate 
(cAMP) which correlates with loss of axonal growth has also been reported (Cai et al.,  2001). 
A down-regulation of histone acetyltransferases has also been observed which results in more 
compact chromatin during maturation and may contribute to the decline in the ability of 
regeneration-associated transcription factors to promote axonal regeneration in CNS neurons 
(Gaub et al.,  2011; and reviewed in Danzi et al.,  2018).  
 The low intrinsic axon regeneration capacity of adult CNS neurons is an important 
component restricting functional recovery after spinal cord injury. This dissertation focuses 
on genetic approaches to enhance the axonal regeneration capacity of cortical neurons. 
Changes in integrin receptor biology are a good example of molecular changes leading to 
restricted axonal regeneration in the adult CNS. Several studies have shown that targeting 
integrins and related regeneration-associated molecules can promote axonal regeneration after 
injury of the nervous system. The tools used for the discovery of integrins and approaches to 
manipulate them could also act as a model for other mechanisms that limit axonal 
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regeneration. Strategies that aim to promote axonal transport of regeneration-associated 
receptors and downstream axonal growth signalling are therefore topics of this thesis. Work in 
this thesis aimed to explore whether dismantling the axon initial segment could enhance the 
transport of regeneration-associated receptors in the axon. Another approach investigated 
whether improving axonal growth signalling, downstream of receptor signal transduction, 
promotes axon regeneration in CNS neurons. Adeno-associated viral (AAV) vectors are the 
preferred carriers to transduce CNS neurons, and were also used in this thesis to deliver 
transgenes into cortical neurons and the corticospinal tract. Part of this dissertation focussed 
on optimising AAV-mediated transduction of the corticospinal tract because regeneration of 
this neuronal pathway is a key event to restore motor function after spinal cord injury. Gene 
therapy is a promising strategy to promote axonal regeneration. The overall objectives of this 
dissertation were the following: (i) to enhance axon regeneration in cortical neurons in vitro; 
and (ii) to optimize AAV-mediated transduction of the corticospinal tract in vivo.  
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OUTLINE OF THIS DOCTORAL DISSERTATION 
Chapter I is a literature review about the cell surface receptors integrins and their role 
in axonal regeneration. Integrins contribute to the spontaneous axon regeneration in the 
peripheral nervous system by interacting with ligands in the extracellular matrix. Integrin 
biology is different in the CNS. These receptors are transported into the axon of developing 
neurons, but selective axonal transport limits the regenerative response in adult CNS neurons. 
Manipulation of integrins and related molecules that control their transport and activation 
state is a promising tool to promote robust regeneration in the CNS. The platforms and 
experimental therapies used in integrin research are also relevant for other mechanisms 
limited axon regeneration.    
 Chapter II is based on the hypothesis that the axon initial segment is a barrier for the 
axonal transport of integrins and other growth-promoting receptors. The aim was to dismantle 
the axon initial segment by knockout of the cytoskeletal scaffolding protein Ankyrin-G. Two 
genetic tools were made and tested to knockout Ankyrin G: (1) a short hairpin RNA, and (2) a 
dual promoter AAV viral vector that drives the expression of a CRISPR-associated 
endonuclease 9 from Staphylococcus aures and one guide RNA targeting Ankyrin-G.   
 Chapter III is based on the hypothesis that low axonal PtdIns-3,4,5-P3 (PIP3) 
signalling, due to the absence of growth-promoting receptors in the axon, contributes to 
regenerative failure in the CNS.  This chapter investigates whether overexpression of 
phosphoinositide 3-kinases (PI3Ks), which generates PIP3, can promote axon regeneration in 
cultured cortical neurons.   
 Chapter IV aimed to identify the best method to deliver transgenes into the 
corticospinal tract by using AAVs. The choice of serotype and promoter has a crucial impact 
on gene therapy as it can ultimately depict whether it will be successful or unsuccessful. This 
study consisted of a direct comparison between the AAV1 and AAV5 viral vector serotypes 
and four promoters (CMV, PGK, sCAG, synapsin) in their efficiency to express eGFP 
following injection at the sensory-motor cortex in mice and rats.   
 Chapter V is a summary and general discussion of the obtained results in dissertation.  
It highlights future perspectives of the current work and how the research contributes to 
advance the field of gene therapy and axon regeneration.  
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CHAPTER I - Integrins promote axonal regeneration after injury of 
the nervous system 
 
Declaration:  
This chapter of the dissertation has been published as an open access article under the terms 
of the Creative Commons Attribution, which permits use, distribution and reproduction in any 
medium, provided the original work is properly cited. The citation is: Nieuwenhuis, B., 
Haenzi, B., Andrews, M. R., Verhaagen, J. and Fawcett, J. W. (2018), Integrins promote 
axonal regeneration after injury of the nervous system. Biol Rev, 93: 1339-1362. 
doi:10.1111/brv.12398.  
 
This literature review was written in collaboration with the above authors. The contribution of 
each author is the following: 
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Joost Verhaagen contributed by critical reading and editing of the manuscript. 
James Fawcett edited the final version of the manuscript before submission to the journal. 
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not mentioned above, and I am the corresponding author of the published article.   
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I. INTRODUCTION 
 The integrin receptor family plays a role in a variety of processes including the 
development of various tissues (reviewed in Danen & Sonnenberg,  2003; Avraamides, 
Garmy-Susini, & Varner,  2008), the formation of the nervous system (reviewed in Colognato 
& Tzvetanova,  2011; Gardiner,  2011; Kazanis & ffrench-Constant,  2011; Myers, Santiago 
Medina, & Gomez,  2011), the immune response (reviewed in Means & Luster,  2010), cancer 
(reviewed in Guo & Giancotti,  2004; Desgrosellier & Cheresh,  2010; Schittenhelm, 
Tabatabai, & Sipos,  2016; Paolillo, Serra, & Schinelli,  2016), synaptic plasticity (reviewed 
in Park & Goda,  2016) and axonal regeneration in the peripheral nervous system (PNS) 
(reviewed in Gardiner, 2011; Eva & Fawcett,  2014). This review describes and discusses the 
role of integrins in axonal regeneration and their use as therapeutic targets to stimulate repair 
after spinal cord injury.  
 
(1) Structure 
 The structure of integrins is well characterised and has been described in many 
reviews (Takada, Ye, & Simon,  2007; Wegener et al.,  2007; Arnaout, Goodman, & Xiong,  
2007; Campbell & Humphries,  2011; Hu & Luo,  2013). Integrins are heterodimeric 
receptors that consist of one alpha (α) and one beta (β) subunit. In mammals, 18 α and 8 β 
subunits have been identified giving rise to 24 unique integrin receptors (reviewed in Hynes,  
2002). Integrins are type I (C-terminus located intracellularly) glycoproteins. The ectodomain 
is the largest part of both the α and β subunits containing the metal-ion and extracellular-
matrix (ECM) ligand-binding sites. The interaction between the transmembrane domains of 
the subunits determines the conformation and therefore the activation state of the receptor. 
Inactivated integrins exist in a bent orientation as the two transmembrane domains interact 
closely. By contrast, activated integrins have less interaction between the transmembrane 
parts, resulting in a straight conformation and allowing them to bind to ligands in the ECM. 
The cytoplasmic tails of integrins are relatively short. They lack enzymatic activity and 
integrins are therefore reliant on multi-protein complexes for signal transduction. The 
particularly short tail of the α subunit indicates a limited role for this subunit in intracellular 
processes. The cytoplasmic tail of the β subunit is also short, but contains two NPXY motifs 
that can interact with phosphotyrosine binding domains of intracellular proteins, such as talins 
(Tadokoro et al.,  2003), kindlins (Moser et al.,  2008; Harburger, Bouaouina, & Calderwood,  
2009) and various other signalling and scaffolding molecules.  
 
 
	19	
(2) Signalling 
 Each integrin bears a unique binding affinity for components in the heterogeneous 
ECM (reviewed in van der Flier & Sonnenberg,  2001; Hynes,  2002; Humphries,  2006), 
such as laminin, fibronectin, collagen and tenascin-C. Importantly, integrins mediate bi-
directional signalling between the extracellular matrix and the cytoskeleton across the plasma 
membrane. Activated integrins bind to specific ECM ligands and induce signalling to the 
intracellular compartment of the cell, a process known as ‘outside-in’ signalling. The 
activated integrin signalling regulates the actin cytoskeleton via many proteins. Firstly, talin, 
which interacts with the cytoplasmic tail of integrins, links them directly, or via vinculin, to 
the actin cytoskeleton. Secondly, focal adhesion kinase (FAK) is recruited to activated 
integrins and is a key signalling scaffold protein that activates downstream proteins such as 
paxillin and Src. Thirdly, integrin-linked kinase (ILK) is another important signalling scaffold 
protein that phosphorylates downstream proteins. Conversely, ‘inside-out’ signalling refers to 
the mechanism in which intracellular proteins bind integrins thereby inducing a 
conformational change that enhances the binding activity of integrins towards their ligands in 
the ECM, enabling intracellular signalling. Talin and kindlin, the main mediators of inside-out 
signalling, are subject to various regulatory pathways that thereby affect integrin function 
(reviewed in Calderwood, Campbell, & Critchley,  2013; Ye, Lagarrigue, & Ginsberg,  2014; 
Rognoni, Ruppert, & Fässler,  2016). Importantly, the integrin receptor family can form 
hundreds of protein complexes to link the ECM with the cytoskeleton. These protein 
complexes are also referred to as the integrin adhesome (Zaidel-Bar et al.,  2007; Robertson et 
al.,  2015; Horton et al.,  2015; reviewed in Winograd-Katz et al.,  2014; Humphries et al.,  
2015).  
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(3) Integrin subunit knockouts 
 Whole-system and tissue-specific knockout studies of integrins have been fruitful in 
demonstrating their functional importance. It has been demonstrated in integrin-knockout 
mice that integrins are important for tissue development. Depending on which integrin 
subunit is knocked out, the mouse phenotypes range from mild developmental defects to 
embryonic or perinatal lethality (reviewed in Hynes,  2002; Bouvard et al.,  2013). The 
architecture and function of the nervous system is also reliant on the coordinated expression 
of integrin receptors and components of the ECM. Several studies examining deletion of 
different integrin subunits have shown varying degrees of impairment and/or changes in gross 
morphology, thereby confirming their fundamental role in the development and maintenance 
of the nervous system. For example, mutant mice carrying brain-specific (neurons and glia) 
deletion of α6 integrin had abnormalities in the foliation of the cerebellum along with a 
reduction in process outgrowth of the Bergmann glia, yet the cerebral cortex developed 
normally (Marchetti et al.,  2013). Selective deletion of αV integrin in the brain resulted in 
severe neurological abnormalities including seizures and ataxia as well as cerebral 
haemorrhage (beginning in utero), leading to death by four weeks of age in the majority of 
cases (McCarty et al.,  2005). Deletion of the β1 subunit influences the majority of integrin 
heterodimers and not surprisingly a whole-body knockout is embryonically lethal (Fässler & 
Meyer,  1995). Deletion of β1 integrins in the brain leads to death shortly after birth (Graus-
Porta et al.,  2001) highlighting that expression of β1 integrin heterodimers in neurons and 
glia is essential. Several integrins have specific roles in axon regeneration that are discussed 
below (see Sections III and IV.i). The fact that integrins are located at the growth cone 
(Robles & Gomez,  2006) and respond to diverse extracellular molecular signals present in 
the environment of the injured PNS and central nervous system (CNS) makes them an 
interesting target to study axonal regeneration (Fig. 1). 
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Fig. 1. Integrins are localised to the growth cone of immature and peripheral nervous system neurons. 
Active and inactive integrins are present on the surface of the neuronal growth cone. However, only active 
integrins bind molecules of the extracellular matrix. 
 
 
II. THE LOCALISATION OF INTEGRINS IN THE NERVOUS SYSTEM AND 
IMPLICATIONS FOR AXONAL REGENERATION 
 Integrins are expressed by every cell in the body (except red blood cells) which in the 
CNS includes neurons, astrocytes, microglia, oligodendrocytes, and endothelial cells 
(reviewed in Milner & Campbell,  2002; Schmid & Anton,  2003). Integrin function depends 
on the cellular localisation of the receptor. For the purposes of this review, we confine our 
discussion below to integrin localisation in the nervous system. Various integrins are 
expressed in particular sets of neurons and glia. There is also specific localisation of integrins 
within neurons to the somatodendritic and axonal compartments.  
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(1) mRNA expression 
 Much of our knowledge of patterns of integrin expression comes from in situ 
hybridization and RT-PCR studies (Table 1). In two whole-brain expression studies, 
differential expression patterns of several integrin subunits were demonstrated in various 
brain regions. Messenger RNA (mRNA) labelling within CNS neurons varying from 
relatively low to significantly high levels was detected in layer V of the cortex, hippocampus 
(CA1, CA3 pyramidal neurons and granule neurons of the dentate gyrus), olfactory bulb, and 
cerebellar Purkinje neurons for α1, α2, α3, α4, α5, α6, α7, αV, β1, β3, β5, β6, and β7. 
Furthermore, it has been found that α8 integrin can be detected in the hippocampus and 
olfactory bulb (Pinkstaff et al.,  1999; Chan et al.,  2003). In the red nucleus, mRNA of α3, 
α7, αV and β1 was detected, including an up-regulation in β1 mRNA following axotomy 
(Plantman et al.,  2005). In addition, examination of rat dorsal root ganglia (DRGs) also 
revealed expression of α5, α6, α7, and β1 integrins (Wallquist et al.,  2004; Gardiner et al.,  
2007; Gonzalez Perez et al.,  2016), whereas spinal motor neurons expressed α3, α7, and β1 
integrins with α6 expression appearing in these neurons after axotomy (Hammarberg et al.,  
2000). 
 
 
 Table 1. Integrin mRNA expression in the adult nervous system. 
 
Shaded squares indicate that integrin mRNA was detected and they are labelled with the corresponding 
reference; white squares illustrate that mRNA expression was not tested or not detected. The asterisk (*) 
indicates that expression was observed only following axotomy. The integrins α9, α10, α11, αD, αE, αL, αM, 
α2b, αX, β2, β4 and β8 are not included because they were not tested or there was no mRNA detected in any of 
the cell types analysed. 1, Pinkstaff et al. (1999); 2, Hammarberg et al. (2000); 3, Chan et al. (2003); 4, 
Wallquist et al. (2004); 5, Plantman et al. (2005); 6, Gardiner et al. (2007); 7, Gonzales-Perez et al. (2016). 
DRGs, dorsal root ganglia.  
 
mRNA α1 α2 α3 α4 α5 α6 α7 α8 αV β1 β3 β5 β6 β7 
Cerebellum 3 3 1, 3 3 1, 3 1, 3 1, 3  1, 3 1, 3 3 1, 3 3 3 
Cortex layer V 1, 3 3 1, 3 3 3 3 1, 3  1, 3 3 3 1, 3 3 3 
DRGs     6, 7 4 4, 7   4     
Hippocampus 1, 3 3 1, 3 3 1, 3 1, 3 1, 3 1 3 1, 3 3 1, 3 3 3 
Olfactory bulb 3 3 1, 3 1, 3 1, 3 1, 3 1, 3 1 1, 3 3 3 1, 3 3 3 
Red nucleus   5    5  5 5     
Spinal motor 
neurons 
  2   2* 2   2     
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 (2) Subcellular localisation 
 In order to assess the subcellular localisation of integrin receptors, 
immunohistochemical approaches or expression of labelled integrins are required. 
Determining whether integrins are expressed in the axonal or somatodendritic compartment is 
useful for understanding their potential function. In this regard, numerous studies have 
examined integrin expression in cultured cells, with fewer studies documenting expression in 
tissue sections. There are many studies demonstrating integrins in axons during embryonic 
development, using both immunohistochemistry and staining of cultured embryonic neurons. 
This is not surprising; integrins are necessary for axon growth during development (reviewed 
in Gardiner,  2011; Myers et al.,  2011). However, in the mature CNS the picture is very 
different as discussed below.  
 Integrins have been localised within the somatodendritic compartment of adult layer V 
pyramidal neurons, CA1 and CA3 hippocampal neurons, granule neurons of the dentate 
gyrus, and Purkinje cells (Grooms, Terracio, & Jones,  1993; Murase & Hayashi,  1996; 
Rodriguez et al.,  2000; Bi et al.,  2001; Schuster et al.,  2001; Chan et al.,  2003; Kawaguchi 
& Hirano,  2006; Mortillo et al.,  2012; see Table 2). Interestingly, certain integrin subunits 
including α3, α5 and β1 are found in the somatodendritic compartment of diverse neuronal 
types, which may indicate an important role in dendritic function. Other somatodendritic 
integrins displayed a more restricted neuron sub-type distribution. For instance, α8 is 
expressed in layer V pyramidal neurons, olfactory bulb, and hippocampal neurons (Einheber 
et al.,  1996), αV and β8 in cerebellar and hippocampal neurons (Nishimura et al.,  1998; 
Kang et al.,  2008) whereas β3 was detected in hippocampal neurons and the inner plexiform 
layer of the retina in addition to α5 (Kang et al.,  2008; Vecino et al.,  2015). Additionally, 
following injury, α7 and β1 subunits were found to be expressed in facial motor neurons 
(Kloss et al.,  1999; Werner et al.,  2000). The localisation of integrins in the somatodendritic 
compartment of adult neurons is summarised in Table 2.  
 The question of whether integrins are found in axons during development and in 
adulthood is important to understand their function in regeneration. Very few studies however 
have demonstrated the presence of integrin receptors in the axonal compartment in tissue 
sections from the mature CNS. This is partly due to the lack of suitable antibodies, but mainly 
due to the down-regulation of expression of many integrins in the adult CNS in addition to the 
active exclusion of integrins from most mature CNS axons as discussed below (Section VII). 
Some studies however have succeeded in localising endogenous integrins specifically (see 
Table 3); for instance α5 integrin has been found within rodent axons of layer V pyramidal 
neurons and reticular formation (King, McBride, & Priestley,  2001; Bi et al.,  2001). 
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Interestingly, the majority of studies demonstrating axonal localisation of integrins have been 
in retinal ganglia cells (RGCs) and DRGs, two neuronal subtypes that have been shown 
experimentally to have increased regenerative capacity relative to many other CNS neuronal 
subtypes (Richardson & Issa,  1984; Neumann & Woolf,  1999; Leon et al.,  2000; Qiu et al.,  
2002; Monsul et al.,  2004). Within adult RGCs, α1, α3, α5, αV, and β1 subunits have been 
detected in axons (Hernandez,  2000; Vecino et al.,  2015). α4, α5, α6, α7 and β1 subunits 
have been found in both processes of DRGs (Bossy, Bossywetzel, & Reichardt,  1991; 
Yanagida, Tanaka, & Maruo,  1999; Vogelezang et al.,  2001; Schuster et al.,  2001; Ekström 
et al.,  2003; Wallquist et al.,  2004). Overall, it appears that integrins are present in most 
axons during embryonic development, but in adulthood they are excluded from many CNS 
axons but present in retinal and sensory axons. The localisation of integrins in the axonal 
compartment of adult neurons is summarized in Table 3.  
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Table 2. Integrins localised in the somatodendritic compartment of adult neurons. 
Somatodendritic α3 α5 α7 α8 αV β1 β3 β8 
Cerebellum 10 8   4 3, 10  4 
Cortex layer V 6, 10 8  2  10   
Hippocampus 10 8  2 4, 11 1, 9, 10, 12  11 4 
Olfactory bulb    2     
RGCs  13     13  
Facial motor 
neurons   7*   5*, 7*   
 
Shaded squares indicate that integrin protein levels were detected in the somatodendritic compartment of 
neurons and they are labelled with the corresponding reference; white squares illustrate that protein expression 
was not tested or not detected. The asterisk (*) indicates that expression was observed only following axotomy. 
The integrins, α1, α2, α4, α6, α9, α10, α11, αD, αE, αL, αM, α2b, αX, β2, and β4–β7 are not included because 
they were not tested or there was no protein detected in the somatodendritic compartment. Dorsal root ganglia 
are pseudo-unipolar neurons and have therefore been excluded from this somatodendritic compartment analysis. 
1, Grooms et al. (1993); 2, Einheber et al. (1996); 3, Murase & Hiyashi (1996); 4, Nishimura et al. (1998); 5, 
Kloss et al. (1999); 6, Rodriguez et al. (2000); 7, Werner et al. (2000); 8, Bi et al. (2001); 9, Schuster et al. 
(2001); 10, Chan et al. (2003); 11, Kang et al. (2008); 12, Mortillo et al. (2012); 13, Vecino et al. (2015). RGCs, 
retinal ganglia cells. 
 
Table 3. Integrins localised in the axonal compartment of adult neurons. 
 
Shaded squares indicate that integrin protein levels were detected in the axon compartment of neurons and they 
are labelled with the corresponding reference; white squares illustrate that protein expression was not tested or 
not detected. The asterisk (*) indicates that expression was observed only following axotomy.  The integrins, α2, 
α8, α9, α10, α11, αD, αE, αL, αM, α2b, αX, and β2–β8 are not included because these were not tested or there 
was no protein detected in the axon.  Integrins were not detected or analysed in the axonal compartment of the 
hippocampus and olfactory bulb. We hypothesise that the presence of integrins in the axonal compartment of 
neurons corresponds with axonal regeneration capacity of the tissue. 1, Murase & Hiyashi (1996); 2, Yanagida et 
al. (1999); 3, Hernandez (2000); 4, Werner et al. (2000); 5, King et al. (2001); 6, Schuster et al. (2001); 7, 
Vogelezang et al. (2001); 8, Ekström et al. (2003); 9, Wallquist et al. (2004); 10, Vecino et al. (2015). DRGs, 
dorsal root ganglia; RGCs, retinal ganglia cells. 
 
Axon α1 α3 α4 α5 α6 α7 αV β1 
Cerebellum        1 
Cortex layer V    5     
DRGs   7 2 9 4*, 8, 9  2, 4*, 6, 8, 9 
RGCs 10 10  10   10 3, 10 
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(3) Correlation between integrin localisation and regeneration 
 The neurons that have been shown to regenerate most readily are also those in which 
integrins are localised within axons. It is therefore potentially interesting to link the 
subcellular localisation of integrins to the regenerative ability of the nervous system. As 
discussed above, DRGs express high levels of integrins in their axons and at least some RGC 
axons contain integrins (see Table 3). Furthermore, it is also known that these neurons have 
the capacity to regenerate successfully under certain conditions. Mature RGCs project axons 
through the optic nerve. These cells do not regenerate readily without intervention. However, 
many groups have demonstrated robust levels of axonal regeneration of RGCs following 
implantation of a peripheral nerve graft, generation of a lens injury, injection of zymosan (a 
pro-inflammatory compound), genetic ablation of PTEN or SOCS3, and other interventions 
(So & Aguayo,  1985; Leon et al.,  2000; Yin et al.,  2003; Monsul et al.,  2004; Park et al.,  
2008; P. D. Smith et al.,  2009b). Likewise, central projections of DRGs readily grow through 
crushed dorsal roots (Baer, Dawson, & Marshall,  1899), but are prohibited from growing into 
the spinal cord through the dorsal root entry zone without interventions including 
implantation of a peripheral nerve graft, a (pre-)conditioning lesion of the sciatic nerve, 
injection of dibutyryl cyclic AMP, or forced expression of α9 integrin among many others 
(David & Aguayo,  1981; Richardson & Issa,  1984; Neumann & Woolf,  1999; Qiu et al.,  
2002; Andrews et al.,  2009). We have mentioned above that integrins are localised within the 
somatodendritic compartments of many cells in the brain (see Table 2), but are barely 
detected in the axons of Purkinje cells or within the corticospinal tract that originates from 
layer V cortical neurons (see Table 3). At the same time adult motor tracts are largely 
resistant to long-distance regeneration in the mature CNS, presenting a major problem in 
promoting repair after spinal cord injury (reviewed in Case & Tessier-Lavigne,  2005). Taken 
together, these data suggest that there is a strong correlation between pathways that have or 
retain axonal localisation of integrins and those that have the ability (albeit with growth-
promoting enhancement) to regenerate over long distances. 
 
(4) Integrins in the somatodendritic compartment 
 Discussion on the diverse function of integrins in the somatodendritic compartment is 
beyond the scope of this review but a recent review can be found in Park & Goda,  2016. 
Furthermore, there is an extensive literature on the role of integrins in dendrites, spines and 
synapses, including participation in spine dynamics and plasticity (Rohrbough et al.,  2000; 
Shi & Ethell,  2006; McGeachie, Cingolani, & Goda,  2011; Babayan et al.,  2012; Levy, 
Omar, & Koleske,  2014; Heintz, Eva, & Fawcett,  2016).  
	27	
III. INTEGRINS AND AXONAL REGENERATION IN THE PERIPHERAL 
NERVOUS SYSTEM 
 Certain integrins are up-regulated after peripheral nerve injury (Kloss et al.,  1999; 
Werner et al.,  2000; Hammarberg et al.,  2000; Wallquist et al.,  2004; Gardiner et al.,  2005; 
Gonzalez Perez et al.,  2016) and can therefore be regarded as regeneration-associated genes 
(reviewed in Fagoe, van Heest, & Verhaagen,  2014b). After injury of the peripheral nerve, 
the composition of the ECM changes and collagen, fibronectin and laminin become major 
components of the basal lamina and the endoneurium of the peripheral nerve stump distal to 
the lesion (reviewed in Gonzalez Perez, Udina, & Navarro,  2013). Together, this creates an 
environment that stimulates cell adhesion and axonal regeneration (reviewed in Gardiner,  
2011; Jessen, Mirsky, & Arthur-Farraj,  2015). Here, we outline the important role of 
integrins in promoting axonal regeneration in the injured PNS. Knockout of several integrin 
subunits have inhibitory effects on peripheral nerve regeneration. It is unclear whether a 
single knockout will prevent regeneration in the PNS, due to the presence of many integrins in 
the axons recognizing several ligands.  
 
(1) Laminin-associated integrins 
 Laminins are secreted by Schwann cells and are a major component of the basal 
lamina (Wallquist et al.,  2002). They consist of α, β and γ chains that form 18 different 
isoforms (reviewed in Timpl & Brown,  1994; Aumailley et al.,  2005; Durbeej,  2010). Many 
in vitro studies have shown that laminin promotes adhesion, migration and regeneration of 
sensory axons and Schwann cells. The laminin-interacting integrins are α1β1, α2β1, α3β1, 
α6β1 and α7β1 with each bearing different affinities for the different isoforms of laminin 
(Table 4). The interaction of integrins and laminins was discovered in vitro by using 
function-blocking antibodies as well primary cultures generated from wild type or integrin-
knockout mice that were grown on various laminin isoforms. 
 The high diversity of laminin-associated integrins contributes to the ability of 
peripheral neurons to grow and regenerate on laminin-rich areas in vivo. The laminin-
associated integrins α6β1 and α7β1 are up-regulated in various peripheral nerve-injury models 
(Table 5). A causal relationship of laminin-associated integrins promoting regeneration was 
shown in mice that are deficient in α7, which exhibited reduced facial- (Werner et al.,  2000) 
and sciatic nerve- (Gardiner et al.,  2005) regeneration after axotomy. More specifically, 
depletion of α7 reduced axonal regeneration by 2 millimetres (35%) at 4 days after facial 
nerve crush and delayed the re-connection of the nerve with the whisker pad compared to 
wild-type mice (Werner et al.,  2000). Gardiner et al. (2005) found that fewer axons in α7-
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depleted mice regenerated beyond the injury site compared to controls 2 days post-sciatic 
nerve crush. Another study found that inhibiting α7 and β1 function (using function-blocking 
antibodies) impaired neurite outgrowth of cultured DRGs following a conditioning lesion in 
vivo (Ekström et al.,  2003; Gardiner et al.,  2005). Thus, loss of expression or function of 
laminin-associated integrins results in less-efficient regeneration of peripheral neurons. In 
addition, the expression of laminin-associated integrins seems to correlate with the 
regenerative state of neurons. For example, neurons with a poor regenerative capacity 
including DRGs after a dorsal root injury (Wallquist et al.,  2004), red nucleus neurons 
(Plantman et al.,  2005), pyramidal cells and septal neurons (Werner et al.,  2000) have 
unaltered integrin expression after axotomy.  
 
Table 4. Laminin-associated integrins with their laminin ligands. 
 
The laminin (LN) isoforms are shown according to current laminin nomenclature (Aumailley et al.,  2005). The 
isoforms LN-211 and LN-221 were assumed to be identical in the above studies and are therefore labelled LN-
211/221 
 
 
Integrin 
receptor 
Laminin 
isoform 
References 
α1β1 LN-111 
LN-211/221  
LN-511  
LN-521  
Condic,  2001; Desban et al.,  2006 
Colognato et al.,  1997 
Desban et al.,  2006 
Desban et al.,  2006 
α2β1 LN-111  
LN-211/221  
Colognato et al.,  1997 
Colognato et al.,  1997 
α3β1 LN-111 
LN-211/221  
LN-332  
LN-511  
LN-521  
Ivins et al.,  1998; Plantman et al.,  2008 
Tomaselli et al.,  1993; Plantman et al.,  2008 
Gout et al.,  2001; Mechai et al.,  2005; B. E. Smith et al.,  2009a 
Kikkawa, Sanzen, & Sekiguchi,  1998; Eble et al.,  1998 
Kikkawa et al.,  1998 
α6β1 LN-111  
LN-211/221  
LN-332  
LN-411  
LN-511  
Condic & Letourneau,  1997; Ivins et al.,  1998; Schöber et al.,  2000 
Delwel et al.,  1994 
Gout et al.,  2001 
Geberhiwot et al.,  1999; Plantman et al.,  2008 
Plantman et al.,  2008 
α7β1 LN-111  
LN-211/221  
Schöber et al.,  2000; Gardiner et al.,  2005; Plantman et al.,  2008 
Schöber et al.,  2000; Plantman et al.,  2008 
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Table 5. Summary of studies that assessed the expression of laminin-associated integrins after peripheral 
nerve 
 
Integrin  Injury model Main finding regarding integrin expression References 
α6β1 Ventral root 
avulsion 
 
Sciatic nerve 
transection 
 
Sciatic nerve 
transection 
 
Sciatic nerve 
crush 
Up-regulation of mRNA until 42 days after injury  
(2.5-fold increase at 7 days post-injury) 
 
Up-regulation of mRNA until 42 days after injury  
(2.5-fold increase at 7 days post-injury) 
 
Up-regulation of mRNA until 14 days after injury  
(3.0-fold increase at 3 days post-injury) 
 
Protein present in regenerating axons at 3 days after 
injury 
Hammarberg et al.,  
2000 
 
Hammarberg et al.,  
2000 
 
Wallquist et al.,  2004 
 
 
Wallquist et al.,  2004 
α7β1 Ventral root 
avulsion 
 
Facial nerve 
transection 
 
Sciatic nerve 
transection 
 
Sciatic nerve 
transection 
 
Sciatic nerve 
transection 
 
Sciatic nerve 
transection 
 
Sciatic nerve 
crush 
 
Sciatic nerve 
crush 
 
Up-regulation of mRNA until 42 days after injury  
(6.0-fold increase at 3 days post-injury) 
 
Upregulation of protein until 42 days after injury  
(6.0 fold increase at 7 days-post injury)  
 
Up-regulation of protein at 4 days after injury 
(quantification was not performed) 
 
Up-regulation of mRNA at least 42 days after injury  
(9-fold increase at 14 and 21 days post-injury) 
 
Up-regulation of mRNA until 14 days after injury  
(3.0-fold increase at 3 days post-injury) 
 
Up-regulation of mRNA at 2 days after injury  
(2.5-fold increase) 
 
Protein present in regenerating axons at 3 days after 
injury 
 
Up-regulation of protein for at least 14 days in 
medium- to large-diameter (NF200 positive) dorsal 
root ganglion neurons and to a lesser extent in 
smaller peptidergic neurons. No expression in 
smaller non-peptidergic neurons 
Hammarberg et al.,  
2000 
 
Werner et al.,  2000 
 
 
Werner et al.,  2000 
 
 
Hammarberg et al.,  
2000 
 
Wallquist et al.,  2004 
 
 
Gonzalez Perez et al.,  
2016 
 
Wallquist et al.,  2004 
 
 
Gardiner et al.,  2005 
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 (2) Fibronectin-associated integrins 
 Fibronectin is another important component of the ECM that stimulates the pro-
regenerative state of PNS neurons. Fibronectin is a large glycoprotein that consists of two 
subunits which form a dimer (reviewed in Singh, Carraher, & Schwarzbauer,  2010; 
Schwarzbauer & DeSimone,  2011). Fibronectin is secreted mainly by fibroblasts (Zhu et al.,  
2015) but also by astrocytes and Schwann cells (Baron-Van Evercooren et al.,  1986; Egan & 
Vijayan,  1991; Tom et al.,  2004a). Fibronectin is enriched in the injured PNS and 
contributes to an environment that is permissive for integrin-mediated adhesion and 
regeneration. Integrins bind to fibronectin via an Arg-Gly-Asp (RGD) domain, which is also 
found on other matrix molecules such as tenascin-C and some laminins.  
 Fibronectin-associated integrins in adult neurons include α4β1, α5β1, α8β1 and αV 
integrins. α4β1 binds to fibronectin, however its main role is as a thrombospondin and 
osteopontin receptor and as a VCAM receptor in inflammatory cells. α4β1 and α5β1 integrins 
are expressed at high levels in native DRG neurons and growth cones of regenerating neurons 
(Lefcort et al.,  1992; Mathews & ffrench-Constant,  1995; Yanagida et al.,  1999; 
Vogelezang et al.,  2001; Hu & Strittmatter,  2008; Saunders et al.,  2014). Several studies 
have shown that the expression of fibronectin-associated integrins is enhanced acutely after 
injury. α5β1 mRNA expression levels were shown to double in DRGs and spinal cord at 2 
days post-sciatic nerve transection (Gonzalez Perez et al.,  2016), but were found to remain 
unaltered 7 days post-sciatic nerve crush (Gardiner et al.,  2007). At longer time points after 
injury, a few studies suggest that there are changes in the localisation of integrins. For 
instance, the localisation of α5β1 was targeted towards the growth cones favouring neurite 
elongation of cultured preconditioned DRG neurons (Gardiner et al.,  2007). Consistently, 
α4β1 has been detected at the growth cones in vivo while expression levels were unaltered at 
4 days after a sciatic nerve injury (Vogelezang et al.,  2001). 	
 The pro-regenerative phenotype of fibronectin-associated integrins has been 
investigated in vitro. PC12 cells, that grow poorly on fibronectin, were shown to express α5β1 
at low levels and α4β1 not at all (Tomaselli, Damsky, & Reichardt,  1987; Vogelezang et al.,  
2001). However, cells engineered to express α4β1 showed a 2.5-fold increase in outgrowth on 
fibronectin compared to controls, indicating that α4β1 expression promotes neurite growth on 
fibronectin (Vogelezang et al.,  2001; 2007). The regenerating effects of α5β1 on a 
fibronectin substrate was first shown when it was overexpressed in vitro in adult DRGs that 
had a roughly threefold increase in neurite count and length on fibronectin compared to 
controls (Condic,  2001). Taken together, both α4β1 and α5β1 enhance neurite outgrowth on 
fibronectin in vitro. There are no reports on axonal regeneration experiments in transgenic 
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mice that lack α4 or α5 because these animals are not viable (Yang, Rayburn, & Hynes,  
1993; 1995).  
 
(3) Collagen-associated integrins 
 Collagen is another ECM molecule that is highly up-regulated after peripheral nerve 
injury and is synthesised by Schwann cells and fibroblasts (reviewed in Koopmans, Hasse, & 
Sinis,  2009). The high amount of collagen at the injury site could indicate an important role 
for axonal integrins that interact with collagen. The collagen-associated integrins expressed 
by neurons are α1β1 (Ivins, Yurchenco, & Lander,  2000; Vecino et al.,  2015), α2β1 
(Bradshaw et al.,  1995; Emsley et al.,  2000; Khalsa et al.,  2000), and αVβ8 (Venstrom & 
Reichardt,  1995; Nishimura et al.,  1998). α10β1 and α11β1, two other collagen-associated 
integrins, are not expressed in the nervous system. The neuronal collagen-associated integrins 
have been shown to contribute to neurite outgrowth on collagen in cell cultures (Bradshaw et 
al., 1995; Venstrom et al., 1995; Ivins et al., 2000; Vecino et al., 2015). However, to our 
knowledge, there are no reports on manipulation of collagen-associated integrins after injury 
in vivo. It would therefore be interesting to explore whether activation or overexpression of 
the collagen-associated integrins is beneficial for regeneration in the PNS.  
 In summary, peripheral nerve injury leads to an up-regulation of many ECM 
molecules including laminin, fibronectin and collagen. Neurons in the PNS express many of 
the integrins that respond to this post-injury ECM environment, which contributes to the 
spontaneous regeneration observed after peripheral nerve injury. Thus, studies in the PNS 
have shown that matching the ECM environment with the appropriate integrin expression 
pattern promotes axonal regeneration of mature neurons. It is therefore reasonable to try the 
same approach in the CNS and promote regeneration via integrin overexpression.  
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IV. INTEGRINS THAT BIND TO TENASCIN-C PROMOTE AXONAL 
REGENERATION IN THE CENTRAL NERVOUS SYSTEM 
 
(1) Tenascin-C-associated integrins 
Tenascin-C is a ligand for integrins (reviewed in Tucker & Chiquet-Ehrismann,  2015) 
and is predominantly expressed in the CNS during development. However, injury results in a 
steep up-regulation of this ECM glycoprotein by reactive astrocytes (reviewed in Silver & 
Miller,  2004; Gervasi, Kwok, & Fawcett,  2008; Wiese, Karus, & Faissner,  2012). Tenascin-
C is enriched within and surrounding the glial scar after spinal cord injury (Zhang et al.,  
1997; Tang, Davies, & Davies,  2003; Andrews et al.,  2009), and it is expressed at the dorsal 
root entry zone after a dorsal root injury (Andrews et al.,  2009; Cheah et al.,  2016). 
Tenascin-C is expressed not only by astrocytes but also by fibroblasts and spinal neurons 
among others (Zhang et al.,  1995a; 1997; Tang et al.,  2003; Zhang et al.,  2015). Thus, 
tenascin-C is enriched at the site of injury which regenerating axons have to penetrate in order 
to reconnect to their target tissue. Therefore, tenascin-C is a promising target to promote 
axonal regeneration after CNS trauma. 
The tenascin-C-associated integrins include α2β1 (Sriramarao, Mendler, & Bourdon,  
1993; Schaff et al.,  2011), α7β1 (Mercado et al.,  2004), α8β1 (Schnapp et al.,  1995; 
Varnum-Finney et al.,  1995; Denda, Reichardt, & Müller,  1998) and α9β1 (Yokosaki et al.,  
1994; 1998). They are expressed in developing neurons and most of them recognise the 
fibronectin type 3 repeat domain of tenascin-C through its RGD attachment site. α9β1 is an 
exception as it recognises a different sequence in this domain, AEIDGIEL (Yokosaki et al.,  
1998). Tenascin-C-associated integrins have been shown to be required for neurite outgrowth, 
as assessed in experiments with function-blocking antibodies in vitro (Varnum-Finney et al.,  
1995; Mercado et al.,  2004; Andrews et al.,  2009). Providing that neurons express an 
appropriate integrin, tenascin-C is a substrate that favours neurite outgrowth and axonal 
regeneration (Götz et al.,  1996; Rigato et al.,  2002; Chen et al.,  2009; Liu et al.,  2010; Yu 
et al.,  2011), but for neurons lacking the appropriate receptors tenascin-C is inhibitory 
(reviewed in Faissner,  1997). Adult CNS neurons do not express tenascin-C-binding 
integrins within their axons, even after injury (Pinkstaff et al.,  1999; Andrews et al.,  2009). 
Although glial cell types retain the ability to interact with tenascin-C, it is anti-adhesive to 
most adult neurons due to their lack of expression of tenascin-C-binding integrins (Zhang et 
al.,  1995b; Golding et al.,  1999). Thus, up-regulation of tenascin-C results in an anti-
adhesive and growth-inhibiting environment for neurons in the CNS. In the next section, we 
will discuss experiments that show that tenascin-C is only an axon-regeneration ligand in the 
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injured adult CNS when neurons are engineered to express an appropriate integrin, such as 
α9β1.  
 
(2) Viral vector-mediated delivery of α9 integrin in dorsal root ganglia promotes sensory 
axon regeneration in the central nervous system 
We hypothesized that low or absent integrin expression in CNS axons (see Table 3) 
contributes to the poor regenerative capacity of most CNS neurons. To achieve regeneration 
in the CNS, expression of tenascin-C-binding integrins in neurons might provide a promising 
tool to overcome the tenascin-C-rich injury site. Viral vector-mediated delivery of α9 into 
DRGs results in integrin localisation in the axon and could therefore induce integrin-mediated 
axonal regeneration (Andrews et al.,  2009; Cheah et al.,  2016; Andrews et al.,  2016). 
Indeed, exogenous expression of α9 allowed cultured adult DRGs to extend neurites on 
tenascin-C substrates in vitro, while neurite outgrowth was largely absent in controls 
(Andrews et al.,  2009). Furthermore, in vivo reintroduction of α9 in DRGs improved sensory 
axonal regeneration into tenascin-C-rich regions after a dorsal root injury or dorsal column 
crush lesion (Andrews et al.,  2009). However, regeneration was limited to the lesion site; 
there was no axonal growth extending beyond the lesion. Nevertheless, this was enough to 
result in limited sensory recovery (Andrews et al.,  2009). These results demonstrate that 
tenascin-C-associated integrins such as α9β1 are a viable target to promote axonal 
regeneration in the CNS. However, this approach should be combined with additional factors, 
such as integrin activators, to promote long-distance regeneration as well as functional 
recovery in vivo. Section V will demonstrate that integrins become inactivated by stimuli of 
the extracellular environment, and thus methods that target the activation of the receptor 
(discussed in Section VI) could enhance axonal regeneration (discussed in Section VI.c.iii).  
 
V. INTEGRINS BECOME INACTIVATED AT THE LESION SITE AFTER 
CENTRAL NERVOUS SYSTEM INJURY 
 Axon-repulsive molecules at the injury site, such as chondroitin sulphate 
proteoglycans (CSPGs) (reviewed in Kwok et al.,  2011), myelin-derived molecules 
(reviewed in Schweigreiter & Bandtlow,  2006; Alizadeh, Dyck, & Karimi-Abdolrezaee,  
2015; Boghdadi, Teo, & Bourne,  2017) and classical repulsive axon-guidance molecules 
(reviewed in de Wit & Verhaagen,  2003; Giger, Hollis, & Tuszynski,  2010; Hollis,  2015) 
have a broad range of functions. Here we highlight that most axon-repulsive molecules 
initiate inactivation of integrins (see Fig. 2).  
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Fig. 2. Molecular mechanisms of integrin inactivation after trauma in the nervous system. Integrins at the 
growth cones of regenerating axons are exposed to the extracellular environment of the lesion site. Integrins 
recruit focal adhesion kinases (FAKs) among others, which in turn, activate downstream signalling molecules 
such as protein kinase B (Akt3), phosphoinositide 3-kinase (PI3K), Ras homolog gene family member A 
(RhoA), and Src kinase. However, most integrins exist in a bent, inactive state at the cell surface. The lesion site 
is rich in axon-repulsive molecules, including Nogo-A, myelin-associated glycoprotein (MAG), class III 
semaphorins (Sema3s), and chondroitin sulphate proteoglycans (CSPGs). These molecules bind to several 
receptors, such as leukocyte common antigen-related phosphatase (LAR), Nogo receptors (NgR1, NgR2), the 
plexin/neuropilin (PLXN/NRP) complex and protein tyrosine phosphatase σ (PTPσ), to suppress integrin 
signalling and axon regeneration. Nogo-A binds to NgR1 and inhibits the phosphorylation of FAK. MAG is a 
direct ligand for integrins and stimulates integrin signalling. However, MAG also has an opposing effect by 
NgRs signalling that indirectly elevates intracellular calcium levels and stimulates clathrin-mediated endocytosis 
of integrins. Most Sema3s mediate signalling via the PLXN/NRP receptor complex that results in inactivation of 
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R-Ras, which in turn interferes with integrin signalling, and activates ADP-ribosylation factor 6 (ARF6) to 
remove integrins from the cell surface. Sema3A signalling results in the phosphorylation (Tyr397, Tyr576, 
Tyr577, Tyr925) and de-phosphorylation (Tyr407, Tyr861) of different residues of FAK for Sema3A-mediated 
axonal remodelling. CSPGs interact with many receptors, including LAR, NgR1 and PTPσ. The CSPG aggrecan 
has been shown to reduce FAK signalling, but the exact mechanisms remain to be identified. Other ligands such 
as ephrins, netrins and slits are also known to interfere with integrin signalling. In addition, there is evidence that 
integrin activation by kindlins and talins is inhibited by various regulatory mechanisms (illustrated as x).  
 
(1) Nogo-A  
 Nogo-A is a myelin-derived axon repulsive molecule that restricts axonal regeneration 
after CNS injury (Schnell & Schwab,  1990; Bregman et al.,  1995; Brösamle et al.,  2000; 
Kim et al.,  2003; Simonen et al.,  2003; Zheng et al.,  2003; Sicotte et al.,  2003; Dimou et 
al.,  2006; Cafferty & Strittmatter,  2006; Lee et al.,  2010b; J.-W. Wang et al.,  2015a). Nogo 
receptor 1 (NgR1) is a GPI-linked molecule, and was the first receptor identified for Nogo 
proteins (Fournier, GrandPre, & Strittmatter,  2001). NgR1 has been shown to transduce 
Nogo signalling across the plasma membrane by interacting with several other receptors such 
as Lingo-1, p75, and Troy (Wang et al.,  2002; Mi et al.,  2004; Park et al.,  2005; Shao et al.,  
2005). Interestingly, Nogo-A has been shown to suppress integrin signalling through integrin 
inactivation in vitro (Hu & Strittmatter,  2008; Tan et al.,  2011) and in vivo (Huo et al.,  
2015). Specifically, it has been shown in cell lines that Nogo-A interferes with the function of 
fibronectin-associated integrins α4β1, α5β1 and αVβ3, but not laminin-associated integrin 
α6β1 (Hu & Strittmatter,  2008). Nogo-A’s attenuation of DRGs neurite outgrowth in vitro 
has been consistently greater on fibronectin than on laminin (Hu & Strittmatter,  2008). 
Further, it has been shown in vivo after an optic nerve crush that Nogo-A down-regulates the 
expression of αV integrins and thereby reduces integrin signalling, in this case the 
phosphorylation of FAK (Huo et al.,  2015). The same study showed that the expression of 
another fibronectin-associated integrin, α5, was unaltered by Nogo-A in the injured optic 
nerve suggesting that Nogo-A has varied effects on different fibronectin-associated integrins, 
perhaps dependent on the function of the integrin. Taken together, both studies suggest that 
Nogo-A inhibits specific integrin signalling by inactivation and internalisation (Hu & 
Strittmatter,  2008; Huo et al.,  2015). However, the mechanisms that dictate the interaction 
between Nogo proteins and integrins require further investigation.  
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(2) Myelin-associated-glycoprotein 
 Myelin-associated-glycoprotein (MAG) is another myelin-derived axon-repulsive 
molecule (Mukhopadhyay et al.,  1994; McKerracher et al.,  1994; Schäfer et al.,  1996). 
MAG binds to NgR1 (Domeniconi et al.,  2002; Wang et al.,  2002; Liu et al.,  2002; Laurén 
et al.,  2007) and NgR2 (Venkatesh et al.,  2005) and many other neuronal receptors (Wong et 
al.,  2002; Atwal et al.,  2008; Stiles et al.,  2013). It has been known for more than two 
decades that MAG antagonises integrin signalling and function (Bachmann et al.,  1995). 
More recently, the underlying mechanism became clearer when it was shown that MAG is 
axon repulsive in cultured postnatal hippocampal neurons and cerebellar granule cells by 
modulating integrin-signalling independently of NgRs (Goh et al.,  2008). This study found 
that β1 integrin is a direct receptor of MAG and led to increased phosphorylation of FAK. 
This result is unexpected since FAK signalling is associated with axonal growth. It may 
therefore be that the signalling is only locally affected and shifts to sites of axon attraction at 
the growth cone, where new integrin adhesion complexes form to initiate axon guidance. This 
asymmetrical signalling hypothesis is supported by a study that showed that a local MAG 
gradient removed integrins at the site of the MAG source only, while untreated neurons had a 
symmetric distribution of integrins at the growth cone (Hines, Abu-Rub, & Henley,  2010). 
MAG signalling has also been shown to initiate changes in intracellular Ca2+, thereby 
inducing clathrin-mediated endocytosis of integrins from the growth cones of Xenopus laevis 
spinal neurons (Hines et al.,  2010). Taken together, MAG mediates its axon-repulsive effects 
by modulating integrin signalling, partly through direct interaction and partly through another 
signalling complex most likely including NgRs that cause Ca2+-dependent internalisation of 
integrins.  
 
(3) Aggrecan 
 Aggrecan is one of the CSPGs produced by neurons and astrocytes, and it is present in 
the scar tissue that restricts axonal regeneration (Lemons et al.,  2003; reviewed in Silver & 
Miller,  2004). Not surprisingly, adult DRG neurons have restricted neurite outgrowth when 
cultured on substrates that contain the glycan chains of CSPGs (Tom et al.,  2004b; Steinmetz 
et al.,  2005). Aggrecan has been shown to cause a temporary but rapid decrease in integrin-
mediated phosphorylation of FAK, and a long-term decrease of Src phosphorylation which is 
downstream of FAK, leading to inhibition of DRG neurite outgrowth (Tan et al.,  2011). The 
molecular mechanism of how aggrecan inhibits integrin signalling is currently unknown. 
However, it is known that aggrecan does not affect the number of integrin receptors at the 
plasma membrane (Tan et al.,  2011). Thus, it interferes with integrin signalling independent 
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of receptor endocytosis. It may interfere indirectly with integrin signalling via activation of 
CSPG receptors such as protein tyrosine phosphatase σ (PTPσ) (Shen et al.,  2009; Fry et al.,  
2010), leukocyte common antigen-related phosphatase (LAR) (Fisher et al.,  2011; Xu et al.,  
2015) or the Nogo receptors NgR1 and NgR3 (Dickendesher et al.,  2012).  
 
(4) Class III semaphorins 
 Class III semaphorins (Sema3s) are classical axon-guidance molecules that are mainly 
produced by migrating fibroblasts, pericytes and vascular cells in the core of the scar 
(Pasterkamp, Giger, & Verhaagen,  1998; Pasterkamp et al.,  1999; de Winter et al.,  2002; 
Tannemaat et al.,  2007; Mire et al.,  2008; Minor et al.,  2011). It has been shown that 
Sema3s restrict axonal regeneration after spinal cord injury (Kaneko et al.,  2006; Mire et al.,  
2008; Lee et al.,  2010a; Minor et al.,  2011; reviewed in Mecollari, Nieuwenhuis, & 
Verhaagen,  2014). Most Sema3s interact with neuropilins (NRPs), while signal transduction 
is mediated via the plexin (PLXN) co-receptor (reviewed in Sharma, Verhaagen, & Harvey,  
2012). The pleiotropic NRPs have also been shown to interact with integrins (Fukasawa, 
Matsushita, & Korc,  2007; Valdembri et al.,  2009) which could suggest that Sema3s affect 
integrin signalling via NRPs. Nonetheless, it has been shown that PLXN signalling leads to 
rapid disassembly of integrin adhesion at the cell surface and causes actin depolymerisation in 
various non-neuronal cell lines (Barberis et al.,  2004). It has been observed in cultured 
cortical- and hippocampal neurons that Sema3A-induced collapse of growth cones requires 
FAK signalling downstream of integrins (Bechara et al.,  2008; Chacón, Fernández, & Rico,  
2010). More specifically, Sema3A resulted in the phosphorylation (Tyr397, Tyr576, Tyr577, 
Tyr925) and de-phosphorylation (Tyr407, Tyr861) of different residues of FAK, confirming 
the central signalling role of this kinase, and this may result in the activation and inhibition of 
several signalling pathways to induce growth-cone collapse (Chacón et al.,  2010). The 
strongest evidence that Sema3s regulate the activation of integrins originates from studies of 
angiogenesis. Sema3s, except for Sema3C, inhibit integrin signalling in blood vessels (Table 
6). Sakurai et al.,  2010 highlighted two mechanisms by which Sema3E signalling via PLXN 
reduces the function of integrins in endothelial cells: (1) activation of endosomes that contain 
ADP-ribosylation factor 6 (ARF6) removes integrins from the cell surface; and (2) 
inactivation of R-Ras GTPases, which normally activate integrins (Zhang et al.,  1996; Keely 
et al.,  1999; Wang et al.,  2000; Ivins et al.,  2000; Self et al.,  2001) via the phosphoinositide 
3-kinase (PI3K) signalling pathway (Berrier et al.,  2000; Oinuma et al.,  2010). Sema3s 
could exert the same and other integrin-mediated mechanisms in neurons resulting in axon 
repulsion after CNS injuries. 
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 Table 6. Summary of studies in the field of angiogenesis that show that class III semaphorins (Sema3s) 
modulate integrins.  
 
 ARF6, ADP-ribosylation factor 6; FAK, focal adhesion kinase; NRP, neuropilin; PLXN, plexin; R-Ras, Ras-
related protein R-Ras. 
 Taken together, a variety of molecules in the scar and lesion milieu have the ability to 
regulate integrin function (Fig. 2). These molecules affect integrin binding to their ECM 
ligands and thereby subsequent downstream signalling as well as integrin levels at the cell 
surface by endocytosis. Integrins are not the only receptors and ligands affecting growth and 
regeneration. There are other signalling cascades that feed positively or negatively into 
integrin downstream signalling. For instance, molecules such as Akt, RhoA and PI3K are 
regulated by many receptors. Finally, another level of control is the pathways that influence 
integrin activation through kindlins and talin. Studying integrin inhibition has revealed 
integrin-specific and general mechanisms whereby axonal regeneration fails in adult CNS 
neurons. Inactivation of integrins in the injured spinal cord also explains the modest axonal 
regeneration that was observed after forced expression of α9 in vivo (Andrews et al.,  2009). 
Expression of an appropriate integrin and overcoming integrin inactivation could therefore be 
a general approach to promote axonal regeneration in the CNS.  
 
 
 
 
 
 
 
 
 
 
Sema3s Main finding regarding integrins after Sema3 overexpression References 
Sema3A 
 
Inhibiting the signalling of αIIbβ3 in vitro 
Inhibiting the activation of β1 via NRP1/PLXN in vivo 
Kashiwagi et al.,  2005 
Serini et al.,  2003 
Sema3C Phosphorylation of β1, but not FAK, via NRP/PLXN in vitro Banu et al.,  2006 
Sema3E Inhibiting the activation of integrins by inactivation of R-Ras in vitro 
Endocytosis of integrins by activation of ARF6-postive vesicles in vitro 
Sakurai et al.,  2010 
Sema3F Inhibiting the activation of β1 via NRP1/PLXN in vivo Serini et al.,  2003 
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VI. INTEGRIN ACTIVATORS PROMOTE SENSORY AXONAL REGENERATION 
IN THE SPINAL CORD 
 Integrins need to be in their active state to interact with components of the ECM and 
thereby induce an increase in neurite outgrowth and axonal regeneration. Once activated they 
stimulate FAK and other downstream signalling molecules that are essential for growth cone 
dynamics and axonal guidance (Robles & Gomez,  2006; reviewed in Mitra, Hanson, & 
Schlaepfer,  2005). Here we discuss the best-characterised integrin activators with regard to 
axonal regeneration (see Fig. 3).  
 
(1) Manganese 
 Manganese (Mn2+) is widely used in in vitro experiments to enhance the ligand-
binding affinity of integrins to the ECM. Divalent cations such as Ca2+ and Mn2+ interact with 
metal-ion binding sites of the α integrin subunit and facilitate integrin signalling (Mould, 
Akiyama, & Humphries,  1995; Oxvig & Springer,  1998). This ‘outside-in’ activation of 
integrins by Mn2+ has been shown to increase neurite outgrowth in various neuronal cell 
culture assays (Ivins et al.,  2000; Lein et al.,  2000; Lemons & Condic,  2006; Tan et al.,  
2011). Importantly, activation of integrins has been shown to reverse the growth-inhibitory 
effects of Nogo-A and aggrecan in cultured DRG neurons (Tan et al.,  2011). Recently, Mn2+ 
has also been shown to abolish ephrinA3-mediated collapse of proximal dendritic spines in 
Purkinje cells via integrin activation in vitro (Heintz et al.,  2016). Thus, it is possible to 
reverse integrin inactivation with Mn2+ treatment in vitro. However, Mn2+ is not suitable for in 
vivo studies because excess and long-term exposure to Mn2+ causes neuronal toxicity 
(reviewed in Guilarte,  2013). 
 
(2) Integrin-activating antibodies 
 Another classic approach to activate integrins is using antibodies that bind selectively 
to the ligand-binding region of activated β1 integrin, which can be used both for detecting 
activated integrins and for maintaining them in the activated state (Takada & Puzon,  1993; 
Takagi et al.,  1997); these antibodies are mostly effective on human integrins. The anti-β1-
activating monoclonal antibody TS2/16 interacts with all human integrin heterodimers that 
contain β1 and less strongly with rodent β1, regardless of the α subunit (Tsuchida et al.,  
1997). Due to the wide spectrum of integrins that can be targeted, the antibody TS2/16 is 
particularly interesting and has been used in outgrowth assays. For example, TS2/16-mediated 
activation of integrins has been shown to reverse the inhibitory effects of Nogo-A on a human 
T-lymphocyte cell line grown on fibronectin (Hu & Strittmatter,  2008) as well as to inhibit 
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the effects of aggrecan on axon growth of motor neurons that were derived from human 
embryonic stem cells (Tan et al.,  2011). Thus, the TS2/16 antibody reverses axon-repulsive 
effects of molecules such as Nogo-A and aggrecan. However, a limitation of applying integrin 
antibodies is that these need frequent or continuous delivery in vivo. In addition, masking of 
epitopes due to integrin interactions with ECM ligands can reduce the efficiency of integrin-
binding antibodies (Mould et al.,  2016).  
 
(3) Intracellular proteins 
 The kindlins and talins are two families of intracellular proteins that bind to the 
cytoplasmic tail of β integrins and activate the heterodimeric receptor. Integrin activation is 
ubiquitous throughout the body, but the exact mechanism of the ‘inside-out’ activation by 
kindlin and talin is subject to intense debate (reviewed in Moser et al.,  2009b; Shattil, Kim, 
& Ginsberg,  2010; Campbell & Humphries,  2011; Calderwood et al.,  2013; Eva & Fawcett,  
2014). Despite the limited number of studies investigating the role of these molecules in the 
nervous system, they have been utilised to enhance integrin-ligand binding and axonal 
outgrowth of neurons (Tan et al.,  2012; 2015; Dingyu et al.,  2015; Cheah et al.,  2016) as 
discussed below.  
 
(a) Talins 
 Talin isoforms 1 and 2 are expressed in the nervous system (Monkley, Pritchard, & 
Critchley,  2001; Senetar, Moncman, & McCann,  2007; Debrand et al.,  2009; Tan et al.,  
2015). In nerve growth factor-stimulated PC12 cells, overexpression of the full-length and 
constitutively activated isoforms of talin has been shown to promote neurite outgrowth in the 
presence of the repulsive extracellular matrix protein aggrecan (Tan et al.,  2015). Dingyu et 
al. (2015) examined the structural tensions of the cytoskeleton in this cell line by fluorescence 
resonance energy transfer (FRET) imaging and application of genetically encoded optical 
force probes. They found that CSPGs including aggrecan reduce intracellular structural forces 
and that overexpression of full-length talin rescued these tensions. In addition, talin decreased 
the phosphorylation of ROCK1 and increased the activation of ERK and FAK proteins 
(Dingyu et al.,  2015). Based on these results in vitro, full-length talin could be a valuable 
activator of integrins to reverse the effects of the axon-repulsive molecules that are present in 
the injured spinal cord. However, the large size of the full-length protein presents a challenge 
for talin expression in neurons. In studies using primary cultures of DRG neurons, only the 
talin head domain has been overexpressed (Tan et al.,  2015). The talin-head domain is 
required to interact with the cytoplasmic tail of the β integrin subunit and to activate the 
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heterodimeric receptor (García-Alvarez et al.,  2003; Tadokoro et al.,  2003; Wegener et al.,  
2007). However, the talin head domain alone acted as a dominant negative for endogenous 
talin, and DRG neurite outgrowth on laminin and on aggrecan-laminin substrates was reduced 
(Tan et al.,  2015). Based on these results, the talin head domain alone is not suitable to 
promote integrin signalling. The limited effect of the talin head is possibly due to the 
endogenous expression of full-length talins in neurons or because the rod domain is required 
to link integrins directly with the cytoskeleton. Another disadvantage of talin-targeted 
experiments and therapeutics is the fact that full-length talins are so large that they are not 
suitable for an adeno-associated viral vector (AAV)-based gene-delivery approach. The 
coding sequence for talin is roughly 7500 base pairs, which exceeds the AAV packaging limit 
of approximately 4700 base pairs. Taken together, talin overexpression would be a promising 
target to enhance axonal regeneration since it enables integrin signalling directly to the 
cytoskeleton but is not feasible with the AAV technologies currently available. Talin itself is 
subject to several regulatory influences, which in turn affect integrin activation and function 
(reviewed in Ye et al.,  2014). 
 
(b) Kindlins 
 There are three isoforms of kindlin: kindlin-1, kindlin-2 and kindlin-3. Localisation of 
the kindlin isoforms in the nervous system is described here. Kindlin-1 is not expressed by 
cells of the nervous system (Ussar et al.,  2006; Tan et al.,  2012), but is primarily found in 
epithelial cells (Lai-Cheong et al.,  2008; Ussar et al.,  2008). Kindlin-2 is ubiquitously 
expressed throughout the body (Ussar et al.,  2006) and in situ hybridisation and RT-PCR 
studies on whole-brain lysate demonstrated that kindlin-2 mRNA is present in the brain, while 
kindlin-1 and kindlin-3 were not detected (Ussar et al.,  2006; Tan et al.,  2012). 
Immunochemistry on cultured cells confirmed that this isoform is expressed by neurons 
including DRGs, RGCs, and hippocampal and Purkinje neurons (Tan et al.,  2012). In these 
cultures, kindlin-2 was also found in non-neuronal cells like astrocytes, fibroblasts and 
Schwann cells (Tan et al.,  2012). The latter study demonstrated by short hairpin RNA 
knockdown that kindlin-2 is required for integrin signalling and axonal growth of neurons. 
Thus, kindlin-2 is the only isoform endogenously expressed in neurons and plays a role in 
normal axonal growth. Kindlin-3 is predominantly expressed by cells of the immune system 
(Malinin et al.,  2009; Moser et al.,  2009a; Feigelson et al.,  2011; Cohen et al.,  2013; 
Moretti et al.,  2013) and recently has been discovered in microglia of the brain (Meller et al.,  
2017). 
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 Kindlin-1 has been used in vivo to promote integrin activation and sensory axonal 
regeneration in rats. Forced expression of kindlin-1 (but not the overexpression of the 
endogenously present kindlin-2) enhanced the signalling of the integrins that are expressed by 
DRG neurons. Importantly, kindlin-1 promoted neurite outgrowth on the axon-repulsive 
substrates aggrecan and Nogo-A (Tan et al.,  2012). Furthermore, kindlin-1 counteracted the 
inhibiting effects of aggrecan on neurite outgrowth of α9 integrin-transfected DRG neurons in 
vitro (Cheah et al.,  2016). In accordance with the enhanced outgrowth, the decreased 
phosphorylation of FAK induced by repulsive substrates was reversed by kindlin-1 (Tan et 
al.,  2012; Cheah et al.,  2016). Thus, kindlin-1 overcomes aggrecan- and Nogo-A-mediated 
inhibition of integrin signalling and restores DRG neurite outgrowth in vitro. Furthermore, 
after a dorsal root crush injury in vivo, forced expression of kindlin-1 in the DRG enhanced 
sensory axonal regeneration. In this study, kindlin-1 treatment using viral vectors resulted in a 
fairly large number of axons extending towards the spinal cord, while the regenerating axons 
of the control animals did not pass the axon-repulsive dorsal root entry-zone boundary. 
Consistent with the improved sensory axonal regeneration, kindlin-1 treatment also improved 
recovery of thermal sensation after injury (Tan et al.,  2012). Thus, kindlin-1 activates 
integrins that are expressed by DRG neurons and overcomes the inactivation of the axon-
repulsive environment to promote sensory axonal regeneration. In other words, kindlin-1 
overexpression renders integrins less vulnerable to integrin inactivation and thereby 
restriction of axonal regeneration. Kindlins are subject to regulation by other pathways, 
although at present this is not well understood (reviewed in Rognoni et al.,  2016). 
  
(c) Kindlin-1 and α9 integrin overexpression 
 Integrin-mediated regeneration is most successful when the appropriate integrin is 
both present and activated. Thus, co-overexpression of kindlin-1 and α9 integrin forms a 
strong stimulus for axonal regeneration in tenascin-C-rich areas such as the dorsal root entry 
zone and spinal cord after a dorsal root crush (Cheah et al.,  2016). Viral vector-mediated 
delivery of both molecules to DRGs indeed resulted in a synergistic effect on sensory axonal 
regeneration. The α9- and kindlin-1-overexpressing axons that reached the spinal cord 
regenerated from the cervical dorsal root at levels C8 to C5 all the way up into the medulla 
(Cheah et al.,  2016). Mechanical pressure and thermal sensation in the paw as well as limb 
proprioception improved after injury in animals that had combined α9 and kindlin-1 
overexpression. Furthermore, electrophysiological recordings demonstrated that sensory 
pathways from the paw to the dorsal horn of the spinal cord had regrown following injury and 
α9/kindlin-1 overexpression. Thus, the combination of α9 and kindlin-1 leads to robust axonal 
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regeneration of at least 25 mm and partial functional recovery after a dorsal root crush. 
Furthermore, these results demonstrate that there is a synergistic effect exceeding that of 
overexpression of α9 (Andrews et al.,  2009) or kindlin-1 (Tan et al.,  2012) alone. 
Surprisingly, no severe degree of axonal misguidance occurred in this study, with 
regenerating axons being found mainly in the dorsal column and terminations in the dorsal 
horn being predominantly in the correct laminae. These results suggest that when activated 
integrins encounter an appropriate ECM environment, the remaining structures in the CNS 
can exert guidance effects on the α9/kindlin-1-overexpressing sensory neurons.  
 Taken together, there are various approaches to activate integrins, each with a unique 
mechanism to promote integrin signalling (Fig. 3). We have reviewed the evidence that 
stimulation of integrin signalling in injured neurons is a powerful strategy to boost sensory 
axon regeneration following CNS injury because it can overcome the repulsive molecules that 
prevent axonal regeneration in the injured spinal cord. To date, the synergistic effects of 
kindlin-1 and α9 delivery achieved the longest regeneration observed in the dorsal column 
pathway by modulating integrin signalling in vivo (Cheah et al.,  2016). Identifying the 
integrin adhesome is an active field of research and novel integrin activators are therefore 
continuously being discovered, such as reelin (Lin et al.,  2016), sema7A (Pasterkamp et al.,  
2003), shank (Lilja et al.,  2017) and vimentin (Kim et al.,  2016). The identification of new 
integrin-activating molecules also offers opportunities for future regeneration research.  
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Fig. 3. - previous page - Molecular mechanisms for integrin activation. Integrins exist in two activation 
states on the cell surface: a bent inactive and a straight active state. There are several ways to activate integrins: 
(i) cations such as Ca2+ and Mn2+ interact with a metal ion-binding site at the ectodomain of the integrin to 
activate the receptor; (ii) kindlins and talins are two families of intracellular proteins that bind to the cytoplasmic 
tail of β1 integrins to activate the heterodimeric complex; (iii) the monoclonal antibody TS2/16 binds to the 
ectodomain of human β1 integrins to induce a conformational change and receptor activation. Activated 
integrins have their ectodomain exposed and bind extracellular matrix ligands, which leads to intracellular 
signalling and changes of the cytoskeleton. Activation of certain integrins can result in cell adhesion and axonal 
regeneration. FAK, focal adhesion kinase; ILK, integrin-linked kinase; PI3K, phosphoinositide 3-kinase.  
 
VII. DEVELOPMENTAL CHANGES IN NEURONAL INTEGRIN LOCALISATION 
 
(1) Exclusion of integrins from the axon of certain adult central nervous system neurons 
 Integrins are expressed in developing neurons and have essential roles in the formation 
of a functional nervous system. They are important for migration (Tate et al.,  2004; 
Andressen et al.,  2005; Marchetti et al.,  2010), proliferation (Blaess et al.,  2004; Leone et 
al.,  2005), adhesion (Tate et al.,  2004), differentiation (Tate et al.,  2004; Andressen et al.,  
2005), axon outgrowth (Sakaguchi & Radke,  1996; Harper et al.,  2010), axon guidance 
(Huang et al.,  2006; Myers et al.,  2011) and lamination (Georges-Labouesse et al.,  1998; 
Marchetti et al.,  2010) of neuronal precursor cells of the nervous system. However, during 
maturation of CNS neurons selective transport mechanisms are set up that send some 
molecules to dendrites and others to axons (reviewed in Lasiecka & Winckler,  2011; Britt et 
al.,  2016; Bentley & Banker,  2016). This selective polarised transport is essential for giving 
axons a set of molecules and properties appropriate for their function. As part of this general 
acquisition of polarity, integrins become excluded from CNS axons (Bi et al.,  2001; Franssen 
et al.,  2015). The overall result of these polarity changes is that mature neurons are not able 
to regenerate, probably due to the absence of various receptors including integrins in their 
axons. 
The distribution of integrins in axons during maturation has been intensively studied, 
since any treatment involving integrin expression aiming at promoting axon regeneration 
requires the expressed integrins to reach the axonal compartment and growth cone. By 
examining localisation of tagged integrins (α6, α9, and β1) in vivo in mature and immature 
sensory, retinal, cortical and red nucleus neurons, a differential ability for integrins to localise 
within axons became apparent (Andrews et al.,  2016). Integrins were transported into the 
still-developing early postnatal axons of the corticospinal tract, but the investigated α6, α9 
and β1 integrins were excluded from mature corticospinal tract and rubrospinal tract axons. 
High levels of integrins were found in both branches of adult DRG axons and in some RGC 
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axons (Andrews et al.,  2016). It is tempting to correlate this transport with the ability of 
immature and sensory axons to successfully sprout and regrow following damage (Bregman 
& Bernsteingoral,  1991; Bates & Stelzner,  1993). In addition and as reviewed earlier, 
overexpression of α9 integrin in the DRGs indeed stimulated axonal regeneration (Andrews et 
al.,  2009; Cheah et al.,  2016). Integrin-driven regeneration in the spinal cord and elsewhere 
will require an intervention to ensure that the molecules are transported into the axons. 
However, it is not just integrins that are excluded from axons, but many growth-related 
molecules, as described below (Section VIII).  
 
(2) Developmental changes in the integrin transport machinery  
 The exclusion of integrins from the axons of many adult CNS neurons, such as the 
corticospinal tract, is mediated by the development of selective transport mechanisms that are 
responsible for neuronal polarity (Fig. 4). Studying integrins provides a good tool to study 
these mechanisms. Integrin trafficking is well studied in cancer cells, where it was found to be 
transported in recycling endosomes, which are regulated by small GTPases (Powelka et al.,  
2004). In neurons axonal integrins are mostly transported in Rab11- (Caswell et al.,  2008; 
Eva et al.,  2010) and ARF6- (Powelka et al.,  2004; Eva et al.,  2012) positive recycling 
endosomes. These GTPases control endosomal targeting and are turned on by GTP exchange 
factors (GEFs) and turned off by GTP activating proteins (GAPs). Rab11 and ARF6 are 
responsible for transporting integrins into axons probably as part of a complex with 
scaffolding molecules, such as the JNK-interacting protein 3 (JIP3) and JIP4 and kinesin- and 
dynein-motors (Isabet et al.,  2009; Suzuki et al.,  2010; Montagnac et al.,  2011). In 
immature neurons there exists anterograde integrin transport, but with maturation there is 
gradually less anterograde and more retrograde integrin transport in the axon, leading to the 
exclusion of integrins. In cultured cortical neurons from embryonic day 18 rat pups, 
expression levels of α5, αV and β1 integrins started to decrease after 7 days in culture and 
were undetectable in the axon after 14 days (Franssen et al.,  2015). This exclusion of 
integrins from the axon coincides with the formation of the axon initial segment (AIS) (Song 
et al.,  2009), which plays a part in the exclusion of integrins since disruption of the AIS 
increased the amount of integrin within mature axons (Franssen et al.,  2015). The AIS 
exhibits a dense network of proteins including actin, which can restrict access of molecules to 
axons by acting as a size filter or by supporting retrograde myosin-driven transport (Song et 
al.,  2009; Lewis et al.,  2009; Arnold,  2009). There is also a role for actin and modifications 
of the microtubule cytoskeleton in regulating integrin transport (Franssen et al.,  2015). 
However, the main mechanism for exclusion is the gradual change of the transport direction 
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during maturation and the establishment of the AIS. The direction of transport is defined by 
the activation state of ARF6. ARF6 can be inactivated by its GAP ACAP1 and in its inactive 
state favours anterograde transport (Jackson et al.,  2000; Dai et al.,  2004). In turn, active 
ARF6 favours retrograde transport (Eva et al.,  2012). Activators of ARF6 are GEFs; two 
known ARF6 GEFs are ARNO and EFA6 (Sakagami et al.,  2006). Importantly, it has been 
found that during cortical neuronal maturation ARNO and EFA6 are strongly up-regulated 
(Sakagami et al.,  2006) and EFA6 localises to the AIS (Eva et al.,  2017). Both, ARNO and 
EFA6 are important for the exclusion of integrins from axons (Franssen et al.,  2015; Eva et 
al.,  2017). Interestingly, it has also been found that Rab11 was largely excluded from mature 
axons, being present at low levels in axons compared to dendrites in primary cortical neurons 
grown in culture for more than 14 days (Franssen et al.,  2015; Koseki et al.,  2017). 
Overexpression of Rab11 in these neurons permitted integrin transport into the axon and 
promoted regeneration after laser-induced axotomy in vitro (Koseki et al.,  2017).  
 In summary, a developmental switch in the transport of essential growth molecules, 
such as integrins, results in the exclusion of these molecules from mature CNS axons, likely 
rendering them unable to regenerate after injury. Interfering with this developmental switch 
will result in the presence of integrins and other excluded molecules in the axon (Franssen et 
al.,  2015; Koseki et al.,  2017). Based on our observations in vitro, we further hypothesise 
that interfering with this developmental transport switch will lead to increased regeneration 
after injury.  
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Fig. 4. Comparison of immature and mature central nervous system neurons. (A) Immature neurons do not 
have a fully developed axon initial segment and their axons have been shown to transport integrins both antero- 
and retrograde to an equal extent. Vesicles bound to ADP-ribosylation factor 6 (ARF6)- and Ras-associated 
binding (Rab) protein 11 (Rab11)-GTP are retrograde transported, while vesicles bound to ARF6- and Rab11-
GDP move in the anterograde direction. (B) Mature neurons have developed an axon initial segment and are 
characterised with predominant retrograde axonal transport of integrins.  
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VIII. THE LOCALIZATION OF OTHER REGENERATION-ASSOCIATED 
RECEPTORS 
 Cell surface receptors are promising targets to promote axonal regeneration (reviewed 
in Cheah & Andrews,  2016). Rab11-positive recycling endosomes contain integrins, but also 
regulate the transport of other regeneration-associated receptors including tropomyosin 
receptor kinase receptors (Trks) (Ascaño et al.,  2009; Lazo et al.,  2013) and insulin-like 
growth factor receptors (IGFRs) (Romanelli et al.,  2007). The observation that Rab11 
vesicles are excluded from the axon in vitro (Franssen et al.,  2015; Koseki et al.,  2017) is 
consistent with an in vivo study that observed a somatodendritic distribution of Rab11 in the 
forebrain, cerebellum, thalamus and brainstem (Sheehan et al.,  1996). Here, we discuss that 
TrkB and insulin-like growth factor 1 receptor (IGF-1R) are also excluded from axons of the 
adult corticospinal tract and the implications of this for regeneration.   
 
(1) Tropomyosin receptor kinase B 
 TrkB is a cell-surface receptor that can boost the regenerative response of injured 
neurons. It binds several neurotrophic factors including brain-derived neurotrophic factor 
(BDNF), neurotrophin-3, and neurotrophin-4. These neurotrophic factors promote neuronal 
survival and axonal growth and are involved in synaptic plasticity (reviewed in Minichiello,  
2009; Park & Poo,  2013; Harrington & Ginty,  2013). Due to the important role of these 
factors, it may not be surprising that there is a widespread distribution of TrkB in the adult 
brain (Yan et al.,  1997). Interestingly, adult corticospinal neurons express TrkB in their cell 
bodies and dendrites, but not in the axon (Yan et al.,  1997; Lu, Blesch, & Tuszynski,  2001). 
Furthermore, TrkB and its other family members, TrkA and TrkC, are not up-regulated after 
spinal cord contusion (Liebl et al.,  2001). Consistent with the absence of TrkB in the 
corticospinal tract, BDNF-secreting cell grafts in a spinal cord lesion site did not promote 
axonal regeneration of this motor pathway (Lu et al.,  2001). Viral vector-mediated 
overexpression of TrkB has been shown to result in receptor trafficking into the axon at the 
level of the subcortical white matter but not further down into the spinal cord (Hollis et al.,  
2009b). These neurons were able to regenerate into BDNF-secreting cell grafts that were 
placed into subcortical lesions (Hollis et al.,  2009b). However, as elaborated above for 
integrin receptors, additional interventions would be required to enhance the transport of 
TrkB into the corticospinal tract to promote substantial regeneration after spinal cord injury. 
In addition, it had been shown in hippocampal slice cultures that the activation state of TrkB 
correlates with axonal sprouting (Aungst, England, & Thompson,  2013). The activation state 
of Trk receptors may therefore influence the regeneration response as well. Taken together, 
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the absence of TrkB in corticospinal tract axons likely contributes to the restricted axonal 
regeneration and responsiveness to BDNF treatments after spinal cord injury.  
 
(2) Insulin-like growth factor receptor 
 IGFR is the transmembrane receptor for insulin-like growth factors (IGFs) and has 
been shown to promote neuronal survival and outgrowth (reviewed in Sullivan, Kim, & 
Feldman,  2008). Its mechanism of axonal transport is unknown. IGF-1R has been shown to 
be essential for the formation of the axon in adult RGCs in vitro (Dupraz et al.,  2013), 
highlighting its crucial role in promotion of axonal growth. IGF-1R and insulin receptors were 
also found to be localized in adult DRGs after injury (Craner et al.,  2002; Xu et al.,  2004), 
with their presence likely correlating with the pro-regenerative response of these sensory 
neurons. IGFs play an important role during the development of the corticospinal tract 
(Arlotta et al.,  2005; Ozdinler & Macklis,  2006), but IGFRs become excluded from axons 
during maturation of this motor pathway. More specifically, IGF-IR is exclusively localised in 
the somatodendritic compartment of the neurons in layer V motor cortex (Hollis et al.,  
2009a). Consistent with the absence of the receptor in the axonal compartment, corticospinal 
tract axons were not able to regenerate through IGF-secreting cell grafts that were 
transplanted into the lesion after a spinal cord injury in vivo (Hollis et al.,  2009a). 
Interestingly, the latter study showed that the ceruleospinal and raphespinal axons did 
regenerate into these grafts. We therefore hypothesise that these two descending motor 
pathways retained IGFRs in their axonal compartments, but the authors did not examine the 
receptor expression in these neurons. A recent study took an alternative approach and 
delivered IGF-1 together with osteopontin into the sensorimotor cortex in order to promote 
corticospinal tract regeneration. Viral vector-mediated delivery of both ligands in the cortex, 
but not IGF-1 or osteopontin alone, promoted axonal regeneration approximately 1 mm 
beyond the lesion site after spinal cord hemisection (Liu et al.,  2017). The treatment showed 
the strongest effect on compensatory sprouting from the uninjured side of the spinal cord (Liu 
et al.,  2017). The axonal regeneration and sprouting contributed to the improved hindlimb 
function of the animals after spinal cord injury. The mechanism by which IGF-1 and 
osteopontin in the cortex mediate their growth-promoting effect is unclear. It is possible that 
both ligands activate their receptors in the somatodendritic domain of cortical neurons, which 
in turn, activate the PI3K/mTOR signal transduction cascade. This is sufficient for robust 
sprouting in the spinal cord, and short-range regeneration (Liu et al.,  2017).  
 Taken together, like integrins, the deficit of TrkB and IGF-IR in the axons within the 
corticospinal tract may limit its regeneration. Further investigation is required to determine 
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whether the exclusion of these receptors in corticospinal tract axons also depends on the 
presence of the axon initial segment as a barrier and whether the same transport vesicles are 
involved for their transport as for integrins.  
 
IX. PERSPECTIVES 
 Integrins are important mediators of axonal regeneration in the injured nervous 
system. Integrins stimulate axonal regeneration when they are activated and localised at the 
growth cone to interact with the ECM. In order to use receptors as potential therapeutic 
targets to promote axonal regeneration, the mechanisms of axonal transport and trafficking 
need to be better understood. The successful use of activated integrins to promote 
regeneration of sensory axons leading to recovery of mechano- and temperature sensations in 
vivo (Cheah et al.,  2016) indicates that the overall strategy can be successful. Regeneration of 
the corticospinal pathway is a key event that is necessary to restore motor control after spinal 
cord injury. If in addition to integrin activation, the integrin trafficking barrier in descending 
corticospinal motor neurons could be overcome, then motor recovery could be a surmountable 
obstacle. Strategies to initiate trafficking to the axonal compartment of the corticospinal tract 
could therefore be based on: (1) overcoming the transport block of the axon initial segment 
and; (2) stimulation of anterograde transport by modulation of transport vesicles; or (3) 
adding axonal localisation signals to growth promoting receptors to enter the axon.  
 
X. CONCLUSIONS  
(1) Integrins are localised at the growth cone of immature and regenerating neurons and 
connect the extracellular and intracellular compartments of the neuron.  
(2) Matching the extracellular matrix environment with the appropriate integrins promotes 
limited axonal regeneration of mature neurons. 
(3) Presence of integrins in the axon correlates with the regenerative capacity of neuronal 
pathways.  
(4) Integrins participate in spontaneous axonal regeneration after peripheral nerve injuries.  
(5) Axon-repulsive molecules at the lesion site of spinal cord injuries inactivate integrins and 
thereby inhibit axonal regeneration in the central nervous system. 
(6) Stimulation of integrin signalling can overcome the repulsive molecules at the site of 
injury and promote limited sensory axon regeneration in the central nervous system.  
(7) Integrins become excluded from the axon during maturation of most central nervous 
system neurons and this correlates with the loss of the regeneration ability of mature neurons.  
(8) Manipulation of the receptor activation state and localisation within axons is not only 
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important for integrin-mediated axon regeneration, but also for other regeneration-associated 
receptors such as TrkB and IGF-1R.  
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CHAPTER II – shRNA and CRISPR-Cas9 to dismantle the axon 
initial segment in cortical neurons by targeting Ankyrin-G 
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I. INTRODUCTION  
 The axon initial segment (AIS) is a structure located at the proximal part of the axon. 
It contains a high number of voltage-gated ion channels and many other membrane-bound and 
cytoskeleton proteins. The AIS is essential for neuronal polarisation (reviewed in Rasband,  
2010). It is crucial for action potential propagation and it anatomically forms the border 
between the somatodendritic- and axonal compartment of multipolar neurons. How the AIS 
regulates protein trafficking between the sub-cellular compartments of the neuron is not well 
understood. However, it is clear that the AIS is important for neuronal functioning as 
mutations affecting the AIS are associated with human diseases (reviewed in Huang & 
Rasband,  2018). For instance, mutations in the ANK3 gene (encoding the Ankyrin-G protein) 
are associated with bipolar disorders, epilepsy and intellectual disabilities. 
 
(1) Structure of the axon initial segment 
 The AIS is approximately 20 to 60 microns long and consists of microtubule bundles 
and a high-density of proteins (Palay et al.,  1968). Proteins found at the AIS include clusters 
of cell adhesion molecules, cytoskeletal scaffolds, extracellular matrix molecules, and 
voltage-gated ion channels. The AIS is often visualised by immunochemistry for one of the 
following proteins: Ankyrin-G (AnkG), βIV spectrin, neurofascin, neuronal cell-adhesion 
molecule (NrCAM), voltage-gated sodium and potassium channels, or others (reviewed in 
Ogawa & Rasband,  2008; Rasband,  2010; Leterrier,  2018; Huang & Rasband,  2018). The 
high number of voltage-gated channels, approximately a 30-fold increase compared to 
dendrites and distal axon (Kole et al.,  2008), is a key characteristic of the AIS.  
 The cytoskeletal protein AnkG is essential for the AIS as it acts as a so-called ‘master 
scaffolding protein’. All AIS proteins directly or indirectly interact with AnkG, and therefore 
not surprisingly AnkG consist of many protein interaction sites.  
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 There are two isoforms of the AnkG protein that are 480- and 270 kilodaltons (kDa) in 
atomic mass. The two isoforms differ in the size of the protein tail structure at the C-terminus. 
In other words, the 270 kDa isoform has a shorter protein tail than the 480 kDa isoform. The 
tail consists of multiple SxIP motifs that are important for binding of microtubules (Freal et 
al.,  2016) and a second binding residue to β4-spectrin (Jenkins et al.,  2014). The anchoring 
of microtubules to the AIS is important for axonal protein trafficking (Sobotzik et al.,  2009; 
Nakata et al.,  2011; van Beuningen et al.,  2015; Kuijpers et al.,  2016). The membrane-
binding- and spectrin-binding domains of AnkG are both found at the N-terminus of the 
protein.  The membrane-binding domain consists of 24 Ankyrin repeats (Wang et al.,  2014) 
which anchors ion channels and cell-adhesion molecules (CAMs) to the AIS. Examples of 
CAMs at the AIS are neuronal cell adhesion molecule (NrCAM) and neurofascin (Davis, 
Lambert, & Bennett,  1996, Hedstrom et al.,  2007). The spectrin-binding domain of AnkG 
recruits actin-spectrin complexes which are important for cytoskeletal stability of the AIS 
(Yang et al.,  2007; Albrecht et al.,  2016; Huang et al.,  2017a; 2017b).  
 The formation of the AIS occurs relatively early in the development of multipolar 
neurons. Our laboratory and others observed that the AIS starts to appear at 3 to 4 days in 
cultured cortical neurons of rats. The AIS is formed in vivo in the time period between 
embryonic day 13 and postnatal day 1 in vivo depending on the brain area and animal species 
(Galiano et al.,  2012; Gutzmann et al.,  2014; Le Bras et al.,  2014). The intrinsic mechanism 
of the assembly of the axon initial segment is a topic of intense research.    
  
(2) Removal of scaffolding protein Ankyrin G dismantles the axon initial segment 
 The many protein interactions by AnkG make this protein crucial to sustain the AIS.  
This was confirmed by studies using transgenic knockout mice (Jenkins & Bennett,  2001; 
Pan et al.,  2006; Zhou et al.,  1998) and short hairpin RNA (shRNA) interference (Hedstrom 
et al.,  2007; Hedstrom, Ogawa, & Rasband,  2008), as removal of this scaffolding protein 
dismantles the AIS in vitro and in vivo.   
  That knockout of AnkG results in dismantling of the AIS was first shown in vivo in 
transgenic mice that lack AnkG in a subset of purkinje cells in the cerebellum (Zhou et al.,  
1998). Several studies used these mice to identify that AnkG is required for maintenance of 
the AIS by staining for multiple proteins that are normally found in this important structure 
(Zhou et al.,  1998; Jenkins & Bennett,  2001; Pan et al.,  2006; Sobotzik et al.,  2009). The 
purkinje cells that had complete knockout of AnkG failed to concentrate the following 
proteins at the AIS: voltage-gated sodium channels (Zhou et al.,  1998, Jenkins & Bennett,  
2001; Pan et al.,  2006), voltage-gated potassium channels (Pan et al.,  2006), neurofascin 
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(Zhou et al.,  1998, Jenkins et al.,  2001), L1 cell adhesion molecule (Jenkins & Bennett,  
2001), NrCAM (Jenkins & Bennett,  2001), βIV spectrin (Jenkins & Bennett,  2001), and 
bundles of microtubules (Sobotzik et al.,  2009). All of above studies reported that depletion 
of the AIS resulted in disturbed firing of action potentials, and the mice developed ataxia.  
 The importance of AnkG for AIS assembly was also shown in cultured CNS neurons 
by using shRNA interference (Hedstrom et al.,  2007). The latter study delivered the shRNA 
for AnkG, via a lentivirus, 3 hours after plating of hippocampal neurons and the cells were 
examined for multiple AIS proteins at 17 DIV. The transfected neurons had knockout of 
AnkG and as a result the typical AIS structure was not visible anymore by 
immunofluorescence. In addition to AnkG knockout, the membrane proteins Nav 1.x, βIV 
spectrin, neurofascin, and NrCAM, failed to localise at the AIS (Hedstrom et al.,  2007). In 
contrast, shRNA interference for neurofascin did not result in disassembly of the AIS 
(Hedstrom et al.,  2007) suggesting that only AnkG is required for upholding of the AIS. 
 
 (3) The axon initial segment as a barrier for axonal transport 
 The AIS is one of the known selective-transport barriers for proteins to enter the axon. 
Knockout of AnkG not only demolishes the AIS, but also allows proteins from the 
somatodendritic domain to enter the axon. The studies that observed the mis-trafficking of 
somatodendritic proteins into the axon will be discussed below.    
 RNA interference for AnkG in cultured hippocampal neurons resulted in the axonal 
localisation of cytoplasmic protein microtubule-associated protein-2 (MAP2) and the 
membrane-associated protein chloride potassium symporter 5 (KCC2) (Hedstrom et al.,  
2008). Transgenic mice that lack AnkG in purkinje cells had post-synaptic membrane proteins 
such as metabotropic glutamate receptor 1 in the axon (Sobotzik et al.,  2009). Interestingly, 
both studies observed that loss of the AIS also resulted in axons with characteristics of 
dendrites such as formation of spines and post-synaptic terminals (Hedstrom et al.,  2008; 
Sobotzik et al.,  2009).  
 The AIS has also been suggested to form a barrier for integrins to enter the axon of 
polarized CNS neurons. In rat cortical cultures, integrins (α5, αV, β1) are ubiquitously 
distributed throughout the cell on the first day in culture, but become exclusively localized to 
the somatodendritic domain when the AIS is matured (Franssen et al.,  2015). AAV-mediated 
delivery of integrins in the corticospinal tract also results in a somatodendritic localisation and 
the receptors are not found beyond the AIS in vivo (Andrews et al.,  2016). Both studies 
suggest a correlation between AIS formation and the sub-cellular distribution of integrins. 
However, the study by Franssen and colleagues also showed that the AIS contributes to the 
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exclusion of the axonal integrins via knockdown of AnkG. Lentivirus mediated-shRNA 
interference allowed endogenous β1-integrin from the somatodendritic domain to enter the 
axons of transduced cortical neurons in vitro. The integrins were detected 400 µm into the 
axon three days after shRNA application (Franssen et al.,  2015). I would consider this as a 
limited distance of receptors mis-trafficking. Hedstrom et al.,  2008 demonstrated in cultured 
hippocampal neurons that AnkG is a stable protein and successful dismantling of the AIS 
requires at least two weeks by using the same lentivirus shRNA construct. According to their 
data, the majority (> 95%) of the transfected neurons still have an AIS at four days post-
transduction, and there is only a 40% reduction in the average fluorescent intensity of AnkG. 
The neurons undergo a complete knockout of AnkG and thereby destruction of the AIS after 
14 days of shRNA interference. It is therefore likely that integrins and other regeneration-
associated receptors will reach further into the axons by longer time exposure to the shRNA. 
It is unknown whether dismantling the AIS can promote axonal transport of integrins in CNS 
neurons in vivo.    
It is generally accepted that the AIS is important for selective polarized transport. Yet, 
the intrinsic mechanisms how the AIS regulates protein trafficking remains poorly 
understood. 
 
(4) Hypothesis ‘understanding regenerative failure’ 
 Genetic changes and selective polarised transport contribute to neuronal polarisation, 
and this correlates with the decline in the intrinsic regeneration capacity of CNS neurons (Fig. 
1). For instance, Rab11-positive endosomes contain regeneration-associated receptors 
(reviewed in Nieuwenhuis & Eva,  2018b) are down-regulated and excluded from the axon 
during maturation which contributes to less efficient axon regeneration (Koseki et al.,  2017). 
In addition, integrins become localised in the somatodendritic domain of matured CNS 
neurons in vitro (Franssen et al.,  2015) and in vivo (Andrews et al.,  2016).  The formation of 
the axon initial segment is one of the important events that contribute to selective polarised 
transport in multipolar neurons. We hypothesize that dismantling the AIS, via knockout of 
AnkG, is one approach to overcome the axonal transport block of regeneration associated-
receptors and can thereby promote axon regeneration in CNS neurons.  
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Fig. 1. Polarisation of cultured cortical neurons. Neurons undergo various developmental stages during 
polarisation. Genetic changes and selective transport of proteins contribute to neuronal polarisation. For 
simplification purposes, two developmental stages are categorized here. Developing cortical neurons exist in a 
growth state that promotes axonal and dendritic outgrowth. As neurons mature, there is a decline in their growth 
capacity as they become geared for neurotransmission. The neurons form an axon initial segment that propagates 
action potentials and also contributes to polarised membrane protein transport. Mature cortical neurons have a 
poor intrinsic capacity for axon regeneration. This figure was published in Nieuwenhuis & Eva, 2018b (Small 
GTPases). 
 
(5) Aim of study 
 The aim of this study is to make/generate genetic tools to knockout AnkG. The initial 
approach was to make a plasmid containing shRNA interference for AnkG. During the second 
year of my PhD, I made a novel plasmid to knockout AnkG based on recent advances in 
CRISPR-Cas9 technology. This dissertation chapter will be focussed on the generation and 
characterization of these genetic tools for protein knockout. This chapter also serves as 
guideline for others that would like to use the CRISPR-Cas9 vector, which is suitable for 
rAAV production, to knockout their protein of interest.  This chapter contains preliminary 
data in which shRNA interference and CRISPR-Cas9 were tested for their efficiency to 
knockout AnkG and to dismantle the AIS in cultured cortical neurons. Future research is 
needed to investigate whether dismantling of the AIS, via AnkG knockout using the tools 
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created here, enables axonal transport of regeneration-associated receptors in the (injured) 
corticospinal tract in vivo.   
 
 (6) Genetic tools to knockout proteins 
 A common approach to study the function of proteins is by knockout (in addition to 
overexpression of the corresponding gene, as done in Chapter III). There are many protein 
knockout technologies available including the generation of transgenic knockout mouse. In 
this chapter, shRNA interference and CRISPR-Cas9 were used as method to knockout AnkG.  
 
(a) shRNA interference 
 RNA interference regulates the expression of genes by degrading the messenger RNA 
after gene transcription. It thereby prevents protein translation in the cell, resulting in protein 
knockout. This post-transcriptional gene silencing occurs in eukaryotic cells (Agrawal et al.,  
2003). RNA interference via short interfering RNA (siRNA) and the synthetic shRNA were 
discovered in the 1990s (Fire et al.,  1998). Delivery of siRNA into the cytoplasm results in 
temporary expression. In contrast, vector-mediated delivery of shRNA results in long-term 
expression of siRNA-like nucleic acids, because the shRNA is continuously transcribed in the 
nucleus of the host cell. shRNA interference could therefore result in protein knockout after 
one single administration.   
 The mechanism of shRNA interference is described in many reviews and textbooks 
(Manjunath et al.,  2009; Moore et al.,  2010); a brief summary is given below. Plasmids 
containing a RNA promoter and the shRNA sequence can be delivered into cells via 
transfection, viral vector-mediated delivery, or other molecular techniques.  In the cell, the 
shRNA sequence will be transcribed by class III RNA polymerases when the H1 (or U6) 
promoter is used. The shRNA will gain a hairpin structure in the nucleus. The structure of the 
short hairpin is relatively simple as it consists of the following components:  1) a stem region 
that consist of paired sense and antisense strands and; 2) unpaired nucleotides that form a loop 
to connect the stem region (see Tables 1 and 2 for the design of the shRNA sequence, and 
see Fig. 2 for a linear schematic illustration). After transcription, a protein complex consisting 
of Drosha and DGCR9 will release the short hairpin from other transcribed mRNA (Han et 
al.,  2004). This so-called pre-shRNA is transported from the nucleus toward the cytoplasm 
via an transporter protein called Exportin-5 (Yi et al.,  2003). In the cytoplasm, a protein 
complex containing RNase enzyme Dicer cleaves off the loop structure to generate double-
stranded siRNA. Finally, the generated siRNA interacts with the RNA induced silencing 
complex (RISC), which in turn separates the sequence in two single RNA strands. The so-
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called guide strand remains in the RISC complex and binds to the mRNA that was targeted 
for protein knockout. The guide strand RNA-RISC complex will cleave the targeted mRNA 
and thereby prevent protein translation of the target gene.  
 
(b) CRISPR-Cas9 interference 
 CRISPR-cas9 does not interfere at the mRNA level, but induces a double-strand break 
(indels) in the DNA. The DNA’s repair mechanisms are error prone and thereby likely to 
induce a point mutation.  When a nucleotide deletion of insertion occurs, this can initiate a 
downstream frameshift to the DNA sequence. The truncated protein, translated from the 
shifted DNA reading frame, will be degraded by the cell’s ubiquitin-proteasome system. 
Thus, the CRISP-induced indel can therefore ultimately results in protein knockout. In 
addition to protein knockout, the CRISP-Cas9 system has been suggested for an array of other 
biological applications (reviewed in Kim & Kim,  2014; Shalem, Sanjana, & Zhang,  2015; 
Wright, Nuñez, & Doudna,  2016; Lopes, Korkmaz, & Agami,  2016; Barrangou & Doudna,  
2016; Barrangou & Horvath,  2017). 
 CRISPR-Cas has originally been identified as an adaptive immune system by bacteria 
against infections by bacteriophages (Barrangou et al.,  2007; Marraffini & Sontheimer,  
2008). Most bacteria store the DNA content from previous phage infections, and when re-
infected deploy RNA-guided nucleases for silencing of the nucleotides released by phages 
(reviewed in Hille et al.,  2018). CRISPR stands for clustered regularly interspaced short 
palindrome repeats, and these DNA sequences together with the associated Cas proteins form 
the bacterial line of defence against foreign DNA.  
 Part of the bacterial genome consists of identical palindrome DNA sequences 
(approximately 20 to 40 nucleotides in length) that are frequently repeated, and have spacer 
DNA in between (e.g. interspaced) (Ishino et al.,  1987; Jansen et al.,  2002). This spacer 
DNA is unique and matches with the DNA of phages that was introduced by previous 
infections (Mojica et al.,  2005; Bolotin et al.,  2005). The bacterial genome also contains 
CAS genes that give rise to Cas-protein complexes that consist of helicases and nucleases that 
can unwind and cleave DNA. The spacer DNA gives rise to CRISPER RNA (crRNA) after 
transcription that binds to the Cas protein. The Cas proteins interact to short protospacer 
adjacent motifs (PAM) that are present along the DNA, and are used by Cas proteins as 
binding sites to unwind double-stranded DNA and to allow the bound crRNA to search for 
complementary target sequences (Sternberg et al.,  2014; Anders et al.,  2014). This crRNA-
Cas protein complex can therefore specifically interact with infectious phages DNA, while the 
Cas protein induces a double strand break. The cleavages of the DNA by the crRNA-Cas 
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protein complex avoids the phage infection and thereby prevents the death of the infected 
bacteria (reviewed in Hille et al.,  2018).  
 The CRISPR-Cas9 system cannot only target DNA sequences in bacteria, but in any 
living cell. The CRISPR-Cas9 system can be used to knockout any gene of interest, when the 
crRNA is replaced by a target sequence of choice and is co-expressed with the CAS protein. 
The crRNA, also known as the guide RNA, will guide the Cas proteins to cleave 
complementary DNA in the transduced cells.  
 
II. MATERIALS AND METHODS 
(1) Detailed cloning procedures for DNA constructs containing shRNA 
 The plasmid pSUPER (OligoEngine, VEC-PBS-0002) was used as the vector 
backbone for the shRNA constructs.  Five shRNA constructs were designed: four constructs 
to knockdown AnkG, and one scrambled shRNA construct that functions as negative control 
by targeting a non-mammalian (drosophila gnu) gene. This scrambled shRNA sequence was 
taken from Hedstrom et al., 2007 that used shRNA interference dismantle the AIS. The 
sequence of AnkG-shRNA1 was taken from studies that successfully interfered with AnkG 
and the AIS (Hedstrom et al.,  2007; 2008; Franssen et al.,  2015). This shRNA sequence 
should therefore result in successful knockout of AnkG and the AIS. The sequences of AnkG-
shRNA2, AnkG-shRNA3 and AnkG-shRNA4 were self-designed, by using the online 
software http://www.invivogen.com/review-sirna-shrna-design, and aimed to target the Ank3 
gene in both rat and mice. The four sequences had a 100% score for AnkG specificity and GC 
ratios of 52.6%, 52.6%, 42.1% and 36.8%, respectively. The designed oligonucleotides 
(Sigma-Aldrich) were 58 nucleotides in length. Both the forward and reverse oligonucleotides 
consisted of 19 nucleotides sense and antisense sequences separated by a 9 nucleotides 
noncomplementary loop sequence. This shRNA sequences were flanked by a 5’ mutated 
BglII restriction overhang (GATCT was mutated in GATCC, which corresponds to BamHI) 
and a 3’ RNA Polymerase III termination signal followed by a HindIII restriction overhang. 
The forward (Table 1) and reverse (Table 2) oligonucleotides were ordered from Sigma-
Aldrich with a 5’ phosphate modification.  
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Table 1. Forward primers to make shRNA in the 5’ to 3’ direction 
Name 
 
Sticky 
end 
BamHI 
(5 nt) 
Stem structure - Sense 
(19 nt) 
Loop 
(9 nt) 
Stem structure – antisense 
(19 nt) 
Term-
inal. 
signal 
(5 nt) 
Sticky 
end 
HindIII 
(1 nt) 
AnkG – 
shRNA1 
GATCC GCCGTCAGTACCATCTTCT TTCAAGAGA AGAAGATGGTACTGACGGC TTTTT A 
AnkG – 
shRNA2 
GATCC AAGCAGAAGTGGTGCGGT TTCAAGAGA TACCGCACCACTTCTGCTT TTTTT A 
AnkG – 
shRNA3 
GATCC GAAGAACCAGATGGACATA TTCAAGAGA TATGTCCATCTGGTTCTTC TTTTT A 
AnkG – 
shRNA4 
GATCC GAAATTATGACCACCACTA TTCAAGAGA TAGTGGTGGTCATAATTTC TTTTT A 
scrambl
ed 
GATCC CTACTGAGAACTAAGAGAG 
 
TTCAAGAGA CTCTCTTAGTTCTCAGTAG TTTTT A 
Abbreviation: nt; nucleotides. 
 
Table 2. Reverse primers to make shRNA in the 5’ to 3’ direction 
Name 
 
Sticky 
end 
HindIII 
(5 nt) 
Term- 
inal 
signal 
(5 nt) 
Stem structure – antisense 
(19 nt) 
Loop 
(9 nt) 
Stem structure – Sense 
(19 nt) 
Sticky 
end 
BamHI 
(1 nt) 
AnkG – 
shRNA1 
AGCTT AAAAA GCCGTCAGTACCATCTTCT TCTCTTGAA AGAAGATGGTACTGACGG
C 
G 
AnkG – 
shRNA2 
AGCTT AAAAA AAGCAGAAGTGGTGCGGTA TCTCTTGAA TACCGCACCACTTCTGCTT G 
AnkG – 
shRNA3 
AGCTT AAAAA GAAGAACCAGATGGACATA TCTCTTGAA TATGTCCATCTGGTTCTTC G 
AnkG – 
shRNA4 
AGCTT AAAAA GAAATTATGACCACCACTA TCTCTTGAA TAGTGGTGGTCATAATTTC G 
Scramb-
led 
shRNA 
AGCTT AAAAA 
 
CTACTGAGAACTAAGAGAG TCTCTTGAA CTCTCTTAGTTCTCAGTAG G 
Abbreviation: nt; nucleotides. 
 
(2) Annealing forward and reverse oligonucleotides to generate the shRNA insert 
 The primers (Table 1 and Table 2) were resuspended in water to a concentration of 3 
mg/ml. An equal amount (3 µg, e.g. 1 µl at 3 mg / ml concentration) of each complementary 
primer was hybridised in sterile annealing buffer that consisted of 100mM NaCl (Sigma-
Aldrich) and 50mM HEPES (Gibco, 15630), pH 7.4. A polymerase chain reaction (PCR) 
machine was utilized to facilitate the annealing. The mixture was incubated at 90°C for 4 min, 
and was followed by 70°C for 10 minutes, 60°C for 5 minutes, 50°C for 5 minutes, 45°C for 5 
minutes, 37°C for 15 minutes, 10°C for 20 minutes, 4°C overnight. The high temperature will 
undo any secondary structures that were formed at the single stranded primers, the 
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temperature range near 37°C will promote the DNA-DNA hybridisation, while the lower 
temperatures are used to store the DNA.  
 After annealing the primers, the double stranded DNA was isolated and purified. The 
complete ligation mixture for each shRNA construct was loaded on a 2% agarose gel 
containing ethidium bromide. A 2% gel was used due to the small size of the annealed 
oligonucleotides. Agarose gel electrophoresis was performed at 100 millivolt and the reaction 
was stopped before the DNA loading dye ran out of the gel. After gel electrophoresis, the 
higher band that contained the double stranded DNA was cut from the gel. The shRNA inserts 
were isolated from the agarose gel using the Wizard® SV Gel and PCR Clean-up System 
(Promega, A9282).  
 
 
Fig. 2 Schematic illustrating the annealing of the oligonucleotides prior ligation of the shRNA insert 
downstream of the H1 promoter in plasmid pSUPER. The colours in the shRNA sequences highly the hairpin 
stem structure (red), the loop structure (cyan blue), the terminal signal (purple) and the flanked mutated 
restrictions site BglII (green) and HindIII (yellow). This cleavage sites of the restriction enzymes were taken 
from the software EnzymeX. Lab journal reference: BN-15-14 
 
(3) Linearization of the vector backbone pSUPER  
 A restriction enzyme digestion was performed to generate overhang ends at the 
plasmid pSUPER that match the generated shRNA inserts. The restriction enzymes BglII 
(New England Biolabs, R0144) and HindIII (New England Biolabs, R0104) were used for 
this purpose. The digestion was performed according to the enzyme supplier instructions. 
NEBuffer III was chosen as buffer and should result in a HindIII and BglII digestion 
efficiency of 100% and 50%, respectively. I did not double the amount of HindIII enzyme 
(due to the 50% digestion efficiency) to avoid unwanted star activity. The restriction enzyme 
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digestion was performed in a PCR machine for 1 hour at 37°C, and was followed by 80°C for 
20 minutes to inactive the HindIII enzyme (BglIII can not be heat inactivated).  
 The vector backbone was not dephosphorylated using phosphatases, because auto-
ligation of the vector backbone should not occur due to the different overhang ends of HindIII 
and BglII. In addition, the BglII treatment after ligation (Section II.5) eliminates the pSUPER 
plasmids that do not contain the shRNA insert.  
 After the digestion, the linearized vector was purified to remove components of the 
restriction enzyme reaction that may interfere with the ligation of the vector backbone and the 
shRNA inserts. The mixture was loaded on a 1% agarose gel and standard gel electrophoresis 
was performed. The linearized vector was isolated from the gel fragments using the Wizard® 
SV Gel and PCR Clean-up System (Promega, A9282). 
 
(4) Ligation of the shRNA insert into the vector backbone pSUPER   
 Ligation of the linearized vector backbone and the shRNA insert was achieved using 
T4 DNA ligase (New England Biolabs, M0202) following the supplier instructions. The 
ligation was done with a vector backbone to insert ratio of 1:5.  An important negative control 
for ligation to include is the digested vector backbone without (shRNA-) insert. This 
condition will demonstrate whether auto-ligation of the vector backbone occurred.   
 
(5) BglII digestion to reduce the background levels of shRNA DNA constructs at 
transformation  
 After ligation and before transformation of the plasmids in bacteria, a BglII restriction 
digestion was performed. The ligation mixture was treated with 10 units (1 µl) of BglII in 
NEBuffer III at 37°C for 30 minutes.   
 The ‘enzyme site mutagenesis’ strategy and the BglII restriction digestion will 
eliminate plasmids that do not contain the shRNA insert. Mutated BglII and HindIII overhang 
ends flank the shRNA insert and allow the cloning of the shRNA downstream of the H1 
promoter at plasmid pSUPER. If the ligation is successful, the BglII restriction site at 
pSUPER is destroyed and becomes a BamH1 site (mutated BglII overhang) (see Fig. 2). The 
BglII digestion therefore does not digest the plasmids containing the shRNA insert. In 
contrast, plasmids that did not uptake the shRNA insert will be digested by the BglII enzyme 
and should therefore not result in bacterial colonies after transformation.  
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(6) Transformation in bacteria 
 GT116 Escherichia coli competent cells (InvivoGen, gt116) were used for the 
transformation of the BglII treated plasmids. GT116 bacteria are engineered to aid the growth 
of plasmids carrying hairpin structures, the transformation was performed according to the 
supplier their instructions. The cells were plated on 1.5% ager plates containing ampicillin 
(1:1000) and kept in a 37°C incubator overnight.  
 
(7) DNA isolation and restriction enzyme digestion to screen for the shRNA insert 
 Bacterial colonies on the ager plates were picked and grown in lysogeny broth (LB) 
containing ampicillin (1:1000) and were left overnight in a shaker, 250 rotations per minute 
(rpm) at 37°C. After incubation, the DNA was isolated using Wizard® Plus SV miniprep 
DNA purification systems (Promega, A1460).  
 The isolated DNA was screened for the presence of the shRNA insert. The DNA was 
digested using Hpy188III in NEB CutSmart buffer and BSA for 1 hour at 37°C. The enzyme 
was heat inactivated by exposing the mixture to 65°C for 20 minutes. The digested DNA 
fragments were visualized on a 2% agarose gel according to standard procedures.  
 The restriction enzyme Hpy188III was selected because it cleaves the plasmid 
pSUPER and, if present, the loop sequence of the shRNA. Hpy188III treatment in pSUPER 
results in fragments of the following length: 749 bp, 670 bp, 495 bp, 429 bp, 259 bp, 134 bp, 
98bp, 98 bp, 87 bp, 83 bp, and 74 bp.   Hpy188III treatment in pSUPER containing the 
shRNA insert will result in fragments of: 749 bp, 670 bp, 429 bp, 277 bp, 270 bp, 259 bp, 134 
bp, 98 bp, 98 bp, 87 bp, 83bp, 74 bp. Thus, the absence of the 495 bp band in the agarose gel 
will be an indicator for the presence of the shRNA insert in pSUPER.  
 Plasmids that were screened positive for the shRNA insert were amplified. One ml of 
LB media containing the plasmid was added into an Erlenmeyer flask containing 100 ml of 
fresh LB media and the appropriate antibiotics. The medium was incubated on a shaker at 200 
rpm for overnight. After incubation, high yields of DNA were obtained using ZymoPURETM 
plasmid maxiprep kit (Zymo Research, D4203). 
 
(8) DNA sequencing  
 DNA sequencing of the shRNA construct was performed by the biochemistry DNA 
sequencing facility at the University of Cambridge. This desalted oligonucleotide 5’ 
GTTGTAAAACGACGGCCAGTGAG 3’ is forward primer that binds upstream of the H1 
promoter in the pSUPER plasmid. By using this self-designed primer, the sequencing reaction 
will detect the downstream shRNA sequence during a single sequence reaction. Each 
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sequencing reaction consisted of 1000 nanogram of DNA plasmid and 10 picomolar of 
forward sequencing primer, which were diluted in nuclease-free water. The sequencing results 
were analysed using FinchTV software.  
 
(9) Design of sgRNA sequence for cloning into the plasmid AAV-SYN-SaCas9-HA-hU6-
backbone  
 The design of the sgRNA target sequence for the CRISPR Cas9 technology is 
relatively simple. In this section, I will describe in six steps how to design an oligonucleotide 
sequence that contains the sgRNA sequence for Staphylococcus aureus Cas9 (SaCas9) which 
is flanked with restriction sites for cloning. After the designed oligonucleotides are annealed, 
they can be inserted into the sgRNA-cloning site of two vector backbones. These vector 
backbones drive the expression of SaCas9 under the DNA promoters CMV or hSYN, while 
the expression of the inserted target sequence and sgRNA will be driven by the RNA 
promoter hU6 (see also Fig. 3).  These CRISPR-cas9 vector backbones can be found under 
the following names in both the plasmid databases of the Fawcett and Verhaagen 
Laboratories: pAAV-CMV-SaCas9-HA-hU6-backbone (sample ID: 697) and pAAV-hSYN-
SaCas9-HA-hU6-backbone (sample ID: 698).  
 
1) Find the open reading frame of the gene of interest, derived from the correct animal specie, 
via NCBI.  Also search in the literature whether there are isoform variants of the gene and 
download these sequences as well. The sequences can be opened in a DNA reading program, 
such as SerialCloner, and the protein sequences can be aligned using www.uniprot.org/align. 
Depending on the research question, search for a common sequence area between the gene 
splice variants to achieve knockout all protein isoforms, or alternatively find a sequence area 
that is unique for the isoform of interest.  
 
2) Find the PAM sites in the open-reading frame of the gene of interest. The PAM sites for 
SaCas9 is any variant of 5’ NNGRRT 3’ (Ran et al.,  2015). These nucleotide abbreviations 
represent: N, any nucleotide; G, Guanine; R, Purine and therefore Adenine or Guanine; or T, 
Thymine. To achieve a complete protein knockout, select the PAM sites in the exon that is 
present in all the splice variants. SaCas9 cleavage in the first overlapping exon increase the 
chances of introducing an early frame-shift mutation and thereby prevention of the translation 
of a functional protein. Note that the PAM site for the Cas9 nuclease of Streptococcus 
pyogenes (SpCas9, the common used isoform for CRISPR) is ‘5 NGG 3’ (Ran et al.,  2015), 
and therefore using published sgRNA sequences for this isoform will not work for SaCas9 in 
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this AAV vector plasmid. I recommend designing multiple target sequences since currently it 
cannot be predicted how efficient a certain sgRNA for SaCas9 would be.   
 
3) Copy and paste the 21 nucleotides (nt) that are at the 5’ end of the selected PAM site. Ran 
and colleagues showed that sgRNA with a length of 21 nt and 22 nt are the most effective to 
introduce double strand breaks (Indels) with the SaCas9 isoform (Ran et al.,  2015). It was 
also suggested to avoid guanine-cytosine-rich sequences as sgRNA.  
 
The two-sgRNA sequences that I selected to target the rat ANK3 gene (NM_001033984.1) 
are:  
sgRNA ANK3 - 1: 5' - GCTTCCCAGTTAAAGAAAAAC - AGGGAT (=PAM) 
sgRNA ANK3 - 2: 5' – AAGAAGCACCGTAAACGGTCC – CGGGAT (=PAM) 
 
4) Blast the target sequence at NCBI to check whether your target sequence is specific for 
your gene of interest in the same animal specie. Blast the target sequences without the PAM 
site, because SaCas9 can bind to multiple PAM site to introduced indels in potential off-target 
genes. 
 
5) Add a guanine nucleotide at the 5’ end of the target sequence, as this is required to initiate 
efficient transcription by the U6 promoter.  
 
A guanine nucleotide was added to the 5’ end of the two selected target sequences:  
sgRNA ANK3 - 1: 5' - GGCTTCCCAGTTAAAGAAAAAC  
sgRNA ANK3 - 2: 5' – GAAGAAGCACCGTAAACGGTCC  
 
6) The target sequences can be cloned into the CRISPR-cas9 vector backbones by utilizing 
the BsaI restriction enzyme (NEB, R0535S). The BsaI enzyme cleave twice downstream of 
the hU6 promoter in the plasmid. The BsaI overhang ends need to be added to the target 
sequences in order to assure ligation in the plasmid along with the correct orientation. The 
insertion of the target sequence in the vector backbone will only succeed with double stranded 
DNA, and therefore an anti-sense oligonucleotide needs to be made before DNA annealing. 
The BsaI overhang ends that need to be added to the sense and antisense oligonucleotides are 
5’ CACC 3’ and 5’ AAAC 3’, respectively. In addition, it is important to order the 
oligonucleotides with one phosphate group attached to the 5’-end for ligation purposes.   
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Generation of the antisense oligonucleotide, and addition of the BsaI overhangs which are 
suitable for cloning into the CRISPR-Cas9 vector backbone: 
 
sgRNA ANK3 – 1 
Primer Sense: 5' - CACCGGCTTCCCAGTTAAAGAAAAAC 3’ 
Primer Antisense: 5’ – AAACGTTTTTCTTTAACTGGGAAGCC 3’ 
 
sgRNA ANK3 – 2 
Primer Sense: 5' – CACCGAAGAAGCACCGTAAACGGTCC 3’ 
Primer Antisense: 5’ – AAACGGACCGTTTACGGTGCTTCTTC 3’ 
 
(10) DNA constructs for CRISPR-Cas9 interference 
 pX601-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA;U6::BsaI-sgRNA was a gift 
from Feng Zhang (Addgene plasmid # 61591, renamed as plasmid 697) and was used as 
vector backbone. The CMV promoter was removed by AgeI (NEB, R0552) and XbaI (NEB, 
R0145) restriction digestion. The human SYN (hSYN) promoter of pTRUF20B-SEW, which 
is described in Korecka et al.,  2011, was next cloned into the vector backbone to generate 
pAAV-SYN-SaCas9-hU6-sgRNA (plasmid 698, see Fig. 3). The designed target sequences 
(see section above) were ordered from Sigma-Aldrich as desalted oligonucleotides with a 5’ 
phosphate (Table 1) and were annealed in 100mM NaCl, 50mM HEPES, pH 7.4. The 
annealed oligonucleotides with BsaI overhang ends were next cloned in pAAV-SYN-SaCas9-
hU6-sgRNA to generate one plasmid that expresses both SaCas9 and the sgRNA. The 
successful cloning of the sgRNA was confirmed by DNA sequencing using the primer 5’ 
GCATATACGATACAAGGCTGTTAG 3’ that binds in the hU6 promoter.  
 
Table 1 - next page - Oligonucleotides used for the insertion of the sgRNA in pAAV-SYN-SaCas9-hU6-
sgRNA. The primers are shown in a 5’ to 3’ orientation and the G + 21 nucleotides sgRNA are underlined. All 
target sequences are located in the first exon of the gene of interest, except for Protrudin that targets regions that 
are unique for the rat gene compared to the human gene, and the corresponding PAM sites are shown. The sense 
and antisense BsaI overhang ends are CACC and AAAC, respectively. The sgRNA are designed to target rat, 
expect for EGR-1 and Sema3A that are designed for mouse. Lab journal references: BN-16-20 (ANk3, Memo, 
Sema3A), BN-16-24 (EFA6), BN-17-52 (Protrudin), BN-18-08 (EGR1), BN-19-07 (NTRK3).  
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sgRNA Sense primer Antisense primer  PAM site 
(NNGRRT) 
Ank3-1  CACCGGCTTCCCAGTTAAAGAAAAAC AAACGTTTTTCTTTAACTGGGAAGCC AGGGAT 
Ank3-2 CACCGAAGAAGCACCGTAAACGGTCC AAACGGACCGTTTACGGTGCTTCTTC CGGGAT 
Efa6-1 CACCGCAGCACAGGATCCCTAATACG 
 
AAACCGTATTAGGGATCCTGTGCTGC ACGAGT 
Efa6-2 CACCGGTGGGCCCAGGTCCTCGAGGC AAACGCCTCGAGGACCTGGGCCCACC 
 
CGGGAT 
Efa6-3 CACCGGAGAAGGCCAGTGTGAGGCCA 
 
AAACTGGCCTCACACTGGCCTTCTCC 
 
CTGAAT 
EGR1-1 CACCGAGTTTGGGGTAGTTGTCCATG AAACCATGGACAACTACCCCAAACTC GTGGGT 
EGR1-2 CACCGGCTATTACCGCCGCTGCCCTC AAACGAGGGCAGCGGCGGTAATAGCC TGGGGT 
EGR1-3 CACCGGTTGTTCGCTCGGCTCCCCTT AAACAAGGGGAGCCGAGCGAACAACC GAGGAT 
Memo1-1 CACCGGAGCCATCATTGCACCCCATG AAACCATGGGGTGCAATGATGGCTCC CAGGAT 
Memo1-2 CACCGTACACCGCCTCAGGACCTCAG AAACCTGAGGTCCTGAGGCGGTGTAC CTGAAT 
NTRK3-1 CACCGCCCAGCCAAGTGTAGTTTCTG AAACCAGAAACTACACTTGGCTGGGC GCGGAT 
NTRK3-2 CACCGTAGAGCTCCATATCCACAGCA AAACTGCTGTGGATATGGAGCTCTAC TTGAGT 
NTRK3-3 CACCGTCCTGGCAGCTCTTCCAGACG AAACCGTCTGGAAGAGCTGCCAGGAC CTGAGT 
Protrudin-1 CACCGATGCAGTCTTCGGATCGGGAC AAACGTCCCGATCCGAAGACTGCATC CTGAGT 
Protrudin-2 CACCGGTACAGGGCTTGTCTGCAGCG AAACCGCTGCAGACAAGCCCTGTACC GCGGAT 
Protrudin-3 CACCGGGCGGATGAGCCCCAAGCAGG AAACCCTGCTTGGGGCTCATCCGCCC AAGAGT 
Sema3A-1 CACCGACTGGGATTGCCTGTCTTTTC AAACGAAAAGACAGGCAATCCCAGTC TGGGGT 
Sema3A-2 CACCGTCCAGTTACCACACCTTCCTT AAACAAGGAAGGTGTGGTAACTGGAC CTGGAT 
 
(11) Cortical neuron cultures and magnetofection 
 Glass bottom cell culture dishes (Greiner bio-one, 627860) were coated with 2.5 
milligrams poly-D-lysine in 0.1M borate buffer (pH 8.5) overnight at room temperature, and 
were washed in PBS the following day. Primary cortical neuron cultures were prepared from 
embryonic day 18 Sprague Dawley rat. The embryonic cortex was dissected in Hanks’ 
balanced salt solutions (HBBS) (ThermoFischer Scientific, 14170) using forceps. The 
neurons were dissociated with 0.1M HEPES (ThermoFischer Scientific, 15630106) in papain 
(Worthington, LK003176) for 10 minutes at 37°C. They were next briefly rinsed with DNase 
(Sigma-Aldrich, D5025) and washed with 1mM HEPES in HBSS solution. The neurons were 
next cultured in neural Q basal medium (Globalstem, gsm9420), supplemented with 2% GS21 
(Amsbio, gsm3100) and 1% glutamax (ThermoFischer Scientific, 35050061) on previously 
coated cell-culture dishes.   
 The cortical neurons were transfected using oscillating nanomagnetic transfection 
(magnefect nano system; nanoTherics). The shRNA interference experiment consisted of the 
following three conditions:  1) 7.5 ug of pAAV-hSYN-eGFP, 2) 3.5 µg of scrambled shRNA 
and 3.5 µg of pAAV-hSYN-eGFP, and 3) 3.5 µg of Ank3 shRNA1 and 3.5 µg of pAAV-
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hSYN-eGFP. These plasmids were transfected 3 days in vitro (DIV) and the cortical neurons 
were fixated on 14 DIV. The CRISPR-Cas9 interference consisted of the following plasmids 
with each 7.5 µg of DNA: 1) pAAV-SYN-eGFP, 2) pAAV-SYN-SaCas9-HA-Hu6-backbone, 
3) pAAV-SYN-SaCas9-HA-hU6-sgRNA-1, 4) pAAV-SYN-SaCas9-HA-hU6-sgRNA-2. The 
cortical neurons were transfected on either 3- or 7 DIV and were fixated on 14 DIV for 
immunocytochemistry procedures and image acquisition. 
 
(12) Immunocytochemistry  
 The cultured cells were fixated with 4% paraformaldehyde (PFA) in PBS for 10 
minutes and were washed in PBS. The neurons were permeabilized by applying 0.3% triton 
(Sigma, X-100) detergent in PBS for five minutes and were afterwards washed in PBS. The 
cells were afterwards incubated with 3% bovine serum albumin (BSA) (Sigma, A7906) in 
PBS for 1 hour to prevent nonspecific binding by the primary antibody. The primary 
antibodies were diluted in 3% BSA and PBS and were added to the cells and kept overnight at 
4°C. The primary antibodies used in the shRNA and CRISPR-Cas9 interference studies were 
anti-Pan-Neurofascin, (A12/18, 1:250, NeuroMab), anti-Ankyrin-G (N106/36, 1:250, 
NeuroMab or sc-28561, 1:250, Santa Cruz), and anti-HA epitope tag (16B12, 1:1000, 
Biolegend). Afterwards, the cells were washed and incubated in Alexa Fluor-conjugated 
secondary antibodies that were diluted in 3% BSA in PBS for 1 hour at room temperature. 
The secondary antibodies were purchased from ThermoFischer scientific. After secondary 
antibody incubation, the cells were washed in PBS and mounted in fluorsave reagent 
(Calbiochem, 345789). 
(13) Image acquisition and analysis 
The images of the axon initial segments were acquired by using an SP5 confocal with a 40x-
oil objective using Leica software. The fluorescent intensities of AnkG and neurofascin were 
determined using ImageJ by manually drawing a ‘segmented line’ (ROI) over the AIS 
markers. The average AnkG and neurofascin intensities were calculated by measuring the 
fluorescence intensity over the ROI and subtracting the intensity in nearby background. The 
segmented line was approximately 80 µm in length. The raw average florescence intensity is 
shown in the graphs, or it was normalised to the average AIS intensity of control neurons and 
next classified as: complete AIS (71-100% AIS), knockdown (20-70% AIS), or knockout.  
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III. RESULTS 
(1) Cellular toxicity following vector-mediated RNA interference 
 The shRNA plasmids were tested in cortical neurons in vitro before adeno-associated 
virus preparation. The plasmids containing the shRNA sequence for AnkG (Hedstrom et al.,  
2008), or a scrambled shRNA (Hedstrom et al.,  2008), were co-expressed with an eGFP 
plasmid to highlight neuronal morphology after transfection. The embryonic day 18 cortical 
neurons were transfected utilizing magnetic nanoparticles on 3 days in vitro (DIV) and were 
examined on 14 DIV. The cultured neurons were stained for AnkG and neurofascin to 
visualize the axon initial segment. Neurons transfected with eGFP had an AIS and typical 14 
DIV neuronal morphology (Fig. 3 - left). The axon initial segment of non-transfected neurons 
were also clearly visible throughout all experimental conditions (Fig. 3). However, neurons 
that were transfected with scrambled shRNA (Fig. 3 - middle) and the shRNA targeting 
AnkG (Fig. 3 - right) were dead. This shows that shRNA interference, delivered via plasmid 
transfection, causes cellular toxicity in primary cortical neurons.   
 
 
Fig. 3 shRNA interference caused cellular toxicity in primary cortical neurons after 11 days of plasmid 
transfection. The cells were cultured in high density and stained for AnkG (red) and neurofascin (blue), while 
the transfected neurons were eGFP-positive (green). Scale bar is 50 µm. Lab journal reference: BN-17-07  
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(2) Adeno-associated dual promoter construct containing SaCas9 and one sgRNA to 
target AnkG 
 After observing that the shRNA interference approach is not suitable for future 
experiments, we decided to switch to recent advanced technology for knockout of the AIS. 
The CRISPR-Cas9 technology was getting more accepted and frequency used for knockout of 
genes as of 2016. At this time, I modified an existing CRISPR-Cas9 plasmid (Addgene 
plasmid # 61591, Zhang) by swapping the CMV promoter, located upstream of the Cas9 
enzyme sequence, for the SYN promoter in order to achieve neuron-specificity (see Chapter 
IV). The optimized plasmid is a dual promoter construct that is suitable for rAAV production. 
A shorter isoform of Cas9 (Staphylococcus aureus Cas9; SaCas9) is fused to a nuclear 
localization signal and a 3x HA-tag and is expressed under a hSYN promoter, while the RNA 
promoter hU6 drives the expression of the guide RNA of interest (Fig. 4). The utilization of 
the short SaCas9 sequence is crucial due to the limited packaging size of rAAVs. Two sgRNA 
sequences which interact in the first exon of the Ank3 gene (Fig. 5) were cloned downstream 
of the hU6 promoter to generate plasmids that could dismantle the AIS. Future experiments 
aiming to knockout gene of interests will therefore consist of four conditions: pAAV-SYN-
eGFP (vector control), pAAV-SYN-SaCas9-HA-hU6-backbone (control for SaCas9), pAAV-
SYN-SaCas9-HA-hU6-sgRNA-1, pAAV-SYN-SaCas9-HA-hU6-sgRNA-2 (experimental 
groups).  
 
 
Fig. 4 Schematic representation of the adeno-associated dual promoter construct containing Cas9 from 
Staphylococcus aureus (SaCas9) and one cloning site for sgRNA insertion. The SYN promoter expresses 
SaCas9 that is fused to Simian vacuolating virus 40 nuclear localization signal (NLS) and 3x HA tag. The hU6 
promoter is upstream of a BsaI cloning site to express any single guide RNA (sgRNA) of interest. The packaging 
cassette has a total length of 4473 basepairs and are flanked by inverted terminal repeats (ITR). The bovin 
growth hormone polyadenylation signal (BGHpA) is not shown. Lab journal reference: BN-16-19. 
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Fig. 5 Schematic showing the beginning 400 nucleotides of the rat ANK3 gene and highlights two target 
DNA sequences (red) upstream of two PAM sites (NNGRRT) (blue). Annealed DNA oligonucleotides 
encoding these target sequences were sub-cloned downstream of the hU6 promoter of plasmid pAAV-SYN-
SaCas9-HA-hU6-backbone to complete the guide RNA. Lab journal reference: BN-16-20. 
 
(3) SaCas9 alone also does not cause neuronal toxicity nor influences the axon initial 
segment 
 To examine whether the CRISPR-Cas9 strategy is viable in primary cortical neurons, 
the cells were co-transfected on 3 DIV, with the plasmid pAAV-SYN-eGFP and pAAV-SYN-
SaCas9-HA-hU6-backbone, and fixated on 14 DIV. The eGFP-transfected neurons had green 
fluorescence spread throughout the cell, and have an axon initial segment (Fig. 6A). The 
neurons that were transfected with the CRISPR-Cas9 construct were immunelabelled for the 
HA-tag that is fused to the SaCas9 sequence. In contrast to the eGFP condition, the SaCas9 
was mainly localized in the cell body and initial parts of neurites only (Fig. 6B). The 14 DIV 
neurons that were transfected with SaCas9 without guide RNA were alive and have an axon 
initial segment (Fig. 6B). There was no statistically significantly difference in the fluorescent 
intensities of AnkG (Fig. 6C) and Neurofascin (Fig. 6D). The intensities of the AIS markers 
were measured over the same distance in the axon (Fig. 6E). In contrast to the shRNA 
interference approach, the CRISPR-Cas9 technology is suitable for experiments and does not 
exhibit any visible toxicity, via plasmid overexpression, in primary neuronal cultures.  
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Fig. 6 Validation of the pAAV-SYN-SaCas9-hU6-backbone construct (plasmid 698 in the Cambridge and 
Amsterdam plasmid databases) in primary cortical neuron cultures. Rat cortical neurons were transfected 
on 3 DIV with pAAV-SYN-eGFP (A) and pAAV-SYN-SaCas9-hU6-backbone (B), and were stained on 14 DIV 
for HA-tag (green), Ankyrin-G (red), and Neurofascin (blue). The confocal scanning microscope settings for the 
red and blue channels were identical; the green intensity setting for exogenous eGFP or the labelled HA-tag 
differs between the two experimental conditions. (C) Quantification of Ankyrin-G fluorescent intensity (P > 
0.05, Student’s t-test). (C) Quantification of the of Neurofascin fluorescent intensity (P > 0.05, Student’s t-test). 
(D) Quantification of the length that was measured as region of interest (P > 0.05, Student’s t-test). The graphs 
depict the averages and standard error of the mean. A total of 20 cultured cells were measured for the eGFP 
condition, and 18 cells for the SaCas9 only condition. Lab journal reference: BN-16-33 
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(4) Axon initial segment knockout in a proportion of neurons following CRISPR 
interference after 11 days of transfection 
 After confirming that SaCas9 itself does not influence the axon initial segment (Fig. 
6), two CRISPR-cas9 vector plasmids containing sgRNA-targeting AnkG were tested on their 
potential capacity to dismantle the axon initial segment. The plasmids were transfected on two 
different time points and fixated on 14 DIV. The half-live time of the AnkG protein in 
cultured hippocampal neurons was estimated on 14 days in a previous study (Hedstrom et al.,  
2008).  
 When the neurons were transfected on 7 DIV and fixated on 14 DIV not a single 
neuron had a complete knockout of the axon initial segment. There was only a small reduction 
of the AnkG fluorescent intensity with the sgRNA-2 condition after seven days of transfection 
(Fig. 7A). No difference was found in the average fluorescence intensity of neurofascin (Fig. 
7B). Thus, seven days is not sufficient to dismantle the axon initial segment after plasmid 
transfection. 
 
Fig. 7. Seven days of plasmid transfection with sgRNA-1 and sgRNA-2 is not sufficient for complete 
knockout of the AIS. Quantifications of the protein fluorescent intensities for Ankyrin-G (A) (4 groups and a 
total of 85 values, K-W=16.8, P<0.001, Kruskal-Wallis test with multiple comparison test) and Neurofascin (B) 
(df=3(81), F=1.03, P>0.05, ANOVA with Tukey’s multiple comparison test). The graphs represent the averages 
and standard error of the mean. Lab journal reference: BN-16-04 
 
 In a follow-up experiment, the neurons were transfected on 3 DIV and kept in the cell 
culture dish until 14 DIV. As expected, the neurons in the eGFP and the SaCas9 without 
sgRNA condition all had an axon initial segment (Fig. 8, see also Fig. 6). Fig 8A shows 
examples of transfected neurons that completely lost their AIS in the sgRNA1 and sgRNA2 
experimental conditions. These HA-tagged neurons lost both AIS proteins AnkG and 
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neurofascin. However, the complete knockout of AnkG (Fig. 8B) and the removal of 
neurofascin (Fig. 8C) was observed only in a small proportion of neurons. Knockout of the 
AIS was observed in 26% and 28% of the neurons that were transfected with the CRISPR-
Cas9 constructs containing sgRNA1 and sgRNA2, respectively. Thus, the time period of 
eleven days after transfection results in dismantling of AIS in a small proportion of neurons 
using CRISPR interference.  
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Fig. 8. – previous page - Pilot experiment for the knockout efficiency of the AIS by the CRISPR-cas9 
constructs containing sgRNA for AnkG. (A) Examples of neurons that were transfected with the plasmids 
pAAV-SYN-eGFP, pAAV-SYN-SaCas9-hU6-backbone, pAAV-SYN-SaCas9-hU6-sgRNA-1, pAAV-SYN-
SaCas9-hU6-sgRNA-2 on 3 DIV and were fixated on 14 DIV for AIS analysis. (B) Categorization of neurons 
based on their fluorescent intensity for Ankyrin-G. (C) Categorization of neurons based on their fluorescent 
intensity for Neurofascin. Complete AIS was classified as 70- till 100% of fluorescence intensity compared to 
the average normalized intensity of eGFP transfected neurons, knockdown was classified as an fluorescence 
intensity less than 70% compared to the average of normalized controls, a knockout was classified as complete 
absence of AIS staining in the transfected neuron. The number of cells for each condition is mentioned in the 
graphs, this experiment was done once (n=1). Lab journal reference: BN-16-33. 
 
IV. DISCUSSION  
 This chapter describes plasmids for shRNA interference and CRISPR-Cas9 to 
knockout AnkG. Both tools for AnkG knockout were tested in cultured cortical neurons and 
were examined for their ability to dismantle the AIS.  The hypothesis whether loss-of function 
of the AIS can promote axonal transport of integrins in vivo has not been investigated yet.      
 
(1) Toxicity in primary cortical neurons by expressing short hairpin RNAs 
 The cloning of the shRNA plasmid was more difficult than expected.  The main 
challenge that I encountered was the removal or modification of the short hairpin sequence 
during transformation. The use of the GT116 bacterial strain is crucial for cloning plasmids 
that contain hairpin structures or ITR repeats. E.coli have genes (e.g SbcCD) that encode 
nucleases that remove hairpin loops from plasmid DNA (Connelly, Kirkham, & Leach,  
1998), which make shRNA-containing plasmids instable in most bacteria. The GT116 
bacterial strain has these nuclease genes depleted and are therefore more suitable for shRNA 
cloning. DNA sequencing indeed revealed that the short hairpins were modified (e.g. 
removed, incomplete, and reversed) when other bacterial strains were used during 
transformation (data not shown). The BglII restriction digestion prior transformation is also 
key to increase the number of shRNA-positive colonies (first year report).  
 This study observed that shRNA interference induced cellular toxicity in primary 
cortical neuronal cultures. Despite that expression of shRNA has been a popular method to 
knockout proteins, there are studies that also reported neuronal toxicity (Ulusoy et al.,  2009; 
Ehlert et al.,  2010; Khodr et al.,  2011; Martin et al.,  2011). AAV5-mediated delivery of 
scrambled-shRNA and shRNA targeting tyrosine hydroxylase in the substantia nigra resulted 
in neuronal cell loss (Ulusoy et al.,  2009). Consistently, delivery of control and shRNA 
targeting α-synuclein in this brain area, via AAV2, resulted in neuronal degeneration (Khodr 
et al.,  2011). Another study observed cell death in the red nucleus after AAV1-mediated 
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delivery of scrambled- and shRNA targeting neuropilins (Ehlert et al.,  2010). AAV1 was also 
used to delivery shRNA in the striatum of two mouse lines which also resulted in toxicity and 
animal illness (Martin et al.,  2011). Above studies are consistent with our in vitro study, 
showing that shRNA vectors cause neuronal cell death. Importantly, the cultured neurons that 
were non-transfected or transfected with eGFP had healthy morphology suggesting that the 
delivery method is not the reason of toxicity.   
 Overexpression of the shRNA plasmids possibly overtake the endogenous siRNA 
machinery in cells (Grimm et al.,  2006).  The abundance of the H1-promoter driven shRNA 
can occupy Exportin-5 and thereby prevent the transportation of endogenous RNA into the 
cytoplasm (Yi et al.,  2005, Grimm et al.,  2006). The binding competition for this transporter 
protein also inhibits the efficiency of the RISC complex (Bennasser et al.,  2011). The brain 
may be in particular more vulnerable to this as exportin-5 is expressed in relatively low levels 
(Yi et al.,  2005). The saturation of these key factors in the RNAi machinery may explain 
observed neuronal cell death.  
 
(2) CRISPR-Cas9 interference for Ankyrin-G 
 Neurons remained healthy after introducing the CRISPR-Cas9 vector plasmid via 
transfection. The SaCas9 protein was visualised by staining for the HA-tag and we observed 
that this DNA endonuclease becomes localised in the soma and proximal parts of neurites. In 
contrast, transfection of eGFP results in a cytoplasmic expression pattern visualising the 
entire morphology of the neuron. This validates that the nuclear localization signal attached to 
the SaCas9 protein is functional. This is an important observation because the SaCas9 needs 
into the cell nucleus for inducing double strand breaks in DNA. The presence of SaCas9 in 
the proximal parts of the neurites could be explained by translation of the overexpressed 
SaCas9 plasmid by cytoplasmic ribosomes in the cell, while this local translated SaCas9 is 
trafficked towards the nucleus via the nuclear localization tag. Importantly, delivery of the 
SaCas9 without sgRNA did also not affect the AIS. In summary, the delivery of SaCas9 
without sgRNA into cortical neurons does not induce neuronal toxicity and does not induce 
changes in the axon initial segment. Thus, vector-mediated expression of SaCas9 can be 
successfully applied in vitro.  
  The two designed target sequences for AnkG do interfere with the AIS. We found that 
the CRISPR-Cas9 vector plasmid needs to be applied for a long time-period to knockout 
AnkG. This is most likely due to the long half-live of the AnkG protein. In order to achieve 
successful AnkG knockout, gene expression needs to be prevented and afterwards the 
endogenous AnkG protein in the AIS need to be degraded. Hedstrom et al.,  2008 
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demonstrated that the half-live time of endogenously expressed AnkG is at least two weeks in 
cultured hippocampal neurons. Our study indeed failed to observe a complete AnkG knockout 
at four- (not shown), and seven days post-transfection. Yet, we observed knockout in a small 
proportion of neurons after eleven days post-transfection.  This is indeed consistent with the 
suggested stable half-live of AnkG. Yet, we do not know what is the time needed for indel 
induction by SaCas9. The activity dynamics of SaCas9 could therefore be another rate 
limiting step for protein knockout. Furthermore, the cultured cortical neurons are 
heterogeneous population of cells each may have a different axon initial segment fluorescent 
intensity. Importantly, this study found that neurofascin failed to localise at the AIS as 
consequence of AnkG knockout as suggested by previous studies (Zhou et al.,  1998, Jenkins 
& Bennett,  2001; Hedstrom et al.,  2007). This confirms that AnkG is crucial to sustain the 
AIS and is a valid target to dismantle this important structure.  
 The designed sgRNA2 seems more efficient than sgRNA1 to knockdown and 
knockout AnkG in cortical neurons. I recently found that sgRNA1 targets only the long 
isoform of Ank3 (see second start codon ‘ATG’ at position 50 in Fig. 5), while sgRNA2 
correctly targets both the short and long neuronal isoforms of Ank3. 
 The CRISPR-interference can be further improved in this study. Firstly, the CRISPR-
Cas9 vector plasmid can be applied for a fourteen-day period to match the AnkG half-live 
time. The earliest time point for a magnetofection reaction that results without neuronal cell 
death is 2 DIV (Fallini, Bassell, & Rossoll,  2010; see Chapter III, section II.3) and cell 
cultures can be maintained healthy until 16-18 DIV. This longer time period should enhance 
the number of cells with successful AnkG knockout. Secondly, the examination of AnkG 
knockout per transduced neuron can be simplified by co-transfection of an eGFP plasmid, as 
this visualises the entire neuronal morphology including the proximal part of the axon. 
Thirdly, the experiment should be repeated, as the current n-number of this study is 1. In 
addition to examine protein knockout, it will be extremely interesting to perform single-cell 
DNA sequencing of a transduced neuron and examine whether a double strand break is 
induced in the target DNA region.   
 The next important step will be to investigate whether the CRISPR-cas9 interference 
is functional in vivo. Based on the finding of Chapter IV, the plasmids can be used for the 
preparation of recombinant adeno-associated viral vectors with serotype 1 for optimal 
neuronal transduction in the cortex. The first experiment should be focussed on the detected 
of SaCas9 in the nucleus of CNS neurons. Daniella Carulli (Netherlands Institute for 
Neuroscience) tested my CRISPR construct designed for Sema3A in the cerebellum with the 
AAV1 serotype and found that SaCas9 was localised in the cell body of Purkinje neurons. 
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She observed that the control vectors without targeting guide RNA were many localised in the 
cytoplasm of the cell body, while the vectors containing the guide RNA were more frequently 
found in the nucleus. The second experiment should validate whether the designed sgRNA for 
Ank3 can dismantle the AIS, by co-staining for the HA-tag, NeuN, AnkG or another AIS 
protein. I experienced that immunohistochemistry for AnkG can be difficult in cortical tissue 
in vivo.  The primary antibodies N106/36 by NeuroMab and sc-28561 by Santa Cruz for 
AnkG with 1:500 dilution needs to be incubated for three days at four degrees Celsius, or kept 
overnight at room temperature for successful detection of AnkG in PFA-perfused tissue (Lab 
journal reference: BN-18-05). The validation of the CRISPR constructs in vivo will be crucial 
for future experiments.  
    It remains unclear whether the AIS contribute to the axonal transport block of 
integrins in vivo. This research question could be addressed by comparing the following two 
experimental conditions in vivo: 1) co-injection of AAV1-SYN-α9integrin-V5 and AAV1-
SYN-SaCas9-HA-hU6-sgRNA-2 2) co-injection of AAV1-SYN-α9integrin-V5 and AAV1-
SYN-eGFP. Staining for the V5-epitope fused to integrins will visualize the potential mis-
trafficking of integrins into the axon following AnkG knockout.  
 
(3) Dismantling the axon initial segment to stimulate axonal regeneration 
Dismantling of the axon initial segment is one strategy to force integrins to enter the 
axons of the adult CNS neurons. We hypothesize that knockout of AnkG could permit 
regeneration-associated receptors to travel down the axon of adult CNS neurons in vivo. 
Disadvantages of dismantling the AIS are: 1) the deregulation of action potential propagation 
and 2) the loss of neuronal polarization. Loss of neuronal polarization and action potential 
propagation may not necessarily impair the intrinsic axonal regeneration response. However, 
these functions are essential for neuronal communication and the innervation of target cells 
after regeneration. Nevertheless, it is essential to demonstrate the proof-of principle that 
dismantling of the AIS allows integrins into the axons of the corticospinal tract in vivo before 
performing spinal cord injury experiments. If we can first show that dismantling the AIS is 
indeed essential for successful axon regeneration, a strategy that temporarily dismantle the 
AIS (namely during the post-lesion period during which axon regeneration takes place) could 
overcome the above discussed disadvantages.  
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CHAPTER III - Phosphoinositide 3-kinases promote axon elongation 
and regeneration of cultured cortical neurons 
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I. INTRODUCTION  
 The phosphorylation and dephosphorylation of inositol lipids control an orchestra of 
cellular mechanisms. Inositol lipid signalling is involved in cell growth, differentiation, 
migration, and survival among other essential functions (reviewed in Falasca & Maffucci,  
2012; Hawkins & Stephens,  2016; Backer,  2016). The most evolutionary conserved function 
of phosphoinositide kinases is the trafficking of vesicles between cellular organelles (Herman,  
1990; Backer,  2016). The inositol lipids are also crucial for axon growth and development of 
the nervous system (reviewed in RodgersTheibert et al., 2002; Cosker & Eickholt,  2007; 
Waite & Eickholt,  2010) Due to the diverse roles of inositol lipid, the signalling pathway is 
complex and involves many signalling cascades. 
 
(1) Signalling 
 Phosphatidylinositols (PIPs) are localised at the plasma membrane and have three 
hydroxyl sites (named 3,4,5) that can be modified by (de-) phosphorylation. These three sites 
give rise to seven unique phosphoinositides with each being involved in different signalling 
cascades. Here, we focus will be on phosphatidylinositol 4,5-bisphosphate (PIP2) and 
phosphatidylinositol (3,4,5)-trisphosphate (PIP3) that are modified by the enzymes called 
phosphatase and tensin homolog (PTEN) and class I Phosphoinositide 3-kinase (PI3K). 
Importantly, PI3K phosphorylates the 3’-hydroxyl site of PIP2 to generate PIP3, while PTEN is 
a 3’-phosphatase that turns PIP3 back into PIP2 (see Fig. 1).  
 There are four class I PI3K isoforms that participate in different signalling pathways:  
P110α, P110β, P110γ, and P110δ. These isoforms originate from different genes, PIK3CA, 
PIK3CB, PIK3CG, and PIK3CD, and are expressed in different cell types.  Importantly, the 
activity of the PI3K isoforms depends on upstream cell surface receptor activation. Integrins 
signalling (Watabe et al.,  2011; Niu et al.,  2012) via FAK (Chen et al.,  1996), and other 
receptors such as TrkB (Tang et al.,  2002; Yoshii & Constantine-Paton,  2007) and IGFR-1 
(Ou et al.,  2014) are known to activate PI3K (see Fig. 1). The kinases P110α and P110β are 
ubiquitously expressed throughout the body, while P110γ, and P110δ are mainly found in 
immune cells (reviewed in Fruman et al.,  2017). A study with LacZ reporter mice highlighted 
that P110α is ubiquitously expressed in the nervous system, while P110δ is expressed in 
peripheral nerves, DRGs and the spinal cord of embryonic mice (Eickholt et al.,  2007). RNA 
sequencing data from our laboratory confirmed that P110α is expressed in cultured cortical 
neurons, while P110β, P110γ and P110δ were expressed in relatively low levels or were not 
detected (Koseki et al., unpublished; Smith et al., unpublished).  
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 The generated PIP3 at the inner surface of the plasma membrane is a secondary 
messenger in many cellular processes.  Here, I categorized PIP3 signalling in three common 
pathways: (1) neuronal growth and survival; (2) calcium regulation; and (3) cytoskeleton and 
protein trafficking (see Fig. 1). Thus, targeting PI3K influence a wide range of cellular 
responses including those beneficial for axonal regeneration.   
  PIP3 signalling is regulated by negative signalling feedback loops (see Fig. 1). The 
most important and upstream feedback loop is phosphatase PTEN. After PIP3 is generated, 
PTEN can immediately end PIP3 signalling by reversing PIP3 into PIP2. A recent study found 
that S6 Kinase 1 (S6K), which is downstream of mTOR, also acts as a negative regulator of 
PIP3 signalling and its mediated neuronal growth (Al-Ali et al.,  2017). S6K interact with 
IRS-1 (Tremblay et al.,  2007; Zhang et al.,  2008), and this may be one of the mechanisms to 
attenuate PI3K signalling.   
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Fig. 1. Schematic of PIP3 signalling. Ligand binding to cell-surface receptors activates many kinases including 
phosphoinositide 3-kinase (PI3K). PI3K converts PIP2 into PIP3, which in turn, activates a diverse range of 
cellular functions including neuronal growth and survival, calcium regulation, and cytoskeleton and protein 
trafficking. PIP3 signalling is inhibited by negative feedback loops within the pathway. Firstly, phosphatase and 
tensin homolog (PTEN) dephosphorylates PIP3 and generates PIP2. Secondly, S6K1 is a negative regulator of 
PIP3 and mediated outgrowth, but the mechanisms remain to be elucidated.   
 
 
 
 
 
	85	
 (2) PTEN knockout and axonal regeneration 
 Many studies aim to boost the intrinsic regeneration response of CNS neurons. That 
PIP3 signalling is crucial for axonal regeneration is clearly demonstrated by genetic deletion 
of PTEN. Removal of PTEN activates the PIP3 signalling cascade. Conditional PTEN 
knockout mice resulted in a strong effect on CNS axonal regeneration in vivo (Park et al.,  
2008; Liu et al.,  2010). Park et al., (2008) injected AAV2-eGFP or AAV2-Cre two weeks 
prior optic nerve crush in the conditional PTEN knockout mice to assess whether PTEN is an 
inhibitor of regeneration.  As expected, RGCs injected with AAV2-eGFP were not capable to 
regenerate their axons beyond the injury site. Genetic deletion of PTEN doubled the survival 
rate of RGCs and 10% of the RGCs regenerated approximately 3 mm beyond the crush site.  
The authors confirmed that PTEN deletion enhanced the mTOR pathway by staining for 
phospho-S6 ribosomal protein (pS6) (see Fig. 1), which is a marker for initiation of protein 
translation.  There was an increase of pS6 in the regenerating neurons of PTEN knockout 
mice (Park et al.,  2008). Liu et al., (2010) went a step further and examined the effect of 
PTEN knockout on corticospinal tract regeneration after spinal cord injury. AAV2-eGFP or 
AAV2-Cre was injected in the sensorimotor cortex four-week prior (T8) spinal cord crush. 
Genetic deletion of PTEN resulted in corticospinal tract regeneration into the lesion site and 3 
mm beyond the site of injury, while controls did not. Consistent with the study in the optic 
nerve, the PTEN deletion prevented down-regulation of pS6 in corticospinal neurons after 
injury (Liu et al.,  2010). Surprisingly, the regenerating axons of the PTEN deleted neurons 
also formed (vGlut1-positive) synapses. Another research group utilized a similar 
experimental design with the PTEN conditional knockout mice, and found enhanced forelimb 
motor functional recovery after (C5) spinal cord contusion injury (Danilov & Steward,  2015). 
Compared to interventions that also successfully enhanced the intrinsic axonal regeneration 
response of the corticospinal tract, such as overexpression of transcription factors KLF7 
(Blackmore et al.,  2012) and Sox11 (Wang et al.,  2015b), genetic deletion of PTEN is 
possibly the most successful strategy today. However, studies that interfered with PTEN via 
AAV-shRNA-PTEN, an approach that is clinically relatively more feasible than genetic 
deletion, were less successful (Zukor et al.,  2013; Lewandowski & Steward,  2014). 
Nevertheless, the PTEN knockout studies showed that PTEN is an important inhibitor of 
axonal regeneration. Despite the upregulation of pS6, the exact mechanisms and downstream 
PIP3 signalling responsible for the observed axonal regeneration remains poorly understood. 
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(3) PI3K and axonal regeneration 
 The known effects of PI3K on axonal regeneration in the peripheral nervous system 
stems from studies that inhibited the endogenously expressed kinase. After establishing that 
P110α and P110δ are expressed in the peripheral nervous system (Eickholt et al., 2007; Eva et 
al., unpublished), their importance for axonal regeneration was examined.  Eickholt et al., 
2007 used transgenic mice expressing a PIK3CD-inactive mutation (PIK3CD D910A) and 
performed a sciatic nerve crush. The inactivation of P110δ impaired the initiation of axonal 
regeneration, as there were less axonal fibers beyond the injury site compared to wild type 
after three days post-injury. However, there was no significant difference between the 
transgenic mice and control seven days post-injury, suggesting that other factors such as the 
ATF3 transcription factor and P110α can still stimulate regeneration in the PNS. 
Nevertheless, the inactivation of P110δ impaired functional recovery including locomotion 
and grasping (Eickholt et al.,  2007). As expected, the inactivation of P110δ alters the PIP3 
signalling pathway in cultured DRG neurons (after NGF stimulation) and brain extracts. 
Neurons with inactive P110δ had less phosphorylation of Akt and S6K, while the expression 
of axon growth inhibitor RhoA was increased (Eickholt et al.,  2007).  
 Eva et al., (unpublished) inhibited various PI3K isoforms in cultured adult DRGs 
before in vitro laser axotomy. Naïve adult DRG had an average regeneration percentage of 
70%, and inhibition of certain PI3K isoforms influenced this outcome. DRG neurons 
inhibited for P110α and P110δ had a regeneration rate of 30%, and 35% respectively. 
Inhibition of the non-neuronal P110β isoform did not affect the regeneration capacity of DRG 
neurons.  
 In summary, the P110α and P110δ isoforms are expressed in the peripheral nervous 
system and contribute to their regenerative capacity.  
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(4) Decline of PIP3 signalling during maturation of CNS neurons 
 Our laboratory has the hypothesis that the PIP3 signalling pathway becomes less active 
in the axon when CNS neurons mature. Here, we discuss three components that we believe 
that contribute to the developmental decline of axonal PIP3 signalling: (1) exclusion of 
regeneration-associated receptors from the axon,  (2) down regulation of PI3K, and (3) down 
regulation of pS6.  
 We discussed in Chapter I Sections VII and VIII, that growth-associated cell-surface 
receptors are not localised in the axons of the adult corticospinal tract. The exclusion of 
integrins (Franssen et al.,  2015; Andrews et al.,  2016), TrkB (Yan et al.,  1997; Lu et al.,  
2001; Hollis et al.,  2009b), and IGF-1R (Hollis et al.,  2009a) from the axon has 
consequences for PIP3 signalling. These cell-surface receptors are essential for the activation 
of PI3Ks and therefore PIP3 signalling. Hence, the exclusion of cell-surface receptors 
contributes to a decline in PIP3 signalling and the corresponding poor intrinsic regeneration 
capacity after injury.  
 In addition to a decline in the receptor-mediated activation of PI3K, our laboratory has 
unpublished data showing that PI3K itself is down regulated during maturation of CNS 
neurons.  Koseki et al., (unpublished) performed an RNA sequencing experiment at different 
time points on cortical neurons that were cultured to maturity (up to 24 days in vitro). As 
expected, the genes PIK3CB and PIK3CG were not expressed in cortical neurons. PIK3CA 
was expressed in relative high levels at 1 DIV (RNA score: 16) and was drastically decreased 
in expression levels towards maturity (24 DIV, RNA score: 7). PIK3CD was expressed in low 
levels throughout polarisation of the neurons (Average RNA score:  6.0). Thus, there is 
developmental decline in the expression of PI3K in cultured cortical neurons.  
 When CNS neurons mature, there is also a decline in the phosphorylation of 
Ribosomal protein (S6), which is downstream in the PIP3/mTOR pathway (see Fig. 1). This 
developmental decline in pS6 was shown in vivo in retinal ganglion cells (Park et al.,  2008) 
and cortical neurons (Liu et al.,  2010).  
  
(5) Hypothesis ‘understanding regenerative failure’  
 We hypothesize that the developmental decline in axonal PIP3 signalling contributes to 
restricted axonal regeneration in the CNS. In other words, there are insufficient growth and 
survival molecules in mature CNS axons for successful regeneration: the signalling receptors 
and PIP3 levels are sparse.  
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(6) Aim of study 
 Because of the importance of PIP3 signalling in growth and regeneration, we explored 
whether a gain-of-function approach of PI3K isoforms could promote axonal regeneration of 
CNS neurons in vitro. Because the P110α and P110δ isoforms are important for axonal 
regeneration in the PNS (see Section I.3), it would be reasonable to expresses or activate these 
kinases in the CNS to promote regeneration. In addition, we investigated the effect of one 
PIK3CA-activation mutation, PIK3CA H1047R. This substitution of the histidine (H) to 
arginine (R) enhances the affinity of P110α towards the plasma membrane (Zhao & Vogt,  
2008; Burke et al.,  2012; Hon, Berndt, & Williams,  2012) and hyper-activates the PIP3 
signalling pathway (Wu et al.,  2014).  
 
II. MATERIALS AND METHODS 
(1) DNA constructs 
 pHR-eGFP and pHR-PI3KCD were a gift from Klaus Okkenhaug (Babraham Institute, 
Cambridge) and were used for subsequent cloning. pHR-PI3KCA was made by amplifying 
the PI3KCA sequence from pBabe puro HA PIK3CA, a gift from Jean Zhao (Addgene 
plasmid # 12522), via the primers 5’ GTGTGGATGTGATGAATACTTCC 3’ and 5’ 
GGAGGCCAATCTTTTACCAAGC 3’ and was cloned into pHR-eGFP between the BamH1 
(NEB, R0136) and Not1 (NEB, R0189) digestion site. pHR-PI3KCA H1047R was made by 
cloning the mutated PI3KCA sequence from pBabe puro HA PIK3CA H1047R, which was a 
gift from Jean Zhao (Addgene plasmid # 12524), into pHR-eGFP via the same procedures as 
pHR-PI3KCA. A schematic representation of the four dual promoter plasmids is shown in 
Fig. 2.  
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Fig. 2. Schematic representation of lentiviral dual promoter constructs. All constructs express emerald green 
fluorescent protein (Emerald) under the Ubiquitin promoter. The spleen focus forming virus (SFFV) promoter 
flanked by a woodchuck hepatitis virus post-transcriptional regulator element (WPRE) drives the expression of 
enhanced green fluorescent protein (eGFP), PIK3CA, PIK3CA H1047R, or PIK3CD, respectively. The 
packaging cassettes are flanked by long terminal repeats (LTR). Note: the SFFV promoter had been shown to be 
capable to successfully drive the expression of transgenes in corticospinal neurons in vivo (Yip et al., 2010). Lab 
journal reference: BN-15-23. 
 
(2) Cortical neuron cultures 
 Primary cortical neuron cultures were prepared from embryonic day 18 Sprague 
Dawley rats. Extensive details are described in Chapter II section II.11 and a short summary 
is below. The neurons were dissociated with papain (Worthington, LK003176) for 10 minutes 
at 37°C. They were next briefly rinsed with DNase (Sigma, D5025) and washed with HBSS 
(Gibco, 14170) containing HEPES buffer solution (Gibco, 15630). The neurons were cultured 
in neural Q basal medium (Globalstem, gsm9420), supplemented with GS21 (Amsbio, 
gsm3100) and glutamax (Gibco, 35050) and plated on glass bottom cell cultures dishes 
(Greiner bio-one, 627860) coated with poly-D-lysine in borate buffer.  
 
 
LTR SFFV eGFP WPRE Ubiquitin Emerald LTR
LTR SFFV PIK3CA WPRE Ubiquitin Emerald LTR
LTR SFFV PIK3CA H1047R WPRE Ubiquitin Emerald LTR
LTRLTR SFFV PIK3CD WPRE Ubiquitin Emerald
pHR-eGFP
pHR-PIK3CA
pHR-PIK3CA H1047R
pHR-PIK3CD 
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(3) Magnetofection 
 The cortical neurons were transfected at 2 days in vitro (DIV) or 10 DIV by using 
oscillating nanomagnetic transfection (magnefect nano system; nanoTherics). The DNA 
constructs (7 µg per dish) were mixed with 8 µl of magnetic nanoparticles (NeuroMag, 
NM50200) in 100 µl of culture medium and were incubated for 30 minutes. The culture 
media was substituted for the transfection mixture, and 900 µl of neuronal media, and 
afterwards the dishes were placed over a magnetic array, which was moving laterally at 2 Hz 
and at 0.2 mm amplitude of displacement for 30 minutes at 37°C in a 7% Co2 incubator. After 
the transfection, the original culture medium was returned to each well and the neurons were 
cultured until 4- or 14 DIV. 
 
(4) BDNF stimulation 
 Cultured pH-eGFP transfected neurons were treated with 400 ng/ml of lyophilized 
human BDNF protein (RAB0026-1VL-KC) in neural Q basal medium (Globalstem, 
gsm9420) for 10 minutes before fixation.  
 
(5) Immunocytochemistry  
 The cultured cortical neurons were fixed with 4% paraformaldehyde (PFA) in PBS for 
10 minutes and were washed in PBS. The PFA fixated cells were permeabilized by applying 
0.3% triton (Sigma, X-100) detergent in PBS for five minutes and were afterwards washed in 
PBS. Neurons that were used to stain for α5 integrin were fixed at 14 DIV with cold methanol 
for 10 minutes. The cells were blocked with 3% bovine serum albumin (BSA) (Sigma, 
A7906) in PBS for 1 hour. After blocking, the cells were incubated with primary antibodies 
diluted in 3% BSA in PBS at 4°C overnight. The primary antibodies used were anti-phospho-
S6 ribosomal protein (Ser235/236) (4857, 1:200, Cell signaling technology), anti-Rab11 (71-
5300, 1:50, ThermoFischer scientific), anti-eGFP (A10262, 1:1000, ThermoFischer 
scientific), Anti-integrin α5 (AB1928, 1:500, Merck), Anti-Pan-neurofascin (A12/18, 1:200, 
NeuroMab). Afterwards, the cells were washed and incubated in Alexa Fluor-conjugated 
secondary antibodies that were diluted in 3% BSA in PBS for 1 hour at room temperature. 
The secondary antibody used were anti-chicken IgY conjugated to Alexa Fluor 488 (A-11039, 
1:1000, ThermoFischer scientific) anti-rabbit IgG conjugated Alexa Fluor 568 (A10042, 
1:500, ThermoFischer scientific), anti-mouse IgG conjugated Alexa Fluor 660 (A21055, 
1:500, ThermoFischer scientific). The cells were mounted using fluorsavetm reagent 
(Calbiochem, 345789).  
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(6) Immunocytochemistry for PIP3 
 The procedures to detect PIP3 were developed by Joachim Fuchs and professor Britta 
Eickholt (Charité University Medicine Berlin). Low-density cultures were fixated using a pre-
warmed (37°C) mixture of 4% PFA and 0.2% glutaraldehyde (GA; G011/3, TAAB 
Laboratories) in PBS for 15 minutes at room temperature. The GA was added to the PFA 
because it makes larger crosslinkers than PFA to stabilize lipids in addition to proteins. After 
fixation, the tissue was washed in 50mM ammonium chloride (NH4CL) in PBS to remove the 
fixative and to quench autofluorescence by PFA/GA. The tissue was stored at 4°C until 
further use, or directly placed on a metal plate with ice for further immunocytochemistry 
procedures to limit the diffusion of lipids. Pre-chilled blocking (and permeabilisation) 
solution consisting of 0.2% saponin, 50mM NH4CL and 3% BSA in PBS was incubated on 
the cells for 30 minutes at 4°C. The cells were incubated in purified anti-PtdIns(3,4,5)P3 
monoclonal antibody (Z-P345b, 1:200, Echelon) in blocking solution for two hours at 4°C. 
After PIP3 labeling, the cells were washed in 50mM NH4CL in PBS for 30 minutes at 4°C. 
The PIP3-labbeled cells were post-fixated in 4% PFA in PBS for 5 minutes on ice and 10 
minutes are room temperature. After the post-fixation, the cells were washed at room 
temperature. The cells were permeabilized with blocking solution for 30 minutes at room 
temperature. After blocking and re-permeabilisation, the secondary antibody anti-mouse IgG 
conjugated Alexa Fluor 568 (A11004, 1:1000, ThermoFischer scientific) was applied and 
incubated for 1 hour at room temperature. The cells were washed and afterwards mounted 
using fluorsavetm reagent.  
 
(7) Neurite outgrowth assay 
 Cultured cortical neurons were transfected at 2 DIV and immunocytochemistry 
procedures were done at 4 DIV to enhance the eGFP fluorescence intensity. Images for 
neuronal morphology were acquired using a fluorescence microscope (BMI-8, Leica) with a 
20x light objective using Leica software. The 15 longest neurons for each condition were 
analysed. Neurons with less than three minor neurites were excluded; hence only polarised 
neurons were included for image analysis. The neurite lengths were measured using a plugin 
of the software ImageJ entitled ‘simple neurite tracer’ (Longair, Baker, & Armstrong,  2011).  
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(8) Morphology analysis of 14 DIV cortical neurons 
 Images for neuronal morphology of 14 DIV neurons were captured on a fluorescent 
microscope (DM6000 B, Leica) with a 40×-oil objective using Leica software. For the 
purpose of sholl analysis, it is crucial that the soma is located in the middle of the acquired 
image to measure the dendritic branches for 150 µm around the soma. Semi-automated and 
standardized analysis of neuronal morphology was performed using MATLAB platform 
version 2017 and the program called SynD (Schmitz et al.,  2011). SynD detects the soma by 
tresholding and component analysis and afterwards detects the neurites by applying steerable 
filters at the immunofluorescence images. We manually extended neurites that were not 
completely traced and removed any unwanted crossing of neurites from a different neuron. In 
addition, we excluded spines that were identified as neurite by SynD. The output of SynD was 
used for data analysis and includes dendritic length, fluorescent intensities, sholl analysis, and 
soma size. Prism 7 for Mac OS X was used for statistical analysis.  
(9) In vitro laser axotomy 
 In vitro laser axotomy (see Fig. 3) was used to study whether overexpression of PI3K 
promotes axon regeneration in CNS neurons. Cortical neurons were cultured and transfected 
with pHR-eGFP, pHR-PIK3CA, pHR-PIK3CA H1047R, pHR-PIK3CD on 10 DIV. The four 
experimental conditions were laser axotomised in a random order on 13 DIV, 14 DIV, 15 
DIV, or 16 DIV, and this was repeated for three independent neuronal cultures (Fig. 3A). The 
axon was axotomised at a minimum distance of 1000 µm distal to the soma and on a region 
that was free from axonal branches. The laser axotomy was done using a 355 nm DPSE laser 
(Rapp OptoElectronic, Hamburg, Germany) connected to a Leica DMI6000B microscope 
with Hamamatsu EM CCD C9100 camera. The site of injury was imaged every 30 minutes 
for 14 hours. The proximal site of the axotomised axon was classified as no regeneration or 
regeneration (see Fig. 3B). Regeneration was defined as the formation of a growth cone 
followed by axon extension for at least 50 µm. No regeneration was defined as a surviving 
axon that did not regrow beyond 50 µm. Leica LAS AF software was used to analyse the 
injured axons for length of axon retraction, initiation time of axon regeneration, and length of 
axon regeneration. The statistical tests for each experiment are shown in the figure legends. 
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Fig. 3. Cell culture model to study the intrinsic axonal regeneration response. (A) A three-step set-up to 
investigate axonal regeneration in cultured neurons. In this example, primary cortical neurons were plated on a 
glass-bottomed imaging dish and were transfected with various DNA plasmids. The axons of the transfected 
neurons underwent laser axotomy and were video recorded for 14 hours. The arrow shows the site of injury. (B) 
Representative images of a non-regenerating axon (upper panels) and a regenerating axon (lower panels) from 
cortical neurons that were cultured for two weeks. The asterisk indicates the location of the proximal stump after 
one-hour post-axotomy, while the arrow marks the growth cone at indicated time-point. The scale bars are 50 
µm. This figure was published in Nieuwenhuis & Eva,  2018a.  
 
(10) Statistical analysis  
 Statistical analysis was performed by using Graphpad Prism 7 for Mac OS X. All 
statistical tests and parameters are mentioned in the figure legends. The graphs represent the 
average for each condition together with the standard error of the mean (SEM), while the 
individual data points for each investigated cell are illustrated as dots. One-way ANOVA with 
Tukey’s multiple comparison was most frequently used in this chapter as one dependent 
variable (e.g. neurite length or fluorescent intensity) was examined in four experimental 
groups. However, if the data distribution breaks the statistical assumption of equal variance in 
ANOVA (e.g. P < 0.05 in the Brown-Forsythe test or Barlett’s test) then a Kruskal Wallis 
with Dunn multiple comparison test was performed. The statistical test for the sholl analysis 
in Fig.  6C was a repeated measure ANOVA followed by Bonferroni multiple comparison 
tests as an interaction/correlation between the two independent variables ‘number of 
branches’ and ‘distance from soma’ was examined between four experimental groups.  
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III. RESULTS 
(1) Reduction of PIP3 during maturation of cortical neurons in vitro 
 Neurons lose their intrinsic regeneration capacity in line with maturation. Here, we 
investigated whether is a decline in PIP3 during maturation of cortical neurons in vitro. 
Embryonic day 18 cortical neurons were cultured and fixated on 3 DIV and 17 DIV. Specific 
immunocytochemistry procedures for PIP3 were performed for both conditions at once. The 
immunofluorescence intensity is different between 3 DIV and 17 DIV neurons (Fig. 4). 
Developing neurons had relatively high PIP3 levels, which is mainly localised in the soma and 
distal end of the axon and the growth cone (Fig. 4A). Maturing neurons had relatively low 
levels of PIP3 through out the cells (Fig. 4B).  
 
 
 
Fig. 4. Immunofluorescence intensities for PIP3 in cultured cortical neurons at different time points. E18 
cortical neurons were cultured and fixated on 3 DIV and 17 DIV. After fixation, the neurons were stained for 
PIP3 and the immunofluorescence intensity was compared. (A) Representative 3 DIV neurons with zoom in on 
the growth cone (B) Representative 17 DIV neurons with a zoom-in on neurites.  The images are shown in 
spectrum scale: blue indicates low fluorescence intensity, red indicates high florescence intensity.  
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(2) PI3K promotes axon elongation of developing cortical neurons in vitro 
 Before doing axonal regeneration experiments in vitro, we investigated whether PI3K 
overexpression affects axon development. For this purpose, cortical neurons were transfected 
with pHR-eGFP, pHR-PIK3CA, pHR-PIK3CA H1047R and pHR-PIK3CD on 2 DIV and 
fixated on 4 DIV for morphological analysis. Neurons expressing pHR-eGFP had an axon 
(see the longest neurite, black arrows) with a length of approximately 500 µm (Fig. 5A, 5B).  
Gain of PIK3CA function did not affect the axon length, while neurons expressing PIK3CA 
H1047R and PIK3CD had a twice-longer axon than eGFP and PIK3CA transfected neurons 
(Fig. 5A, 5B).  The length of dendrites (see minor neurites, red arrows) was similar between 
eGFP- and PIK3CA transfected neurons.  Expression of PIK3CA H1047R and PIK3CD 
overexpression lead to a relatively small increase in dendritic growth (Fig. 5A, 5C). 
Overexpression of PI3K approach did not affect neuronal polarization because the axons were 
clearly visible and approximately 20 times larger than the dendrites in all conditions (Fig. 
5D). 
 
 
Fig. 5. PIK3CA H1047R and PIK3CD promote axon elongation of developing cortical neurons. E18 
cortical neurons were cultured and transfected on 2 DIV. (A) Representative 4 DIV pHR-eGFP, pHR-PIK3CA, 
pHR-PIK3CA H1047R and pHR-PIK3CD transfected neurons. (B) Quantification of the axon length (back 
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arrow) (P < 0.001, Kruskal-Wallis with Dunn multiple comparison test). (C) Quantification of average dendrites 
length (red arrow) (P < 0.001, Kruskal-Wallis with Dunn multiple comparison test). (D) Quantification of the 
axon versus dendrite length ratio (P < 0.05, Kruskal-Wallis with Dunn multiple comparison test). ** P<0.01; 
***P<0.001. Lab journal references: BN-17-27, BN-17-29, BN-17-30. 
 
(3) PI3K overexpression induces morphology alterations and pS6 signalling in cultured 
cortical neurons 
 The effect of PI3K overexpression on neuronal morphology was also studied in more 
mature cortical neurons in vitro. To this aim, cortical neurons were transfected on 10 DIV and 
analyses were performed on 14 DIV after fixation. Neuronal morphology and pS6 
immunofluorescence were analysed using the MATLAB based program SynD (Schmitz et al.,  
2011). The morphology of the neuron was identified by the expression of emerald green 
fluorescent protein (Emerald) (Fig. 6A) and pS6 was visualised by immunofluorescence (Fig. 
6B). Sholl analysis showed that the dendritic branching of eGFP and PIK3CA transfected 
neurons were quite similar, while PIK3CA H1037R and PIK3CD overexpression lead to more 
highly branched neurons compared to eGFP and PIK3CA (Fig. 6C). Consistent with the sholl 
analysis, the total measured neurite length was different between the four conditions (Fig. 
6D). The eGFP and PIK3CA transfected neurons had a similar neurite length. The PIK3CA 
H1047R and PIK3CD neurons had a higher total neurite length than eGFP and PIK3CA 
neurons. Gain of the PI3K isoforms function also influenced the soma size of the cultured 
cortical neurons (Fig. 6E). Expression of PIK3CA H1047R and PIK3CD enlarged the soma 
and this increase was statistically significant higher than eGFP and PIK3CA transfected 
neurons. The soma area of eGFP and PIK3CA were identical. The pS6 intensities were also 
different between the four conditions (Fig. 6F). The eGFP and PIK3CA transfected neurons 
had similar and relative low pS6 expression levels. Overexpression of PIK3CA H1047R and 
PIK3CD resulted in an approximately six-fold increase in pS6 intensity compared to eGFP 
and PIK3CA transfected neurons.  
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Fig. 6. PIK3CA H1047R and PIK3CD initiate morphological changes and enhance pS6 signalling, 
PIK3CA does not affect neuronal morphology and pS6 signalling. E18 cortical neurons were cultured and 
transfected on 10 DIV. Representative 14 DIV pHR-eGFP, pHR-PIK3CA, pHR-PIK3CA H1047R and pHR-
PIK3CD transfected neurons with Emerald in (A) and pS6 immunofluorescence in (B). (C) Sholl analysis of 
neurite branches (df=3(316), F=7.00, P<0.001, Repeated measure ANOVA with Bonferonni’s multiple 
comparison test, n = 80 per group). (D) Quantification of the total neurite length (df=3(236), F=20.7, P<0.001, 
ANOVA with Tukey’s multiple comparison test). (E) Quantification of the soma area (P < 0.001, Kruskal-
Wallis with Dunn multiple comparison test, n = 60 per group). (F) Quantification of pS6 immunofluorescence (P 
< 0.001, Kruskal-Wallis with Dunn multiple comparison test, n = 60 per group). The data shows the average ± 
SEM. The results are obtained from three independent cultures (n=3) and a total of 60 transfected neurons were 
analysed for each condition. ***P<0.001. Lab journal references: BN-17-05, BN-17-16, BN-17-42. 
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(4) Validation of pS6 immunofluorescences 
 Two control experiments were performed to validate the immunolabelling for pS6. 
Firstly, application of BDNF to cultured eGFP neurons resulted in an upregulation of pS6 
(Fig. 7A) Secondly, pS6 immunofluorescence was not detected in PIK3CD transfected 
neurons that underwent immunocytochemistry procedures lacking the primary antibody for 
pS6 (Fig. 7B).  These supplementary experiments demonstrate that the observed pS6 staining 
is part of the BNDF and PI3K signalling pathway, and the pS6 immunofluorescence is not 
due to unspecific binding by the secondary antibody.  
 
 
Fig. 7. Validation of pS6 immunofluorescence staining. E18 cortical neurons were cultured and transfected 
with pHR-eGFP or pHR-PIK3CD on 10 DIV. Exogenous Emerald fluorescence and pS6 staining are shown in 
the upper and bottom panel, respectively. (A) Representative eGFP transfected neuron that was treated with 
BDNF before fixation on 14 DIV. (B) Representative 14 DIV PIK3CD transfected neuron that was stained with 
the secondary antibody only.  
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(5) PIK3CA H1047R and PIK3CD promote axon regeneration of cortical neurons after 
in vitro laser axotomy 
 The effect of PI3K overexpression on axonal regeneration was investigated using in 
vitro laser axotomy (see Fig. 3). This method allows precise injury of the axon of individual 
cultured neurons.  Cortical neurons were transfected on 10 DIV and axotomy was performed 
on 13 – 16 DIV. The axon of transfected neurons was identified based on their morphology. 
The axon is distinctly detectable at low objective magnification because of its length and 
absence of spines (Fig. 7A). The injured axons were imaged for 14 hour and were analysed 
for various regenerative indicators within this timeframe. There was a high survival rate of the 
neurons that underwent axotomy, as only a small proportion of the severed neurons died (Fig. 
8B). Importantly, the regeneration capacity of the transfected neurons was different between 
the four conditions (Fig. 8C). As expected, eGFP transfected neurons had a poor regenerative 
capacity (11.9 ± 2.4 %) after two weeks in culture. The PIK3CA transfected neurons also had 
a low percentage of regenerating axons (22.3 ± 4.6 %), and this percentage was statically 
similar to eGFP. On the other hand, neurons transfected with PIK3CA H1047R (60.7 ± 4.4 
%) and PIK3CD (52.3 ± 4.8 %) had a high percentage of regenerating axons, and this was 
statistically significant higher the eGFP and PIK3CA.  There was no statistically significant 
difference in the length that the axon regenerated between the four conditions (Fig. 8D). 
However, there is clear trend that PIK3CA H1047R (179 ± 23 µm) and PIK3CD (172 ± 24 
µm) transfected neurons regenerated longer distances compared to eGFP (94 ± 31.2 µm) and 
PIK3CA (101 ± 14 µm). There is small statistical difference in the growth cone size between 
the groups (Fig. 7E). The PIK3CA H1047R (17 ± 1 µm2) had a slightly bigger growth cone 
than PIK3CD (13 ± 1.0 µm2), while the other groups were statically similar. The time taken to 
form a growth cone and to successfully regenerate was identical between the four groups 
(Fig. 8F), with a minor trend toward quicker initiation of regeneration in the PIK3CA 
H1047R and PIK3CD groups. The retraction distance of all axotomised neurons was quite 
similar between the transfected neuron (Fig. 8G), however the PIK3CA H1047R (108 ± 8 
µm) transfected neurons retracted slightly more than PIK3CA (64 ± 7 µm) transfected 
neurons.  
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Fig. 8. PIK3CA H1047R and PIK3CD enhance the regenerative capacity of cortical neurons.  E18 cortical 
neurons were cultured and transfected with the dual promoter constructs on 10 DIV. The transfected neurons 
underwent laser axotomy after two weeks of culture. (A) Axon identification of a cortical neuron on 14 DIV. 
Transfected neurons were visualised by exogenous emerald fluorescence. There is a clear morphological 
distinction between the axon and dendrites. The red arrow indicates a dendrite; the arrowhead highlights the 
axon initial segment; three arrows trace the proximal axon. (B) Total number of axotomised neurons together 
with their death and survival rates per experimental condition. (C) Percentage of regenerating axons within 14 
hours after in vitro laser axotomy (df=3(8), F=0.154, P<0.001, ANOVA with Tukey’s multiple comparison test).  
(D) Quantification of axon regeneration length after 14 hours post-axotomy (P > 0.05, Kruskal-Wallis with Dunn 
multiple comparison test). (E) Quantification of growth cone size (df=3(56), F=1.07, P<0.01, ANOVA with 
Tukey’s multiple comparison test). (F) Quantification of regeneration initiation time (df=3(57), F=1.36, P>0.05, 
ANOVA with Tukey’s multiple comparison test). (G) Quantification of retraction length after axotomy and, if 
applicable, before initiation a regenerating growth cone (df=3(142), F=1.01, P<0.01, ANOVA with Tukey’s 
multiple comparison test). The data shows the average ± SEM. The results are obtained from three independent 
cultures (n=3) and the number of neurons analyzed in each group is shown in (B). Ns, not statistically 
significant; * P<0.05; ** P<0.01; ***P<0.001.  Lab journal references: BN-17-32, BN-17-35, BN-17-41, BN-
17-55, BN-17-56.  
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(6) PI3K does not affect endogenous Rab11 and α5 integrin transport in the axon  
 Previous studies have shown that cortical neurons at 14 DIV lack regeneration-
associated receptors in their axon (Franssen et al.,  2015; Koseki et al.,  2017). As discussed 
in Chapter 1, promoting the transport of regeneration-associated receptors into the axon is 
one mechanism to enhance axonal regeneration. Here, we explored whether the expression of 
PI3K can induce mistrafficking of Rab11 vesicles and α5 integrins into the axon. The small 
GTPase Rab11 is of interest because they mark vesicles containing growth-associated 
receptors, including α5 integrin (reviewed in Nieuwenhuis & Eva,  2018b). Furthermore, it 
had been shown previously that axons with more Rab11 vesicles have an enhanced 
regeneration capacity after in vitro laser axotomy (Koseki et al.,  2017). As expected, Rab11 
vesicles are found in the somatodendritic domain and detected in very low levels in the axons 
of eGFP-transfected neurons on 14 DIV (Fig. 9). Rab11 vesicles were also detected in low 
levels in the axon of neurons that were transfected with PIK3CA, PIK3CA H1047R or 
PIK3CD (Fig. 9). Consistent with the low levels of axonal Rab11 vesicles, α5 integrin was 
not detected in the axon and their localisation was limited to the somatodendritic domain in 
the four experimental conditions (Fig. 10). Thus, PI3K overexpression does not affect the 
distribution of endogenous Rab11 and α5 integrin in 14 DIV cortical neurons.   
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Fig. 9. Distribution of endogenous Rab11 in 14 DIV cortical neurons after PI3K overexpression. Cortical 
neurons were transfected at 10 DIV with pHR-eGFP, pHR-PIK3CA, pHR-PIK3CA H1047R or pHR-PIK3CD 
and fixated and stained at 14 DIV. Transfected neurons were detected by exogenous eGFP fluorescence (A), 
while the cells were co-stained for Rab11 (B) and axon initial segment marker Neurofascin (C). An arrowhead 
highlights the axon initial segment of a transfected neuron. Three arrows trace the proximal axon. Lab journal 
reference: BN-17-21. 
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Fig. 10. Distribution of endogenous α5 integrin in 14 DIV cortical neurons after PI3K overexpression. 
Cortical neurons were transfected at 10 DIV with pHR-eGFP, pHR-PIK3CA, pHR-PIK3CA H1047R or pHR-
PIK3CD and fixated and stained at 14 DIV. Transfected neurons were detected by exogenous eGFP fluorescence 
(A), while the cells were co-stained for α5 integrin (B) and axon initial segment marker Neurofascin (C). An 
arrowhead highlights the axon initial segment of a transfected neuron. Three arrows trace the proximal axon. Lab 
journal reference: BN-17-22. 
 
 
IV. DISCUSSION  
 This study investigated whether a gain-of-function approach of PI3K isoforms 
promotes axonal regeneration in CNS neurons. This aim was set because PIP3 signalling is 
known to be crucial for growth regeneration, while CNS neurons have a poor regeneration 
capacity. We examined cultured cortical neurons, instead of hippocampal neurons, because 
these CNS neurons are largely affected after spinal cord injury or stroke. 
 
(1) PIP3 signalling and maturation of cortical neurons 
 The first experiment showed that there is a decline of PIP3 in cultured cortical neurons 
in line with maturation. This result supports the hypothesis that neurons have a decline of 
PIP3 signalling and that this could contribute to their decreasing regeneration capacity during 
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maturation. Furthermore, this could suggest that PIP3 is important during the growth state of 
cortical neurons. It also validates our strategy to target PI3K to enhance PIP3 levels to 
promote axon growth and regeneration in mature cortical neurons.    
 The claim that PIP3 signalling is down regulated during maturation of neurons could 
be strengthen by examining downstream molecules of this signalling pathway. This would 
also complement the unpublished RNA sequencing data from our laboratory (Koseki et al., 
unpublished). For instance, the expression of PDK1, phosphorylated Akt, and pS6 could be 
examined in 1 DIV (neurite extension), 3 DIV (outgrowth), 7 DIV (axon branching) and 14 
DIV (maturation and synapse formation) cortical neurons in vitro. Previous studies have 
shown by immunohistochemistry that pS6 is down-regulated when neurons mature in vivo 
(Park et al.,  2008; Liu et al.,  2010). It will also be interesting to visualise PTEN overtime in 
cultured cortical neurons. These molecules can also be visualised by western blots in cultured 
cortical neurons to strengthen the immunofluorescence and RNA sequencing experiments. It 
is unclear whether it possible to immunolabel for PI3K isoforms in cultured cortical neurons, 
due to lack of suitable antibodies and low expression levels.  
  
(2) Validation of PIP3 immunofluorescence 
 The immunocytochemistry method to visualise PIP3 is currently being optimised and 
validated. Researchers from Charité – Universitätsmedizin Berlin and our laboratory in 
Cambridge are working together on a separate method research article. Recent work by 
Richard Eva provided the first important evidence that the immunocytochemistry for PIP3 is 
specific. He found co-localisation between the PIP3 antibody and the active signalling areas in 
cultured fibroblast of transgenic PIP3 reporter mice (Akt PH domain-GFP).  The next 
validation experiment will be to examine whether the PIP3 immunofluorescence is a product 
of PI3K. A comparison in PIP3 immunofluorescence between cortical neurons that are 
transfected with pHR-EGFP or pHR-PIK3CD will answer this research question. An 
additional approach to demonstrate the PIP3 immunofluorescence is a consequence of PI3K, is 
to apply PI3K inhibitors to cells that express a lot of PIP3. These PI3K inhibitors should 
decrease PIP3 immunofluorescence. Young cortical neurons (see Fig. 4) or immortal cell lines 
would be suitable candidates for this experiment.  
 In general, the visualisation of PIP3 at the inner plasma membrane could also be 
improved by utilizing total internal reflection fluorescence (TIRF) microscopy.  
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 (3) PI3K isoforms and their effect on neuronal morphology of cultured cortical neurons 
 We investigated whether the PI3K isoforms alter neuronal morphology of cortical 
neurons in vitro. The first experiment examined the effect of PI3K isoforms on neurite 
outgrowth in immature cortical neurons. Afterwards, the genes were expressed in mature 
cortical neurons and various morphological markers were analysed. There is a consistent 
effect of the PI3K isoforms at both time points. Expression of wild PIK3CA does not affect 
neuronal morphology signalling. The PIK3CA-activation mutation, PIK3CA H1047R, and 
wild type PIK3CD promote axon outgrowth, dendritic branching, and enlarge the soma. The 
PIK3CA H1047R and PIK3CD had a very similar effect on neuronal morphology.   
 Previous studies showed that PIP3 signalling is important for neurite outgrowth. One 
of the first evidence was that introducing activated PI3K promotes neurite formation and 
outgrowth in PC-12 cell lines (Kobayashi et al.,  1997; Kita et al.,  1998). PI3K signalling 
after stimulation of BDNF or neurotrophin-3 also promotes axon outgrowth in immature 
hippocampal neurons (Labelle & Leclerc,  2000; Yoshimura et al.,  2005).  It was later 
shown, via PIK3CD kinase-inactive transgenic mice, that P110δ is important for neurite 
extension in primary cultures of DRG neurons (Eickholt et al.,  2007). Consistent with these 
studies, our experiments show that activated PIK3CA and PIK3D promote neurite outgrowth 
in immature cortical neurons in vitro.   
 We also observed that that PIK3CA H1047R and PIK3D promote outgrowth in mature 
cortical neurons, which results a more complex dendritic tree. This is another indication that 
PI3K promotes neurite outgrowth. The effect on branching of the axon cannot be clarified 
from the performed sholl analysis, because the method is limited to a single microscopy 
image and the cell body has to be in the centre of the image. However, the increased dendritic 
complexity after expression of PI3K is possible an unwanted phenotype for strategies aiming 
to promote axonal regeneration in the sensorimotor-cortex in vivo (as discussed below in 
Section IV.6).  
 The enlarged soma and increased pS6 signalling is a known phenomena after 
enhanced PIP3 signalling (deletion of PTEN) (Park et al.,  2010; Liu et al.,  2017). 
Importantly, the enhanced phosphorylation of ribosomal protein S6 confirms that PIK3CA 
H1047R and PIK3CD activate the PIP3/mTOR signalling pathway. The increase soma size 
could be an indication for new protein synthesis in order to stimulate neuronal growth. 
However, the current data does not point towards what growth-promoting proteins are being 
translated.  
 A key questions remains why expression of wild type PIK3CA does not affect 
neuronal morphology and stimulation of the PIP3/mTOR pathway (pS6). We confirmed with 
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DNA sequencing analysis that all the made dual promoter plasmids, including pHR-PIK3CA, 
were sound (data now shown). One hypothesis could be that PIK3CA becomes inactivated, 
while PIK3CA H1047R and PIK3CD are resistant to these post-translational modifications in 
neurons. A more likely hypothesis could be that PIK3CA requires upstream receptor 
signalling (by binding a ligand) to become activated and generate PIP3. Comparing pS6 
intensities in neurons treated with BDNF, BDNF and PIK3CA, or PIK3CA alone could test 
this hypothesis. Our experiments showed that the activating-mutant PIK3CA and PIK3CD 
stimulate PIP3 signalling independent of receptor activation. The PIK3CA activation-mutation 
is indeed known to have enhanced kinase affinity towards the plasma membrane (Zhao & 
Vogt,  2008; Burke et al.,  2012; Hon et al.,  2012). That PIK3CA H1047R and PIK3CD alter 
neuronal morphology in similar extend is consistent with a hypothesis formulated by Dr. 
Klaus Okkenhaug and his laboratory (Babraham Institute, Cambridge) which is that P110δ is 
by definition a hyperactive isoform of P110α.  
 The effect of the PI3K isoforms on synapse formation is beyond the scope of this 
research. However, PI3K signalling is also known to be important for synapse formation and 
plasticity (Di Paolo et al.,  2004; Arendt et al.,  2010; Lee, Huang, & Hsu,  2011). It is 
possible to investigate synapse formation with the MATLAB programme SynD (Schmitz et 
al.,  2011) because it includes an feature to measure the number of synapses. This detection of 
synapses requires immunocytochemistry for synaptic markers such as Synaptophysin 
(synaptic vesicle marker) VAMP2/synaptobrevin (synaptic vesicle marker) or PSD-95 (post-
synaptic marker).   
 
(4) PI3K isoforms and axonal regeneration 
 Deletion of PTEN has been the most important indication that PIP3 signalling is 
important for axonal regeneration. As PI3K opposes of PTEN, our experiments demonstrate 
that expression of PI3K promotes the intrinsic regeneration capacity of CNS neurons.  
 We confirmed that 14 DIV (eGFP-transfected) neurons have a restricted axon 
regeneration capacity after in vitro laser axotomy (12% of the axotomised neurons did 
regenerate). The most important finding is that success rate of axonal regeneration is 
increased in neurons expressing PIK3CA H1047R and PIK3CD. As previously discussed 
(Section IV.3), the wild type PIK3CA is not capable to active PIP3 signalling, and therefore it 
not surprising that it is unable to promote axonal regeneration.  
 The length of axonal regeneration is another important indication for regeneration. In 
an in vivo situation, it is important to achieve long-distance regeneration to reach the nerve 
innervation site. Expression of PIK3CA H1047R and PIK3CD seems to stimulate longer 
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distances of axonal regeneration. However, the reason that this indicator did not reach 
statistical significance is because there were only four regenerating axons in the eGFP group. 
In order meet the statistics requirements; more eGFP-transfected neurons could be 
axotomised.  
 The importance of growth cone size for axonal regeneration is unclear. The growth 
cone size depends on many intrinsic and extrinsic factors  (reviewed in Hur, Saijilafu, & 
Zhou,  2012). Koseki et al.,  2017 found that cultured cortical neurons have a decline in 
growth cone size after in vitro laser axotomy when neurons mature. This could suggest that a 
large growth cone (as seen in immature neurons) could be beneficial for axonal regeneration. 
Eva et al.,  2017 found that EFA6 knockout increased the growth size and promote axonal 
regeneration after in vitro laser axotomy. In contrast, Ren & Suter,  2016 found a negative 
correlation between growth cone size and the speed of growth in cultured (uninjured) bag cell 
neurons from Aplysioa californica. We found that the PI3K isoforms that simulate axonal 
regeneration had a non-significant effect on the size of growth cone. Consistently, we found 
no significant effect on the start time of axonal regeneration between the four conditions. 
Although the initiation of axon regeneration time may become statistically significant quicker, 
if the n-size for the eGFP group will be increased.  Another possibility is that PI3K signalling 
occurs in the soma area and does not affect the growth cone. One may speculate that nuclear 
PIP3 (Kwon et al.,  2010; Blind et al.,  2014; Wang et al.,  2017) affects remodelling of 
chromatin and regeneration-associated genes become transcribed.  
 As expected, the axon retraction distance of the axotomised neurons was similar 
between the four groups. The neurons cultured for two weeks have both short and long 
retracting axons after laser axotomy. This also validates that the used laser strength for 
axotomy was the equal in all-experimental conditions.  
 
 (5) PI3K isoforms and integrin transport 
 We hypothesized that expression of PIK3CA H1047R and PIK3CD would stimulate 
anterograde transport of the integrin machinery toward the growth cone. An increase of 
integrins in the axon could be one of the mechanisms that promote axonal regeneration. For 
this purpose, uninjured neurons were plated in low density to avoid that Rab11 and integrin 
enriched dendrites will cross the axon. However, we did not detect a shift of Rab11 and 
integrin distribution in uninjured neurons. This could indicate that PI3K signalling does not 
affect trafficking of integrin receptors in the axon. However, we observed that both PI3K 
isoforms promote dendritic outgrowth and they may therefore not been moved into the axon. 
However, it is also possible that the endogenous expression of Rab11 and integrins are too 
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low to detect in the axon. For this reason, it would be good to include a positive control 
condition such as 4 DIV cortical neurons. Firstly, this would confirm that there is a relatively 
reduction of Rab11 and integrins in the axon, compared to dendrites as neurons mature 
(Koseki et al.,  2017). Secondly, this 4 DIV control will make it possible to examine whether 
expression of PI3K could restore Rab11 and integrins in the axon of 14 DIV neurons similar 
to young neurons. Once this control condition is included, it is worth to quantify the 
axon/dendrite immunofluorescence ratio of Rab11 and α5 integrins. We stained for α5 
integrin since there are only a few reliable integrin antibodies available. It would also be 
interesting to explore if PI3K stimulates anterograde transport of integrins, or Trks, when co-
expressed. A recent study showed, via siRNA interference, that P110δ is required for the 
targeting of α2, α5, β1 integrins in the membrane of epithelial cells (Peng et al.,  2015).  It 
will be particularly interesting to observe the transport direction in the axon via live cell 
imaging rather than immunocytochemistry in fixed tissue.  
 
(6) Future research  
 Our experiments demonstrate that expression of activated PI3Ks enhances the 
regeneration capacity of CNS neurons in cell culture conditions. The in vitro laser axotomy 
method only examines the intrinsic regeneration response.  Koseki et al., 2017 demonstrated 
this by measuring the regeneration of immature neurons (4 DIV) that were plated on top of 
mature cultures (25 DIV). The neurons cultured in the 25 DIV environment regenerated their 
axon as well as neurons plated on PDL, indicating that extrinsic factors do not play a role in 
this cell culture model. The in vitro laser axotomy method therefore identified PIK3CA 
H1047R and PIK3CD as intrinsic regulators of axonal regeneration. This should be taken 
forward to study regeneration in animal models of spinal cord injury. It is crucial to examine 
whether PI3K promotes axonal regeneration and can overcome inhibitory extrinsic factors in 
scar tissue in vivo. It is likely that the PI3K treatment needs to be combined with additional 
factors, such as α9 integrin that recognises TN-C, to promote long-distance axonal 
regeneration of CNS neurons.   
 The mechanisms of PI3K-induced axon regeneration have not been investigated in 
great detail yet. Similar to the PTEN deletion studies, we only highlighted that the PI3K-Akt-
mTOR pathway is beneficial for regeneration. It is important that the mechanism is better 
understood. A first approach to understand the mechanisms would to visualise whether PI3K 
(direct immunolabelling) or it’s signalling (PIP3, PGK, Akt) is localised in the axonal or 
somatodendritic compartment of the neuron. It is most likely that both compartments are 
required. New growth-promoting proteins are synthesized in the cell body, and afterwards 
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growth-promoting receptors needs to be transported towards the growth cone of regenerating 
axons. It will also be interesting to explore weather the PI3K isoforms have a different 
affinity or activity for PIP2 or PIP3 by FRET imaging.  Furthermore, it would be interesting to 
explore a link between PI3K and the small GTPase ARF6. ARF6 is known to be influence by 
the inositol lipids PIP2 and PIP3 (Brown et al.,  2001; Li et al.,  2005) (see also Fig. 1). ARF6 
transport integrins (Eva et al.,  2012) and is an intrinsic regulator of axonal regeneration 
(reviewed in Nieuwenhuis & Eva,  2018b, see Table 1).  
 Caution is required if the PI3K strategy is going to be applied to promote axonal 
regeneration in vivo. Because of the diverse roles of inositol lipids, the signalling pathway 
needs to be strictly controlled and malfunction is associated with many human diseases 
(reviewed in Fruman et al.,  2017), including disorders of the nervous system (reviewed in 
Gross & Bassell,  2014; Kreis et al.,  2014). Enhanced PIP3 signalling is, for instance, 
considered as hallmark for cancers. Despite the fact that the tumour suppressor PTEN is 
expressed in the adult nervous system, it is crucial to specifically target PI3K to layer V 
cortical neurons and avoid transduction in non-neuronal cells (see Chapter IV). Furthermore, 
we observed undesired dendritic growth after expression of PI3K and that might cause 
neurological problems in vivo. Identification of downstream molecules may therefore 
important for precise targeting of axon regeneration, without disturbing other crucial 
functions in the nervous system. However axonal injury in the CNS is also known to cause 
neuronal atrophy, in which the soma and dendrites retract, and thus enlargement of soma and 
neurite growth may therefore not be harmful in that case.  
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Table 1. ARF6 as an intrinsic regulator of axon growth and regeneration. This table highlights the effects of 
ARF6 and its associated GAP and GEFs on axon growth and regeneration in vitro. Stimulation of anterograde 
transport of the axonal growth machinery promotes growth, while retrograde transport hinders growth. This table 
is published in Nieuwenhuis & Eva,  2018b. 
ARF6  
GEF/GAP 
Main findings regarding axonal growth and regeneration References 
ARF6 
(GTPase) 
 
Expression of wild type ARF6 inhibited axon growth by 30% in 
developing cortical neurons in vitro 
 
Expression of wild type ARF6 or constitutively active ARF6 did 
not affect axon growth in developing hippocampus neurons in vitro 
 
Expression of dominant negative ARF6 increased axon growth by 
100% in developing hippocampus neurons in vitro 
 
Expression of dominant negative ARF6 increased axon growth by 
67% in developing cortical neurons in vitro 
Suzuki et al.,  2010 
 
 
Hernández-Deviez et 
al.,  2004 
 
Hernández-Deviez et 
al.,  2004 
 
Suzuki et al.,  2010 
 
ACAP1 
(GAP) 
Expression promoted axon growth by 25% in adult DRG neurons 
in vitro 
Eva et al.,  2012 
ARNO 
(GEF) 
 
Expression of wild type ARNO inhibited axon growth by 50% in 
adult DRG neurons in vitro 
 
Expression of wild type ARNO did not affect axon growth in 
developing hippocampus neurons in vitro 
 
Expression of catalytically inactive ARNO increased axon growth 
by 500% in developing hippocampus neurons in vitro 
 
Expression of catalytically inactive ARNO promoted axon growth 
by 30% in cortical neurons in vitro 
Eva et al.,  2012 
 
 
Hernández-Deviez et 
al.,  2004 
 
Hernández-Deviez et 
al.,  2004 
 
Franssen et al.,  2015 
EFA6  
(GEF) 
Expression inhibited axon growth by 50% in adult DRG neurons in 
vitro 
 
Expression inhibited the regeneration capacity of adult DRG 
neurons by 70% after in vitro laser axotomy  
 
ShRNA interference increased the regeneration capacity of cortical 
neurons by 110% after in vitro laser axotomy 
Eva et al.,  2012 
 
 
Eva et al.,  2017 
 
 
Eva et al.,  2017 
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CHAPTER IV - Adeno-associated viral vector (AAV)-mediated 
transduction of the corticospinal tract: comparison of AAV1 and 
AAV5 and four promoters 
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I. INTRODUCTION 
Gene therapy is a promising strategy for treating genetic and certain acquired disorders 
including those within the nervous system. Gene therapy could be defined as the delivery of 
exogenous DNA or RNA into cells with the aim to treat a disease. Gene therapy is especially 
suitable for conditions in which a single gene and a distinct neuronal subpopulation is 
affected. Viral vectors are utilized for gene therapy because viruses have naturally evolved to 
infect other cells and to deliver their genetic contents to the cell nucleus. There are four 
viruses commonly used for gene delivery in mammalians cells in vitro and in vivo: retrovirus 
(including lentivirus), adenovirus, adeno-associated virus (AAV), and herpes simplex virus 
(HSV). Recombinant adeno-associated viral vectors (rAAVs) are the preferred viral vectors to 
target the neurons of the central nervous system (CNS), and have been used in clinical trials 
for several neurological disorders (reviewed in Gray,  2013; Ojala, Amara, & Schaffer,  2015; 
Naso et al.,  2017). Recently, Luxturna® developed by the company Spark Therapeutics, 
became the first Food and Drug Administration (FDA)-approved gene-therapy for a CNS 
disorder. Luxturna® consists of a rAAV2 vector containing the RPE65 gene and is directly 
injected into the eye to reverse retinal dystrophy and blindness in patients with a mutated 
RPE65 gene. These developments show that rAAV is gaining increasing acceptance as a 
vector for clinical gene delivery.  
 
(1) The corticospinal tract and spinal cord injury 
The corticospinal tract is an important descending motor pathway because it controls 
the movement of extremities, including arms and legs. Spinal cord injury can lead to damage 
of the corticospinal tract, among other motor- and sensory tracts, thereby resulting in 
paralysis. Gene therapy would be an excellent approach to enhance the intrinsic regeneration 
capacity of the corticospinal tract. The anatomy of the corticospinal tract in humans (reviewed 
in Blumenfeld et al.,  2002) and rodents (reviewed in Ebbesen & Brecht,  2017) will be 
briefly described below. The corticospinal tract of rat and mice will be described because it is 
a relevant and widely used model in spinal cord injury research.  Mice are chosen because 
there are many transgenic lines available to study axon regeneration, while rats are often used 
due to their larger size that makes surgical procedures and behavioural testing easier to 
perform.    
The neurons of the descending corticospinal tract are located in the cerebral motor 
cortex. The central sulcus is an important hallmark to identify the sensory-motor cortex in 
humans. The human primary motor cortex is located at the precentral gyrus. The premotor 
and supplementary motor areas also have axons into the corticospinal tract and are located 
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anterior of the primary motor cortex (reviewed in Blumenfeld et al.,  2002). Rats and mice 
have a relatively big motor cortex that almost covers their entire frontal cortex (Gioanni & 
Lamarche,  1985; Neafsey et al.,  1986; Brecht et al.,  2004). The motor neurons that mainly 
contribute to the corticospinal tract are pyramidal neurons in layer V of the motor cortex. 
Therefore, gene therapy for regeneration of the corticospinal tract aims to directly deliver the 
viral vectors into layer V of the motor cortex.  
  The axons of the corticospinal tract form synapses on neurons in the grey matter at 
all levels of the spinal cord. The axons of the corticospinal tract descend via the internal 
capsule towards the midbrain. Afterwards, the fibers pass the pons towards the pyramid in the 
rostral medulla. At the pyramidal decussation, the transition between the medulla and spinal 
cord, a large proportion of the corticospinal tract fibers cross over. In humans, the majority of 
the fibers cross toward the lateral white matter columns in the spinal cord. After descending in 
the spinal cord, the axons connect to motor neurons at the anterior horn of the spinal cord. In 
human fibers that do not cross over at the pyramid in the medulla continue ipsilateral and 
form the anterior corticospinal tract through the ventral column of the spinal cord, which will 
terminate on the anterior horn of the spinal cord (reviewed in Blumenfeld et al.,  2002). In 
mouse and rat, the route of the corticospinal tract through the spinal cord differs from 
humans. Most fibers cross over and will project through the dorsal medial white column of 
the spinal cord (Miller,  1987). A small proportion of the rodent fibers does not cross and will 
continue ipsilateral in the ventral- and lateral columns of the spinal cord before terminating at 
motor neurons in the ventral horn (Brösamle & Schwab,  1997; Steward et al.,  2004; Bareyre 
et al.,  2005).  
The lower motor neurons located in the ventral horn of the spinal cord can stimulate 
muscles in the periphery. The anatomy of the spinal cord is different at each spinal level. For 
instance, the ventral- (descending motor neurons) and dorsal- (ascending sensory neurons) 
horns have the biggest size at the level of the cervical- and lumbar spinal cord. At the cervical 
cord, there are motoneurons that are projecting towards the arms. At the lumbar and sacral 
cord, there are motor neurons projecting towards the legs (reviewed in Blumenfeld et al.,  
2002).  
The severity of the functional consequences of spinal cord injuries depends on the 
location and the extent of the injury. For instance, a lesion at the cervical level can cause 
dysfunction of arms and legs, known as tetraplegia. Injury at the level of the thoracic, lumbar, 
or sacral spinal cord, will have an impact on the legs and is referred to as paraplegia. Due to 
damage of the corticospinal tract, most spinal cord injury patients are bound to a wheelchair.  
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(2) Recombinant adeno-associated viral vectors 
The biology and structure of AAVs have been described in many reviews and books 
(reviewed in Agbandje-McKenna & Kleinschmidt,  2011; Murlidharan, Samulski, & Asokan,  
2014; Samulski & Muzyczka,  2014; Bedbrook, Deverman, & Gradinaru,  2018). AAVs are 
non-enveloped (lacking an outer lipid membrane) parvoviruses, which have an icosahedral 
capsid structure and are approximately 25 nanometers in diameter. AAVs have a linear-single 
stranded DNA genome that encodes the following proteins: replication (rep) proteins, capsid 
(cap) proteins, and one assembly activating protein. The genome is approximately 4700 
nucleotides long and is flanked by inverted terminal repeats (ITR), which are required for 
packaging of the AAV genome (Xiao et al.,  1997). It is important to note that the genome 
size determines the maximum packaging capacity of a virus.   
 Wildtype-AAVs (wtAAV) cannot replicate on their own but require co-infection of 
adenoviruses or HSVs for their replication. Recombinant adeno-associated viral vectors 
(rAAV) are produced with the use of helper plasmids that harbour the rep and cap genes that 
are required for the production of AAV vectors (Xiao, Li, & Samulski,  1998). The 
development of helper plasmids instead of the use of wtAAV and adenovirus as helper viruses 
did overcome the problem of contamination of rAAV preparations with these viruses. The 
rAAV serotypes are produced by a dual- (AAV serotypes 1 to 6) or triple- (AAV serotypes 7 
to 9) plasmid transfection in mammalian cells (Grieger, Soltys, & Samulski,  2016; 
Verhaagen et al.,  2018). The transfer plasmid contains a promoter and the transgene of 
interest, while the helper plasmids contain the rep and cap genes that determine the serotype 
of the rAAV vector. Thus, production of rAAVs with a serotype specific helper plasmid will 
result in a rAAV of the desired serotype.   
 The nine common serotypes are natural variants of AAVs each bearing different 
cellular tropism. The difference between the serotypes is the capsid that surrounds the AAV 
genome. The transduction efficiency of the AAVs depends on the ability of the capsids to 
bind cell surface glycans (reviewed in Huang, Halder, & Agbandje-McKenna,  2014). For 
instance, AAV1 (Wu et al.,  2006) and AAV5 (Kaludov et al.,  2001; Seiler et al.,  2006) 
binds α2-3 and α2-6 N-linked sialic acids, while AAV2 interacts with heparin sulfate 
proteoglycans as their receptor for cell entry (Summerford & Samulski,  1998; Opie et al.,  
2003; Kern et al.,  2003).  In addition to the natural AAV serotypes, there are modified AAV 
variants, e.g. amino acid optimized capsids, to enhance the transduction efficacy in the tissue 
of interest (Rosario et al.,  2016; Chan et al.,  2017).   
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(3) Mechanisms of cell transduction by recombinant adeno-associated viral vectors 
 Cell transduction is a naturally occurring event of non-pathological AAV virus. This 
paragraph will briefly describe the mechanisms of cell transduction by AAVs (reviewed in 
Schultz & Chamberlain,  2008). The capsid of the (r-) AAV vector interacts with receptors on 
the cell surface of the host cell and passes the plasma membrane via endocytosis. The 
endosome is transported towards the nucleus where the AAV vector genome is released. In 
human cells the AAV vector genome does integrate into a specific site in chromosome 19 
(Samulski et al.,  1991), whereas in rat and human cells AAV genomes are also found in 
episomal DNA in the nucleus of the target cells. An episome is a autonomous double-stranded 
DNA unit within the nucleus. The transgene (within the newly formed episome) is transcribed 
by the transcription machinery of the host cell (see Section II.5). The messenger RNA is 
transferred out of the nucleus and is translated by the host cells’ ribosomes into functional 
proteins.   
 (4) Comparison of AAV vector serotypes for optimal transduction in the nervous 
system 
 To determine what would be the best serotype to transduce specific neuronal 
populations, several studies compared the transduction efficiency of AAV vector serotypes 
after direct injection in different parts of the nervous system. AAV1 and AAV5 seem to be 
most efficient to transduce neurons in general as will be discussed in this section. However, 
the serotype for transduction of retinal ganglion cells in the eye is AAV2 (Hellström et al.,  
2009; Nickells et al.,  2017). The AAV2 serotype as part of a treatment for human patients 
with retinal dystrophy caused by an inherited mutation in the RPE65 gene (Bennett et al.,  
2016a; Russell et al.,  2017). The most efficient AAV serotype to transduce primary sensory 
neurons in the dorsal root ganglia (DRG) is AAV5, closely followed by AAV1 and AAV6 
(Mason et al.,  2010). Targeting neurons in the substantia nigra and the striatum is relevant for 
CNS movement disorders such as Parkinson’s disease. The most efficient serotypes to target 
these structures are AAV1, AAV5, and AAV7 depending on the species (McFarland et al.,  
2009; Markakis et al.,  2010; Korecka et al.,  2011). The first direct comparison of AAV 
vector serotypes in the corticospinal tract of rats was done by Hutson et al.,  2012. This study 
found that AAV1, followed by AAV5, are the most efficient to transduce layer V cortical 
neurons. In a follow-up study, the authors observed that the AAV1 serotype can result in 
trans-neuronal expression of transgenes in the corticospinal tract following direct injection in 
the sensorimotor cortex (Hutson, Kathe, & Moon,  2015). The transduction occurs in brain 
tissue that is directly surrounding the injection site and the transgene was transport in the axon 
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of the transduced neurons as pyramidotomy prevented transgene expression in the 
corticospinal axons in the spinal cord (Hutson et al.,  2015).    
 (5) Comparison of promoters for strongest expression of transgenes  
 The promoter is essential for the transcription of transgenes, turning the DNA template 
into messenger RNA, before protein translation. The promoter is a regulatory DNA element 
that is located at the 5’ end of a transgene. It consists of a promoter core called the CAAT 
box, an upstream TATA box that acts as a transcription factor-binding site, and possibly an 
enhancer or repressor sequence that alters the efficiency of the RNA polymerase. Many 
transcription factors can bind to the TATA box region of the promoter. In addition to 
transcription factors binding DNA, they can also interact with each other resulting in protein 
complexes with different affinities for DNA binding (reviewed in Inukai, Kock, & Bulyk,  
2017). The promoter-bound transcription factors initiate the recruitment of RNA polymerase, 
which will start transcription of the DNA template after ATP hydrolysis.    
 The promoter also has an important role in the selective expression of transgenes in 
specific cell types. There are different classes of promoters including, constitutive promoters 
(activated in many cell types e.g. CMV, full-length PGK and human ubiquitin C promoters), 
inducible promoters (can be turned on or off by modulators e.g. administration of light or 
doxycycline), tissue-specific promoters (such as GFAP or SYN) and hybrid promoters (such 
as CAG which is composed of a chicken beta-actin promoter and a CMV enhancer). The 
decision which promoter is optimal for AAV-mediated expression of transgenes depends on 
the experimental requirements, including the target cells that have to be transduced, and the 
levels and duration of transgene expression. The promoter that result in the strongest 
expression of layer V neurons is unknown.   
(6) Aim of study  
 Hutson et al.,  2012 identified AAV1, followed by AAV5, as optimal serotypes to 
transduce layer V cortical neurons of the corticospinal tract. Yet, the strongest/best promoter 
for the expression of transgenes in these CNS neurons is unknown. Here, we aimed to 
replicate the previous findings for the optimal AAV vector serotype for corticospinal tract 
transduction. Furthermore, we compared the AAV1 serotype harbouring four different 
promoters, including the CMV promoter, the mouse PGK (mPGK) promoter, the short-CAG 
(sCAG) promoter, and the human synapsin (hSYN) promoter. These four promoters were 
chosen because: (1) this are relatively compact promoters (size range from 470 to 860 bp) 
thus allowing for the accommodation of relatively large transgenes; (2) these promoters have 
been used to transduce the nervous system but their activity in the brain has not been studied 
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in a side by side comparison; and (3) the specific requirement for a strong promoter in the 
CST due the to the large size of this neuronal pathway. We also examined co-transduction of 
two viruses (AAV1-hSYN-eGFP and AAV1-hSYN-tdTomato), which is relevant for various 
experiments that aim to combine multiple transgenes. In addition, we investigated whether the 
promoters have different selectivity for expression in non-neuronal cells. This promoter 
comparison study contributes to the optimization of AAV-mediated gene delivery to neurons 
of corticospinal tract.    
II. MATERIALS AND METHODS 
(1) AAV vector plasmids 
 Vector plasmids were designed to investigate the expression potential of different 
promoters.  Therefore, the post-transcriptional regulatory element called woodchuck hepatitis 
virus posttranscriptional regulatory element (WPRE) was removed of all vector plasmids 
(Figure 1). AAV-CMV-eGFP was a gift from Connie Cepko (Addgene plasmid # 67634). 
AAV-sCAG-eGFP was provided by the laboratory of Joost Verhaagen and is described in 
Fagoe et al.,  2014a. AAV-mPGK-eGFP was made by utilizing AAV-mPGK-Cre, which was 
a gift from Patrick Aebischer (Addgene plasmid # 24593), as vector backbone after the Cre 
sequence was removed via HindIII-HF (NEB, R3104) and EcoRI-HF (NEB, R3101) 
digestion. The eGFP sequence of AAV-CMV-eGFP was amplified by using the primers 5’ 
GGAATTCATGGTGAGCAAGGGCGAG 3’ and 5’ 
AGCGCTTTACTTGTACAGCTCGTCCATG 3’, which was next cloned into the digested 
AAV-mPGK-backbone. Plasmid pTRUF20B-SEW, which was a gift from Deniz Kirik (Lund 
University) and is described in Korecka et al.,  2011, was modified to make AAV-hSYN-
eGFP by HincII (NEB, R0103) digestion to remove the WPRE. AAV-hSYN-tdTomato was 
made by ClaI (NEB, R0197) digestion of AAV-hSYN-tdTomato-WPRE, which was a gift 
from Hongkui Zeng (Addgene plasmid # 51506).  
 
 
Fig. 1. – next page - Schematic representation of adeno-associated constructs. (a) Four constructs express 
enhanced green fluorescent protein (eGFP), which has a length of 720 bp, under different promoters. The CMV 
promoter has a size of 670 bp and is upstream of a 500 bp b-globin intron (total promoter size: 1170). The mouse 
PGK (mPGK) promoter has a size of 510 bp and contains a b-globin intron of 500 bp. The short CAG (sCAG) 
promoter has a size of 860 bp. The shortest promoter is hSYN with a size of 470 bp. One construct expresses 
tdTomato, which as a length of 1431 bp, under the hSYN promoter. The packaging cassettes are flanked by 
inverted terminal repeats (ITR). The poly-A signals are not shown. 
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(2) Cortical neuron cultures and magnetofection 
 The neuronal cultures were prepared as described in Chapter II section II.11. The 
cortical neurons were transfected at 10 days in vitro (DIV) using oscillating nanomagnetic 
transfection (magnefect nano system; nanoTherics). The vector plasmids (7 µg per dish) were 
mixed with 8 µl of magnetic nanoparticles (NeuroMag, NM50200) in 100 µl of culture 
medium and were incubated for 30 minutes. For co-transfection of hSYN-eGFP and hSYN-
tdTomato, 3.5 µg of each plasmid were mixed. The culture media was substituted for the 
transfection mixture and next the dishes were placed over a magnetic array, which was 
moving laterally at 2 Hz and at 0.2 mm amplitude of displacement for 30 minutes at 37°C in a 
7% Co2 incubator. After the transfection, the original culture medium was returned to each 
well and the neurons were cultured until 14 DIV when the neurons were fixed with 4% 
paraformaldehyde (PFA) in PBS for 10 minutes at room temperature and afterwards were 
washed in PBS. The cells were mounted using fluorsavetm reagent (Calbiochem, 345789). 
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(3) Image acquisition and analysis of cultured cortical neurons 
 The images for fluorescent intensity analysis were captured on a fluorescent 
microscope (DM6000 B, Leica) with a 40x-oil objective. Semi-automated and standardized 
analysis of the images was performed using MATLAB platform version 2017 and the 
program called SynD (Schmitz et al.,  2011). The following output of SynD was used: (1) the 
average fluorescence of each neurite within a 100 µm distance from the soma, (2) soma 
fluorescence intensity, (3) soma area. Prism 7 for Mac OS X was used for statistical analysis. 
The typical images of cultured cortical neurons were taken using an SP5 confocal with a 40x-
oil objective and a 2.5 digital zoom factor using Leica software. The co-transfection rate was 
determined by manual scoring the acquired confocal images of 100 neurons.  
 
(4) Adeno-associated viruses preparation 
 The small-scale production of recombinant adeno-associated viral vectors was recently 
described in detail (Verhaagen et al.,  2018). A summary of the performed AAV preparation 
procedures is described here. 
 Approximately 12.5 million human embryonic kidney (HEK) 293T cells per virus 
batch were plated in twelve 15 cm tissue culture plates.  The cells were grown in Dulbecco’s 
modified eagle medium (DMEM) (Gibco, 10566) supplemented with 10% fetal calf serum 
(FCS) and 1% penicillin/streptomycin (PS). The cells were 70% to 80% confluent one day 
after plating.  
 The vector plasmids were transfected into the HEK293T cells by utilizing 
polyethylenimine (PEI). The cationic polymer PEI provides a positive charge to vector 
plasmids resulting in binding to the negatively charged sugars at the cell-surface and 
ultimately entrance into the cell via endocytosis (Reed et al.,  2006). Two hours prior 
transfection, culture medium was replaced with Iscove’s modified Dulbecco’s medium 
(IMDM) (Gibco, 124400) complemented with 10% FCS / 1% glutamax / 1% PS. A total of 
150 µg of vector plasmid and 450 µg helper plasmid (PVD20 and pDP5 for AAV serotype 1 
or 5, respectively) (Grimm, Kay, & Kleinschmidt,  2003) were mixed in 12 ml 0.9% sodium 
chloride (NaCl) for each batch of virus.  After vortexing, 1800 µg PEI (PolyScience Inc., 
23966) in 12 ml 0.9% NaCl was added and the mixture was incubated for 20 minutes at room 
temperature (DNA to PEI ratio of 1:3). After incubation, 2 ml of the transfection solution was 
applied to each plate containing HEK293T cells in IMDM. One day after transfection, the 
IMDM medium and PEI mixture was removed and replaced with IMDM medium only since 
long-term exposure to PEI causes cellular toxicity and cell detachment from the tissue culture 
plates. 
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 Harvesting of the HEK293T cells was performed three days post-transfection. At this 
time-point, 60% to 80% of the cells should be expressing eGFP or tdTomato (which can be 
examined by fluorescent microscopy). The cells were harvested by removing the IMDM 
medium and next Dulbecco’s phosphate-buffered saline (D-PBS) (Gibco, 14040) was added 
followed by collection of the cells with a 28 cm cell scraper (Greiner Bio-One, 541070).  A 
maximum total volume of 17.5 ml was collected. Afterwards, the cells were frozen at -80 °C 
and thawed in a 37 °C water bath to open the cells and release viral particles. This freeze and 
thaw procedure was performed three times and the samples were vortexed to break any 
remaining clumps of cells. 25 µl of 10 mg/ml endonuclease deoxyribonuclease I (DNase I) 
(Roche, 11284932001) in PBS was added to the cell lysate and was incubated for 1 hour at 37 
°C to prevent cell clumping.  The cells were stored at -20 °C until the iodixanol gradient 
procedures the next day.       	
 The cell lysate was thawed and centrifuged at 3200 x g for 30 minutes to yield crude 
lysate including adeno-associated viruses. The crude lysate was loaded onto a 25 x 89 mm 
quick-seal polypropylene tube (Beckman, 342414) using a Pasteur pipet. After loading the 
17.5 ml crude lysate, a step gradient containing 15% (9 ml), 25% (5 ml), 40% (5 ml) and 60% 
(3 ml) iodixanol (Axis shield, 1114542) was added using a new Pasteur pipet without air 
bubbles forming between the layers. The Beckman tube was topped up with D-PBS and 
sealed using an electric tube topper. Centrifugation of the iodixanol gradient was performed in 
a 70Ti roter (Beckman Coulter) at 69.000 RPM for 70 minutes. A hole was punctured at the 
top of the Beckman tube while leaving the needle in place, afterwards a hole was made at the 
bottom of the tube and the virus was collected at the 40-60% interface (1 ml of 60% and 2 ml 
of 40% iodixanol layer). The iodixanol fraction that contained the virus was diluted in 12 ml 
D-PBS and applied to a 100 kDa MWCO Amicon Ultra-15 centrifugal filter device 
(Millipore, UFC910096) and was next centrifuged at 3200 x g for 15 minutes to concentrate 
the volume and wash out the iodixanol. The buffer was changed to D-PBS with 5% sucrose 
using the same Amicon filter and was centrifuged at least three times until 150 µl to 200 µl 
virus remained in the filter. The produced viruses were stored at -80 °C until use.  
 The titres of AAVs were determined by quantitative PCR (qPCR). Viral genomic 
DNA was isolated from 2.2 µl of virus by applying 85.8 µl of 250 µg/mL DNase I in D-PBS 
(duplicate and 1:40 dilution) and was incubated at 37 °C for 30 minutes. The DNase-treated 
viruses were next lysed by adding 40 µl 1M sodium hydroxide (NaOH) and were incubated at 
50 °C for 15 minutes. After alkaline lysis, the pH was neutralised by applying 40 µl 1M 
hydrochloric acid (HCL) (1:3 dilution by lysis and neutralisation).  After pH neutralisation, 20 
µl of the solution was added to 180 milli-Q H2O (1:10 dilution) and was used as sample for 
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AAV titration (final work dilution of 1:1200).  A calibration curve was made by preparing 
serial dilutions of a reference plasmid (Table 1) ranging from 1010 to 103 molecules/ml in 
milli-Q H2O.  Each qPCR reaction had a total volume of 25 µl and consisted of 12.5 µl SYBR 
green PCR master mix (Applied biosystems, 4309155), 0.75 µl primer mix (10 µM of 
forward and reverse primers, Table 1), 1.75 µl milli-Q H2O, and 10 µl AAV titration sample, 
a plasmid part of the standard calibration curve, or controls such as milli-Q H2O (negative 
control), D-PBS with 5% sucrose (negative control), or an AAV titration sample with known 
titre (positive control). For the reaction, a 96-well PCR plate was used in a qPCR machine 
(Applied biosystems, 7300) and a thermocycling program as shown in Table 2 was used. The 
tires of the AAVs were calculated based on the cycle threshold values using the standard 
calibration curves. The single AAVs were titre matched to 1.42E+12 gc/ml before stereotactic 
injections in animals. The co-injection experiment consisted of AAV1-hSYN-eGFP and 
AAV1-hSYN-tdTomato each with a titre of 1.68 E+11 gc/ml.   
 
Table 1 Reference plasmid and oligonucleotides used for AAV titration 
Virus 
 
Reference 
plasmid 
Primer mix 
name 
Forward primer Reverse primer 
AAV1-CMV-eGFP AAV-hSYN-eGFP qtitre_eGFP3 GTCTATATCATGGCCGACAA CTTGAAGTTCACCTTGATGC 
AAV1-mPGK-eGFP AAV-hSYN-eGFP qtitre_eGFP3 GTCTATATCATGGCCGACAA CTTGAAGTTCACCTTGATGC 
AAV1-sCAG-eGFP AAV-hSYN-eGFP qtitre_eGFP3 GTCTATATCATGGCCGACAA 
 
CTTGAAGTTCACCTTGATGC 
AAV1-hSYN-eGFP AAV-hSYN-eGFP qtiter_hSyn3  
 
GTGCTGAAGCTGGCAGTG 
 
GCAAGTGGGTTTTAGGACCA 
 
AAV5-hSYN-eGFP AAV-hSYN-eGFP ncbi4_syn 
 
CCCTGCGTATGAGTGCAAGT 
 
GGTGCTGAAGCTGGCAGT 
 
AAV1-hSYN-
tdTomato 
AAV-hSYN-eGFP qtiter_hSyn3  
 
GTGCTGAAGCTGGCAGTG 
 
GCAAGTGGGTTTTAGGACCA 
 
 
Table 2 Thermocycling conditions for AAV titration 
Cycle step Temperature (°C) Time (seconds) Number of cycles 
Initial denaturation 50  
95  
120  
600  
1 
Denaturation 
Annealing and Extension 
95  
60  
15  
60  
40 
Dissociation stage 95  
60  
95  
60  
4  
15  
60  
15 
15  
Hold 
1 
 
	122	
(5) Animals and stereotactic injection of adeno-associated viruses in the sensory-motor 
cortex 
 A total of 16 adult female rats (Lister Hooded, Charles River Laboratories) and 16 
adult female mice (C5BL/6, Charles River Laboratories) were used in this study. The animals 
were housed in group cages and had access to water and food ad libitum in standard 
laboratory conditions.  
 This research has been regulated under the Animals (Scientific Procedures) Act 1986 
Amendment Regulations 2012 following ethical review by the University of Cambridge 
Animal Welfare and Ethical Review Body (AWERB). All procedures were performed using 
aseptic techniques. Viral vectors were stereotactically injected into the right sensory-motor 
cortex of mice and rat as described below. The animals were anesthetized with isoflurane (4% 
isoflurane in O2 for induction, 2% isoflurane for maintenance) delivered via a facemask and 
received postoperative analgesia. Body temperature was kept at roughly 36 °C via a heating 
pad with an anal probe. The head of the animal was shaved and the skin was disinfected. The 
animal was next placed in the stereotaxic frame (David Kopf Instruments) were a midline 
incision was made to expose the skull and holes were drilled at coordinates that cover the 
right sensory-motor cortex (Figure 2). A Hamilton syringe with needle was positioned 
through the generated holes and was lowered into the brain by 0.5 mm for mice and 1.5 mm 
for rats. Thereafter, 0.5 µl of AAV vector was injected in each hole at a rate of 0.2 µl per 
minute (total virus volume of 2 µl per mice and 3.5 µl per rat) using a Micro4 micro syringe 
pump controller. The needle was removed three minutes after injection to allow proper 
diffusion of the virus and avoid unwanted leaking. Afterwards, the skin was sutured and the 
animals were recovered at 37 °C before standard housing. 
 
Fig. 2. Injection coordinates for the sensory-motor cortex in the right hemisphere of mice and rat. The 0 
point of the XY-graphs represent Bregma and the coordinates were defined by their mediolateral (x) and 
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anteroposterior (y) position relative to Bregma. (Left) Rats were injected at seven coordinates: +1.5 mm, +1 mm; 
+2 mm, +3.5 mm; +2.5 mm, + 1.5 mm; +2.5mm, +0.5 mm; + 3.5 mm, +2 mm; + 3.5 mm, + 0.5 mm, +3 mm, -
0.5 mm. The virus was injected at a depth of 1.5 mm (z = -1.5 mm). (Right) Mice were injected at four 
coordinates: +2 mm, +1 mm; +2 mm, +0.5 mm; +2 mm, -0.5 mm; +2 mm, -1 mm. The virus was injected at a 
depth of 0.5 mm (z = -0.5 mm).  Labjournal reference: Barbara Haenzi – experiment 26. 
 
(6) Histology  
 Six weeks after adeno-associated virus injection, animals were euthanized by injecting 
an overdose of Euthatal followed by transcardial perfusion with PBS followed by 4% PFA in 
PBS. The brain and spinal cords were collected and were stored in 4% PFA for 24 hours at 4 
°C. Afterwards, the tissue was stored in 30% sucrose in PBS with 0.1% sodium azide at 4 °C 
until further use. The cerebrum was cut into 40 µm tick coronal sections and the spinal cords 
were cut in transverse sections with a thickness of 40 µm using a freezing microtome. The 
tissue was collected in 12 series and was kept in a 24-well plate containing PBS and 0.1% 
sodium azide. 
(7) Immunohistochemistry  
 The sectioned brains and spinal cords were washed in PBS. After washing, the tissue 
was permeabilized and blocked by applying 0.3% triton (Sigma, X-100) and 10% goat serum 
(Sigma-Aldrich, G9023) in PBS for two hours at room temperature. The tissue was next 
incubated with primary antibodies that were diluted in above-mentioned blocking detergent at 
4°C overnight. The primary antibodies used were anti-eGFP (A10262, 1:1000, 
ThermoFischer scientific or Ab290, 1:1000, Abcam) together with anti-NeuN (ABN91, 
1:500, Merck), anti-Glial Fibrillary Acidic protein (Z0334, 1:500, Dako), anti-Iba1 (019-
19741, 1:1000, Wako), anti-APC clone CC-1 (OP80, 1:300, Merck), or anti-Olig-2 (AB9610, 
1:500, Merck). Afterwards, the cells were washed and incubated in Alexa Fluor-conjugated 
secondary antibodies that were diluted in 0.3% triton and 10% goat serum in PBS for 2 hour 
at room temperature. The secondary antibodies used were anti-chicken IgY conjugated to 
Alexa Fluor 488 (A-11039, 1:500, ThermoFischer scientific), anti-chicken IgY conjugated to 
Alexa Fluor 568 (A-11041, 1:500, ThermoFischer scientific), anti-rabbit IgG conjugated 
Alexa Fluor 488 (A-11008, 1:500, ThermoFischer scientific), anti-rabbit IgG conjugated 
Alexa Fluor 568 (A-11011, 1:500, ThermoFischer scientific), anti-rabbit IgG conjugated 
Alexa Fluor 647 (A-21245, 1:500, ThermoFischer scientific), anti-mouse IgG2b conjugated 
Alexa Fluor 568 (A21144, 1:500, ThermoFischer scientific). After washing, the free-floating 
sections were mounted using fluorsavetm reagent (Calbiochem, 345789) on glass imaging 
slides.  
	124	
(8) Microscopy   
 Cultured cortical neurons were imaged on a fluorescent microscope (DM6000 B, 
Leica) with a 40x-oil objective using Leica software. Fluorescence slides containing in vivo 
tissue stained for NeuN were scanned on a Zeiss AxioScan Z1 (Histopathology core facility in 
Cancer Research UK – Cambridge institute) using a 20x light objective. Images containing 
the regions of interest were exported in TIFF format.  All images within an experiment were 
taken with identical settings. Representative images for astrocytes, microglia, the 
oligodendrocytes lineage, and the dorsal corticospinal tract were taken using laser-scanning 
confocal microscopy (Leica, TCS SPE, DMI4000B).  
(9) Quantification   
 Analysis of cultured neurons was performed using MATLAB platform version 2017 
and SynD (Schmitz et al.,  2011). A detailed description about the morphology analysis of 14 
DIV cortical neurons can be found in Chapter III Section II.8.  
 The mean area of transduction per section was measured in ImageJ by manually 
outlining the areas that contained eGFP-positive staining. The transduction area reported for 
each animal is the average taken from two sections with the biggest transduction area. 
 The number of transduced cortical neurons (eGFP+ NeuN+ cells), and the mean eGFP 
intensity per transduced neuron was measured using a custom-made ImageJ Macro designed 
by Alejandro Carnicer-Lombarte (Fig. 3) and Microsoft Excel. An excel template that will 
perform the calculations after inserting the ImageJ output will be uploaded as supplementary 
data. In essence, the ImageJ macro automatically detects the position of all NeuN+ cells in 
the red channel and afterwards measures the fluorescence intensity within the green channel 
of each identified cells. After applying the Macro, the number of transduced cortical neurons 
was determined by counting the detected NeuN+ cells that had a fluorescent intensity that was 
higher than an arbitrary limit of 30% above the average background intensity of the 
transduced area. The background intensity was determined by manually outlining the region 
in-between two transduced neurons, and afterwards taking the average eGFP intensity in three 
of those regions. Because each brain was cut into series of twelve, the number of eGFP+ 
NeuN+ cells of each image was multiplied by 12 to obtain the total expected number of 
transduced neurons per brain section.  The mean eGFP intensity per transduced neuron was 
calculated by taking the average eGFP intensity of the eGFP+ NeuN+ cells and afterwards 
subtracting the average eGFP intensity of three non-transduced cells within the same section. 
In general, the numbers reported for each animal is the average taken from two sections with 
the biggest transduction area.    
	125	
 The number of eGFP-containing axons in the dorsal corticospinal tract was manually 
counted by using microscope eyepiece reticles (Pyser Optics, NE11A – 01B26210) and a 
standard fluorescent microscope (DM6000 B, Leica) with 63x-oil objective.  The squared grid 
covered a region of 80x80 µm with this magnification. Axon transduction per ROI for each 
animal was determined by taking the average number of fluorescent axons in three counting 
grids. This average number was multiplied by factor 10 or 4 for rats or mice, respectively, to 
cover the transduced dorsal corticospinal tract at the cervical spinal cord.  
 One rat (out of the 32 injected animals in total) injected with AAV1-mPGK-eGFP was 
excluded for corticospinal tract analysis because the stereotactic injections poorly covered the 
sensory-motor cortex in this animal (Supplementary figure 1). 
 
Supplementary figure 1 Rat 
injected with AAV1-mPGK-
eGFP with relative poor 
transduction coverage of the 
sensorimotor cortex. Pictures 
were taken with same 
fluorescent intensities as Fig. 11 
(mPGK-brain) and Fig. 13 
(mPGK-spinal cord) Lab 
journal references: BN-18-06 
(brain), BN-18-28 (spinal cord).  
 
 The number of transduced astrocytes, microglia, and oligodendrocytes were manually 
counted by using microscope eyepiece reticles (Pyser Optics, NE10A – 01B26208) and a 
standard fluorescent microscope (DM6000 B, Leica) with 40x-oil objective.  The squared grid 
covered a region of 250x250 µm with this magnification.  The transduced cells were 
visualised by using a filter that permits both green (Alexa 488) and red (Alexa 568) 
fluorescent light through the eyepiece.  The number of transduced cells per ROI for each 
animal was calculated by taking the average number of eGFP+ cells in three counting grids 
within one AAV transduced area.  
(10) Statistical analysis  
 Statistical analysis was performed by using Graphpad Prism 7 for Mac OS X. All 
statistical tests and parameters are mentioned in the figure legends. The graphs represent the 
average for each condition together with the individual data points for each animal, rather 
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than error bars (Cumming, Fidler, & Vaux,  2007), because of the relatively small N-numbers 
per group used in this study.    
 
 
Fig. 3. ImageJ macro for automated histological analysis of AAV transduced cortex tissue. The code is 
highlighted in yellow and purple. The green lines are comments for the user. Lines 1-2: the macro begins by 
removing the scale and therefore all input and output will be in pixels. Lines 3-6: Create a region of interest (roi) 
within the open image. A duplicate is made so that the macro can process any images regardless of the image 
name. Lines 7-8: The macro will open the red channel (e.g. immunofluorescence for cell marker NeuN). Lines 
10-15: The macro will create a mask on the cells positive for the marker in the red channel using the standard 
ImageJ thresholding called ‘Moments’. Note that the thresholding parameters were manually determined by the 
user for this experiment, and should be re-determined for each new experiment. Two cells that are close to each 
other will be separated using the tool watersheding. It is important to manually type the size of the newly drawn 
region of interest, which was created in lines 3-6, in the pop-up screen (The image size in pixel is written in the 
top left corner). Lines 16-18: The particle analysis is important because it identifies cells based on their size. The 
current settings will exclude particles from the red channel that are smaller than 1002 pixels and bigger than 
35002 pixels. After cell identification, the masks are stored in the roi manager and the red channel gets closed. 
Lines 19-27: The masks, which contain cells that are positive for the marker in the red channel, are moved to the 
green channel containing eGFP positive cells. The user can view the overlay on the green cells and when 
satisfied press ‘okay’ to measure the eGFP intensities. Lines 28-31: The output of the ImageJ Macro is the 
‘number of red cells’, the ‘area surface of each red cells’ and the ‘median eGFP intensity of each red cell’. The 
output can be stored in an excel file and the Macro will be closed. I generated an automated Excel file to 
determine the number of eGFP+ red channel marker+ cells (see Fig. 6F and description in the method 
quantification section) 
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III. RESULTS 
(1) Mean eGFP intensity of the transfected cortical neurons in vitro 
 The plasmids were validated in cortical neurons in vitro before AAV vectors were 
produced. The plasmids containing the various promoters and the DNA sequences for the 
fluorescent proteins were transfected into cultured cortical neurons that were derived from 
embryonic day 18 rats. The neurons were transfected utilizing magnetic beads after culturing 
them for 10 days in vitro (DIV) and were examined on 14 DIV, a time point on which they 
are considered to be mature. The transfection of all plasmids resulted in eGFP expression 
(Fig. 4A). The strength of the four promoters in vitro was determined by measuring the 
intensity of eGFP in the transfected neurons. After four days of transfection, the eGFP 
intensity was similar between the CMV, mPGK, sCAG, and hSYN promoters (Fig. 4B, C). 
The eGFP intensity in the neurites was determined by measuring the average fluorescence of 
each neurite within a 100 µm distance from the soma.  The neurite eGFP intensity did not 
statistically differ between groups and was approximately 1000 arbitrary units (Fig. 4C). The 
eGFP intensity in the soma reached almost saturation levels in each group and was 
approximately 4000 arbitrary units (Fig. 4D). As expected, the soma size of the transfected 
neurons was not different between the four groups (Figure 4E). In addition, sholl analysis of 
the neurite branches confirmed that the investigated primary cortical neurons had similar 
morphology for each vector plasmid (Figure 4F).  
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Fig. 4. - previous page - Comparison of four promoters for eGFP expression in cultured cortical neurons 
after transfection. (A) Representative 14 DIV cortical neurons that were transfected with four different 
plasmids: CMV-eGFP, mPGK-eGFP, sCAG-eGFP, hSYN-eGFP (B) Quantifications of the mean eGFP intensity 
in neurites (df=3(8), F=0.23, P>0.05, ANOVA with Tukey’s multiple comparison test). (C) Quantification of the 
mean eGFP intensity in the soma (df=3(8), F=1.39, P>0.05, ANOVA with Tukey’s multiple comparison test). 
(D) Quantification of the soma area (df=3(8), F=0.41, P>0.05, ANOVA with Tukey’s multiple comparison test). 
(E) Sholl analysis of neurite branches (df=3(8), F=0.52, P>0.05, Repeated measure ANOVA, n = 3 per group).  
The data shows the average ± SEM. The results are obtained from three independent experiments (n=3) and a 
total of 45 transfected neurons were analyzed for each condition. Ns, not statistically significant. Scale bar: 25 
µm. Lab journal references: BN-18-08, BN-18-15, BN-18-16.  
 
(2) Validation of a new ImageJ macro for automated histological analysis of AAV 
transduced cortex tissue  
 A custom-made ImageJ macro was made for semi-automated image analysis of 
fluorescent images (Fig. 3) using thresholding, watershedding, particle analysis, and 
transferring a mask from the red channel (NeuN) to the green channel (eGFP). This novel 
ImageJ macro can be used to measure: (1) the total number of NeuN+ cells in the region of 
interest, (2) the number of AAV transduced NeuN+ cells, and (3) the average eGFP intensity 
of the transduced cells. This ImageJ macro was used to analyse rat and mouse tissue that was 
stereotactically injected with various AAV serotypes and different promoters in the right 
sensory-motor cortex.  The tissue was perfused six weeks after injection and underwent 
immunohistochemistry procedures. To examine whether the new ImageJ macro was correctly 
calibrated, we performed manual analysis of ten random cropped images of AAV transduced 
cortical tissue and compared this to the output of the ImageJ macro.  One cropped fluorescent 
image of AAV transduced mouse cortical tissue is shown in Fig. 5A. The number of NeuN+ 
cells was manually counted (Fig. 5B) and automatically detected by the ImageJ macro (Fig. 
5C). There was no statistically significant difference between the numbers of NeuN+ cells 
between the manual (100 ± 0 %) and automated analysis (95.1 ± 4.08 % fraction of 
normalized cells) (Fig. 5D). The eGFP+ NeuN+ cells were also manually counted (Fig. 5B) 
and automatically quantified using the ImageJ macro (Fig. 5C). The ImageJ Macro measures 
the eGFP intensity in all previously detected NeuN+ cells. However, the cells are classified as 
eGFP+ when the fluorescent intensity passes an arbitrary limit of 30% above the average 
background intensity (in other words, the intensity has to be above the 1.3 ratio of eGFP to 
background intensity). There was no statistically significant difference between the numbers 
of eGFP+ NeuN+ cells between the manual (100 ± 0 %) and automated analysis (112 ± 9.5 % 
fraction of normalized cells). In addition, the output of the automated analysis can be directly 
used to calculate the average eGFP intensity per neuron, while manual analysis will require 
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labour-intensive masking of the NeuN+ cells before measuring the eGFP intensity (not 
shown).  
 
 
Fig. 5. Detection of NeuN+ and eGFP+ NeuN+ cells in AAV-transduced mouse cortex via manual analysis 
and a new ImageJ macro. Adult mice were stereotactically injected with AAVs expressing eGFP and perfused 
after six weeks. Immunohistochemistry was performed to visualize NeuN (red) and eGFP (green) in the cortex. 
A cropped image of an AAV-transduced cortical area is shown in (A). The number of NeuN+ cells was 
manually counted in (B) and detected by the ImageJ macro in (C). (D) Quantification of the number of NeuN+ 
cells by manual counting and the ImageJ macro (N=10 per group, Mann-Whitney U=35 P > 0.05, Mann-
Whitney test). (E) Manual analysis of the number of eGFP+ NeuN+ cells. (F) Quantification of the number of 
eGFP+ NeuN+ cells using the ImageJ macro and Excel. The eGFP intensity of all previously detected NeuN+ 
cells were measured and divided by the intensity of the background within the region of interest to obtain a 
eGFP/background intensity ratio. The histogram shows the eGFP/background intensity ratio on the X-axis and 
the frequency (number of cells) on the Y-axis. The grey vertical line represents an eGFP/background ratio of 1 
and therefore the number of NeuN+ cells with eGFP intensity similar to the average background intensity (e.g 
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eGFP- NeuN+ cells). Since measuring fluorescent intensities will follow a normal distribution, it is important to 
set an arbitrary limit for measuring eGFP+ NeuN+ cells. The green vertical line represents an eGFP/background 
ratio of 1.3 (e.g. 30% above the average background intensity) and is the decided arbitrary limit to measure 
eGFP+ NeuN+ cells. (G) Quantification of the number of eGFP+ NeuN+ cells by manual counting and the 
ImageJ macro (N=10 per group, Mann-Whitney U=50 P > 0.05, Mann-Whitney test). The data shows the 
average ± SEM. Ns, not statistically significant. Images were taken with a Zeiss AxioScan Z1 microscope with 
20x objective.  
 
(3) Detection of eGFP in the dorsal corticospinal tract following AAV vector injection in 
the sensorimotor cortex 
 The ImageJ macro described above will be useful to quantify the number of 
transduced neurons in the cortex. A different approach is needed to quantify the number of 
transduced neurons specifically in the layer V motor cortex, we decided to count the number 
of axons in the cervical spinal cord that originated from these neurons.  A pilot staining on 
spinal cords was done to confirm that the coordinates used for stereotactic injections indeed 
target layer V neurons that give rise to the corticospinal tract and whether 
immunohistochemistry procedures for eGFP are required to visualize axons.   
 Immunohistochemistry was performed on 40 µm thick, transverse spinal cord sections 
of one rat that was injected with AAV1-mPGK-eGFP in the right sensory-motor cortex. By 
using an epifluorescence microscope with 20x objective (Fig. 6 – upper panels) the 
transduced axons in the left dorsal corticospinal tract were clearly visible, while the axons on 
the contralateral site were not detectable. The image acquisition was done with high intensity 
power and this resulted in unwanted auto-fluorescence of the grey matter in the 40 µm thick 
sections (Fig. 6 – upper panels). Confocal imaging with a 40x objective resulted in clear 
visualization of transduced axons and did not result in auto-fluorescence of the grey matter 
(Fig. 6 – lower panels).  Axons that were eGFP positive were detectable in both stained for 
eGFP (Fig. 6A) and non-stained sections (Fig. 6B), but the intensity is brighter/higher in 
stained sections.   In summary, this pilot staining showed that the injection coordinates for the 
right sensory-motor cortex of rats (see Fig. 2) targets layer V neurons and that eGFP staining 
is not required for tissue injected with AAV1-mPGK-eGFP. However, I decided to perform 
immunohistochemistry procedures for eGFP on future spinal cord tissue in order to enhance 
the eGFP signal of potentially weaker promoters such as the CMV promoter.  
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Fig. 6. Detection of eGFP-positive axons in the dCST of a rat injected with AAV1-mPGK-eGFP in the 
sensory-motor cortex. Transverse sections of the cervical spinal cord that were stained for eGFP by using a 
1:1000 dilution of the ThermoFisher A10262 antibody (A) or were treated without primary antibody (B).  The 
images in the upper panels are tile-scanned images that were taken with a DMi8 epifluorescence microscope to 
highlight the entire section. The high signal in grey matter is an artefact caused by the imaging of the 40 µm 
thick sections using an epifluorescence microscope. The images in the lower panels were taken using a confocal 
microscope to zoom in on the dCST with high resolution. The artefact in the grey matter disappears and single 
collaterals become visible when imaged with a confocal microscope.  Lab journal reference: BN-18-27.  
 
 
 
 
 
 
	132	
(4) Efficiency of AAV1 and AAV5 in transducing cortical neurons in vivo 
 AAVs serotypes 1 and 5 with hSYN promoter were injected into the sensory-motor 
cortex of rats and mice to compare the transduction and gene expression efficiency of these 
two serotypes in cortical neurons in vivo.  Six weeks after injection, the animals were 
perfused and microscopy analyses were performed.  
 In rats (Fig. 7A), the mean area of transduction was not statistically significantly 
different between AAV1 (1.03 ± 0.17 mm2) and AAV5 (0.73 ± 0.09 mm2) (Fig. 7B). 
However, AAV1 (6473 ± 682 NeuN+ cells) transduced two-fold more cortical neurons than 
AAV5 (3255 ± 377 NeuN+ cells) (Fig. 7C). The mean eGFP intensity per transduced neuron 
was also higher in AAV1 (68.5 ± 2.02 a.u.) compared to AAV5 (28.8 ± 5.45 a.u.) (Fig. 7D). 
 In mice (Fig. 8A), the mean area of viral transduction was bigger in AAV1 (1.03 ± 
0.10 mm2) than AAV5 (0.61 ± 0.08 mm2) injected animals (Fig. 8B). The number of 
transduced cells was almost double in AAV1 (4098 ± 252 NeuN+ cells) compared to AAV5 
(2304 ± 291 NeuN+ cells) (Fig. 8C). The mean eGFP intensity per transduced neuron was 
also superior in AAV1 (64.5 ± 2.40 a.u.) than AAV5 (30.0 ± 5.37 a.u.) (Fig. 8D).  
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Fig. 7. Transduction of AAV1 and AAV5 harbouring the hSYN-eGFP expression cassette in the sensory-
motor cortex of rats. (A) NeuN+ and eGFP staining in the cortex of AAV1-hSYN-eGFP and AAV5-hSYN-
eGFP injected rats. (B) Quantification of the mean area of transduction in 40 µm thick sections (df=6, t=1.55, P 
> 0.05, Student’s t-test). (C) Quantification of the number of transduced NeuN+ cells. eGFP+ NeuN+ cells were 
detected using the ImageJ macro and neurons were considered as transduced when the eGFP intensity was 1.3x 
higher than the eGFP to background intensity ratio (df=6, t=4.13, P < 0.01, Student’s t-test). (D) Quantification 
of the mean eGFP intensity per transduced neurons (df=6, t=6.44, P < 0.001, Student’s t-test). The grey bars 
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depict the averages and each dot represents the mean value of one animal. A total of 4 rats were analysed for 
each condition. Ns, not statistically significant; ** P<0.01; *** P<0.001. Lab journal reference: BN-18-06. 
 
 
Fig. 8. Transduction of AAV1 and AAV5 harbouring the hSYN-eGFP expression cassette in the sensory-
motor cortex of mice. (A) NeuN+ and eGFP staining in the cortex of AAV1-hSYN-eGFP and AAV5-hSYN-
eGFP injected mice. (B) Quantification of the mean area of transduction in 40 µm thick sections (df=6, t=3.22, P 
< 0.05, Student’s t-test). (C) Quantification of the number of transduced NeuN+ cells. eGFP+ NeuN+ cells were 
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detected using the ImageJ macro and neurons were considered as transduced when the eGFP intensity was 1.3x 
higher than the eGFP to background intensity ratio (df=6, t=4.13, P < 0.01, Student’s t-test) (D) Quantification 
of the mean eGFP intensity per transduced neurons (df=6, t=5.87, P < 0.01, Student’s t-test). The grey bars 
depict the averages and each dot represents the mean value of one animal. A total of 4 mice were analysed for 
each condition. * P<0.05; ** P<0.01. Lab journal reference: BN-18-12. 
   
(5) Efficiency of AAV1 and AAV5 to transduce layer V corticospinal neurons in vivo 
 The rAAV injection in the sensory-motor cortex resulted in extensive transduction of 
neurons of the corticospinal tract. eGFP+ fibers were crossing at the pyramidal tract and 
descended into the left dorsal columns of the spinal cord (Fig. 9). 
 
Fig. 9. Transduction of the corticospinal 
tract in a mouse injected with AAV1-
hSYN-eGFP. eGFP-positive fibers are 
crossing at the level of the medullary 
pyramid from the right to left brain 
hemisphere (upper), and the axonal fibers 
are found in the left dorsal columns of the 
cervical spinal cord (lower). The high signal 
in grey matter is an artefact caused by 
epifluorescence microscopy of the 40 µm 
thick sections. The zoom-in figures were 
taken using a confocal microscope and as a 
consequence the artefact is reduced. Lab 
journal references: BN-18-12-typical CST & 
BN-18-28.  
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 After confirming successful transduction of the corticospinal neurons, we determined 
the efficiency of the AAV1 and AAV5 serotypes with the hSYN promoter to transduce layer 
V cortical neurons that give rise to the CST. This was determined by counting the number of 
transduced axons in the dCST of the spinal cord (Fig. 10A). The axons were counted in one 
transverse section per animal. The number of transduced corticospinal axons was statistically 
significantly higher in AAV1 than AAV5 in both rats (Fig. 10B) and mice (Fig. 10C). In the 
spinal cord of rats, 1305 ± 123 axons were transduced in the AAV1 group, while 838 ± 133 
axons were counted in the AAV5 group. In the spinal cord of mice, 484 ± 30 and 250 ± 87 
axons were counted for AAV1 and AAV5, respectively. Thus, AAV1 is the superior serotype 
to transduce layer V neurons in rats and mice. Consistent with the data in the cortex (Fig. 7 
and Fig. 8), the eGFP fluorescence intensity was brighter in the AAV1 condition compared to 
AAV5 (not quantified). 
 
 
Fig. 10. Transduction of AAV1 and AAV5 in layer V cortical neurons measured by quantifying their 
axons in the spinal cord. (A) Representative images of transduced axons in the left dorsal column of the spinal 
cord of AAV1-hSYN-eGFP and AAV5-hSYN-eGFP injected rats and mice. The axons in the AAV1 group were 
brighter than the AAV5 group (B) Quantification of the number of transduced axons in rat  (df=6, t=2.58, P < 
0.05, Student’s t-test). (B) Quantification of the number of transduced axons in mouse  (df=6, t=4.43, P < 0.01, 
Student’s t-test). The grey bars depict the averages and each dot represents the axon count of one animal. A total 
of 4 animals were analysed for each condition. * P<0.05; ** P<0.01. Lab journal reference: BN-18-28. 
 
	137	
(6) Efficiency of the four promoters to express eGFP in cortical neurons in vivo 
 After replicating the findings of Hutson et al.,  2012 that AAV1 is the superior 
serotype for corticospinal tract transduction between AAV1 and AAV5, we were interested to 
determine the optimal promoter for transgene expression in cortical neurons. AAV1-CMV-
GFP, AAV1-mPGK-GFP, AAV1-sCAG-GFP, and AAV1-hSYN-GFP were injected into the 
right sensory-motor cortex of rats and mice for this purpose. The transduction area, the 
number of transduced cells, and the expression intensity of eGFP was measured 6 weeks after 
AAV injection.  
 In rats (Fig. 11A), the mean area of transduction was significantly different between 
the four promoters. The AAV1 vectors with the mPGK and hSYN promoter had an average 
transduction area of approximately 1 mm2 (1.24 ± 0.14 mm2 and 1.03 ± 0.17 mm2, 
respectively), whereas the vectors with sCAG and CMV transduced an area of roughly 0.55 
mm2 (0.59 ± 0.09 and 0.55 ± 0.09 mm2, respectively) (Fig. 11B). A difference between the 
mPGK and hSYN promoter vectors and the sCAG and the CMV promoter vectors was also 
observed when analysing the number of transduced neurons. The AAV1 vector with mPGK 
and hSYN promoters transduced on average the highest number of cortical neurons (7950 ± 
477 and 6473 ± 682 NeuN+ cells, respectively) followed by sCAG and CMV (2172 ± 189 
and 1256 ± 277 NeuN+ cells, respectively) (Fig. 11C). Importantly, not only the number of 
transduced neurons was higher with the mPGK and hSYN promoter but the mPGK and hSYN 
promoters also displayed significantly higher levels of eGFP expression in cortical neurons 
(80 ± 6 and 69 ± 3 a.u., respectively) compared to the CMV and sCAG promoters (26 ± 3 and 
18 ± 2 a.u., respectively) (Fig. 11D).  
 In mice (Fig. 12A), the mean area of transduction was statistically significantly 
different between the four promoters. The AAV1 vector carrying the hSYN promoter (1.03 ± 
0.10 mm2) had the biggest area of transduction area compared to the other promoters (mPGK, 
0.62 ± 0.09 mm2; sCAG, 0.44 ± 0.11 mm2; CMV, 0.40 ± 0.07 mm2) (Fig. 12B). The vector 
with the hSYN promoter transduced the highest number of cortical neurons (4098 ± 252 
NeuN+ cells). The vector with the mPGK promoter had the second best mean number of 
transduced neurons (3464 ± 530 NeuN+ cells) and was followed by CMV and sCAG (1962 ± 
387 and 1704 ± 665 NeuN+ cells, respectively) (Fig. 12C). Importantly, the eGFP intensity 
was different between the four promoters. The AAV vectors with the mPGK and hSYN 
promoters express eGFP with the highest intensity in the neurons (73 ± 10 and 65 ± 2 a.u., 
respectively).  The vectors with the CMV and sCAG promoters had a relatively low eGFP 
intensity in cortical neurons (42 ± 8 and 28 ± 8 a.u., respectively) (Fig. 12D). 
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 In summary, the most efficient promoters for AAV-mediated transgene expression in 
cortical neurons are mPGK and hSYN in both rats and mice.  
 
Fig. 11. Neuronal transduction efficiency and mean eGFP intensity of four promoters in the sensory-
motor cortex of rats. (A) NeuN+ and eGFP staining in the cortex of AAV1-CMV-eGFP, AAV1-mPGK-eGFP, 
AAV1-sCAG-eGFP, and AAV1-hSYN-eGFP injected rats. (B) Quantification of the mean area of transduction 
in 40-micron thick sections (df=3(11), F=6.88, P<0.01, ANOVA with Tukey’s multiple comparison test). (C) 
Quantification of the number of transduced NeuN+ cells. eGFP+ NeuN+ cells were detected using the ImageJ 
macro and neurons were considered as transduced when the eGFP intensity was 1.3x higher than the eGFP to 
background intensity ratio (df=3(11), F=50.4, P<0.001, ANOVA with Tukey’s multiple comparison test). (D) 
Quantification of the mean eGFP intensity per transduced neurons (df=3(12), F=107, P<0.001, ANOVA with 
Tukey’s multiple comparison test). The grey bars depict the averages and each dot represents the mean value of 
one animal. * P<0.05; ** P<0.01; *** P<0.001. Lab journal reference: BN-18-06. 
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Fig. 12. Neuronal transduction efficiency and mean eGFP intensity of four promoters in the sensory-
motor cortex of mice. (A) NeuN+ and eGFP staining in the cortex of AAV1-CMV-eGFP, AAV1-mPGK-eGFP, 
AAV1-sCAG-eGFP, and AAV1-SYN-eGFP injected mice. (B) Quantification of the mean area of transduction 
in 40-micron thick sections (df=3(12), F=9.29, P<0.01, ANOVA with Tukey’s multiple comparison test). (C) 
Quantification of the number of transduced NeuN+ cells. eGFP+ NeuN+ cells were detected using the ImageJ 
macro and neurons were considered as transduced when the eGFP intensity was 1.3x higher than the eGFP to 
background intensity ratio (df=3(12), F=5.74, P<0.05, ANOVA with Tukey’s multiple comparison test). (D) 
Quantification of the mean eGFP intensity per transduced neurons (df=3(12), F=7.58, P<0.01, ANOVA with 
Tukey’s multiple comparison test). The grey bars depict the averages and each dot represents the mean value of 
one animal. A total of 4 mice were analysed for each condition. * P<0.05; ** P<0.01. Lab journal reference: BN-
18-12. 
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(7) Efficiency of the four promoters to transduce layer V corticospinal neurons in vivo 
 The number of eGFP-expressing axons that originate from layer V cortical neurons 
were counted in the dorsal column of the spinal cord. This was done to obtain the transduction 
efficiency of neurons of the corticospinal tract by AAV1 vectors with different promoters.  
 In rats (Fig. 13A, B), hSYN and mPGK had the best transduction of layer V cortical 
neuron as 1497 ± 99 and 1305 ± 123 axons were detected in the dorsal column of the cervical 
spinal cord contralateral to the injected sensory-motor cortex. The sCAG group counted 623 ± 
50 green axons, and CMV contained on average 293 ± 49 eGFP-positive fibres in the spinal 
cord.  
 In mice (Fig. 13A, C), 484 ± 30 and 386 ± 70 axons were visible in the spinal cord in 
the mPGK and hSYN groups, respectively. The sCAG and CMV promoters had 175 ± 47 and 
95 ± 34 axons containing eGFP, respectively.  
 The transduction efficiency of the AAV1 vector carrying the mPGK and hSYN 
promoters were not statistically significant different showing that these two promoters are 
equally strong in both rats and mice. Fewer eGFP-positive axons were observed in the groups 
that contained the AAV1 vector harbouring the CMV and sCAG promoters indicating that 
these promoters are less efficient to target the corticospinal tract in vivo.  
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Fig. 13. Transduction efficiency of layer V cortical neurons depending on the choice of promoters CMV, 
mPGK, sCAG and hSYN measured by eGFP expressing axons in the spinal cord. (A) eGFP positive fibers 
in the dorsal corticospinal tract of AAV1-CMV-eGFP, AAV1-mPGK-eGFP, AAV1-sCAG-eGFP, and AAV1-
hSYN-eGFP injected rats and mice. (B) Quantification of the number of transduced axons in rats  (df=3(11), 
F=43.7, P<0.001, ANOVA with Tukey’s multiple comparison test). (B) Quantification of the number of 
transduced axons in mice  (df=3(12), F=14.2, P<0.001, ANOVA with Tukey’s multiple comparison test). The 
grey bars depict the averages and each dot represents the mean value of one animal. * P<0.05; ** P<0.01; *** 
P<0.001. Lab journal reference: BN-18-28. 
 
(8) Validation of antibodies for detection of non-neuronal cells in the rodent cortex  
 Antibodies for immunohistochemistry of non-neuronal cells were tested on brain 
tissue of naïve (non-transduced) animals. The used antibody concentrations were based on the 
recommendation of the manufacturers or colleagues. The cells of interest are astrocytes, 
microglia, and oligodendrocytes.   
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 Astrocytes can be detected by the markers aldehyde dehydrogenase I family member 
L1 (ALDH1L1) and glial fibrillary acidic protein (GFAP) among others. ALDH1L1 is an 
enzyme found in astrocytes (Cahoy et al.,  2008) and GFAP is an intermediate filament found 
in the processes of astrocytes (reviewed in Hol & Pekny,  2015). The ab87117 antibody for 
ALDH1L1 resulted in nonspecific staining in PFA perfused mouse cortex (Fig. 14A, B). This 
staining pattern was not the result of unspecific binding by the secondary antibody (Fig. 14C).  
In contrast, the Dako Z033429 antibody for GFAP resulted in strong astrocytic staining 
throughout the cortex, and a zoom-in image of a single astrocyte is shown in Fig. 15A, B. The 
astrocytes processes were clearly visible with the 1:500 dilution (Fig. 15A) and less clearly 
visible with the 1:1000 dilution (Fig. 15B). There was little background staining as a result of 
unspecific binding by the secondary antibody (Fig. 15C). For future experiments, the Dako 
Z033429 antibody for GFAP with 1:500 dilution was used to detect astrocytes in vivo. 
 
 
Fig. 14. Dilution range of the ALDH1L1 antibody was unsuccessful to visualize astrocytes in free-floating 
sections of 4% PFA perfused mouse cortex. 1:500 and 1:2000 dilutions of the Abcam ab87117 antibody are 
shown in (A) and (B), respectively. One section that was stained without the primary antibody for ALDH1L1 is 
shown in (C).  The arrows highlight nuclei of glial cells, identified by negative NeuN staining. Lab journal 
reference: BN-18-07. 
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Fig. 15. Validation of the GFAP antibody to detect astrocytes in free-floating sections of 4% PFA perfused 
mouse cortex. 1:500 and 1:1000 dilutions of the Dako Z033429 antibody is shown in (A) and (B), respectively. 
One section that was stained without the primary antibody for GFAP is shown in (C). The arrows highlight the 
nucleus of a GFAP-positive cell. Note: the used confocal laser-scanning settings resulted in bleed through in the 
NeuN channel, which needs to be prevented in future experiments. Lab journal reference: BN-18-21. 
 
 Microglia can be detected by multiple markers including ionized calcium binding 
adaptor molecule 1 (Iba1) (reviewed in Perry, Nicoll, & Holmes,  2010; Li & Barres,  2018). 
Iba1, which is also localized in macrophages, is a calcium-binding protein that is important 
for various calcium-dependent processes such as membrane trafficking and phagocytosis 
(Ohsawa et al.,  2004). The Wako 019-19741 antibody for Iba1 resulted in clear detection of 
microglia morphology in the PFA-perfused mouse cortex with 1:1000 (Fig. 16A) and 1:2000 
dilution (Fig. 16B) resulted in clear detection of microglia morphology in the PFA perfused 
mouse cortex. However, the processes were best visible with the dilution of 1:1000 (Fig. 
16A). The Iba1 immunofluorescence was not due to unspecific binding by the secondary 
antibody (Fig. 16C). For future experiments, a 1:1000 dilution of the Wako 019-19741 
antibody for Iba1 was used.   
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Fig. 16. Validation of the Iba1 antibody to detect microglia in free-floating sections of 4% PFA perfused 
mouse cortex. 1:1000 and 1:2000 dilutions of the Wako 019-19741 antibody are shown in (A) and (B), 
respectively. One section that was stained without the primary antibody for Iba1 is shown in (C).  The arrows 
highlight the nucleus of an Iba1-positive cell. Lab journal reference: BN-18-13. 
 
 The oligodendrocyte lineage can be visualized by multiple markers (reviewed in 
Bergles & Richardson,  2016; Franklin & ffrench-Constant,  2017). The oligodendrocyte 
transcription factor 2 (olig2) is present in the nucleus of both OPC and oligodendrocytes, and 
I validated the Millipore ab9610 antibody for Olig2 with 1:500 dilution previously (pilot data 
not shown in dissertation, but see successful staining in Fig. 22). Here, we explored the 
antibodies for chondroitin sulfate proteoglycan 4 (NG2), and adenomatous polyposis coli 
(APC) clone CC1. NG2 is a hallmark of oligodendrocyte progenitor cells (OPC); the APC 
clone CC1 recognizes mature oligodendrocytes.  Interestingly, in contrast to what the name of 
the antibody suggests, anti-APC clone CC1 does not bind the antigen for APC but Quaking 7, 
an RNA binding protein found in myelinating oligodendrocytes (Bin, Harris, & Kennedy,  
2016).  
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 The Millipore ab5320 antibody for NG2 resulted in a non-convincing or possibly 
weak detection of OPC when high antibody concentrations were used in PFA perfused mouse 
cortex (Fig. 17A, B). A limited degree of unspecific binding by the secondary antibody was 
also detected (Fig. 17C), but this does not explain the weak OPC detection.  
 
 
Fig. 17. Dilution range of the NG2 antibody was unsuccessful to detect oligodendrocyte precursor cells in 
free-floating sections of 4% PFA perfused mouse cortex. 1:100 and 1:250 dilutions of the Millipore ab5320 
antibody are shown in (A) and (B), respectively. One section that was stained without the primary antibody for 
chondroitin sulfate proteoglycan 4 (NG2) is shown in (C).  The arrows highlight the nucleus of a possibly NG2-
positive cell, but it is not a convincing immunolabelling. Lab journal reference: BN-18-13. 
 
 The Millipore OP80 2 antibody for APC did detect cells in the dilution range from 
1:100 to 1:500 (Fig. 18A, B, C) with a secondary antibody for isotope IgG2a (Fig. 18D). 
Despite that the biggest population of cells was found in and near the corpus callosum area, 
the detected cells did not display typical oligodendrocyte morphology.  The primary antibody 
is derived from the mouse subclass IgG2b and therefore the wrong secondary antibody 
(IgG2a) was used for the visualization of the labelled oligodendrocytes in this pilot 
experiment. Typical oligodendrocyte morphology was detected when the Millipore OP80 2 
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antibody was used together with the secondary antibody that detects the mouse IgG2b epitope 
(Fig. 19A, B, C). As expected, a majority of oligodendrocytes was detected in and near the 
corpus callosum. Application of the secondary antibody alone resulted in limited background 
staining (Fig. 19D), and did not result in oligodendrocyte morphology as shown with the 
primary antibodies.  For future experiments, the Millipore OP80 2 clone CC1 antibody with 
1:300 dilution was used to detect mature oligodendrocytes in vivo. 
 
 
Fig. 18. Dilution range of the anti-APC clone CC1 antibody to detect oligodendrocytes was unsuccessful 
when combined with secondary IgG2a antibodies in free-floating sections of 4% PFA perfused mouse 
cortex. Images were taken at the corpus callosum and can be identified by the border of NeuN+ cells. 1:100, 
1:250 and 1:500 dilutions of the Millipore OP80 2 antibody is shown in (A), (B), and (C), respectively. One 
section that was stained with the secondary antibody for the IgG2a isotope only is shown in (D). The arrows 
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highlight the nucleus of APC-positive cells. Note that the scale bar represents 25 microns, in the other glial 
stainings the scale bar represented 10 microns. Lab journal reference: BN-18-25. 
 
 
Fig. 19. Validation of the anti-APC clone CC1 antibody to detect oligodendrocytes in free-floating sections 
of 4% PFA perfused mouse cortex. Images were taken at the corpus callosum and can be identified by the 
border of NeuN+ cells. 1:100, 1:250 and 1:500 dilutions of the Millipore OP80 2 antibody is shown in (A), (B), 
and (C), respectively. One section that was stained with the secondary antibody for the IgG2b isotope only is 
shown in (D).  The three arrows highlight the nucleus of APC-positive cells. Note that the scale bar represents 25 
microns, in the other glial pilot stainings the scale bar represented 10 microns. Lab journal reference: BN-18-26.  
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 In summary, I tested several antibodies for immunohistochemistry of non-neuronal 
cells in the mouse cortex. The determination of the optimal dilution to visualize the non-
neuronal cells is subjective. Based on above data, I decided to use below antibodies and 
concentrations for the detection of non-neuronal cells in the AAV transduced tissue (See 
section II.7): astrocytes, GFAP Dako Z033429 1:500; microglia, Iba1 Wako 019-19741 
1:1000; a co-staining for the oligodendrocytes lineage e.g. APC clone CC1, Millipore OP80 2 
1:300; and olig2 Millipore ab9610 1:500. The co-staining would, therefore, indicate the 
following:  olig2+ CC1+ cells label mature oligodendrocytes and olig2+ CC1- cells 
oligodendrocytes precursor cells. 
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(9) Expression of eGFP in non-neuronal cells depending on the promoter driving eGFP 
expression 
 The transduction of astrocytes was determined by counting the number of GFAP-
positive cells that expressed eGFP in the cortex. This was determined for the AAV1-CMV-
eGFP, AAV1-mPGK-eGFP, AAV1-sCAG-eGFP, and AAV1-hSYN-eGFP transduced brains 
(Fig. 20A). The AAV vectors harbouring the mPGK and hSYN did not result in eGFP 
expression in astrocytes for both rats (Fig. 20B) and mice (Fig. 20C). In contrast, the viral 
vectors containing the CMV (36 ± 5 and 78 ± 11) and sCAG (92 ± 5 and 103 ± 26) promoter 
did mediate eGFP expression in astrocytes within the injected cerebral hemispheres of rats 
and mice (Fig. 20B, C).  
 
Fig. 20. Expression of eGFP in astrocytes with CMV and sCAG promoters, but not with mPGK and 
hSYN promoters. (A) GFAP (red) and eGFP (green) staining in the cortex of AAV1-CMV-eGFP, AAV1-PGK-
eGFP, AAV1-sCAG-eGFP, and AAV1-hSYN-eGFP injected rats and mice. Quantification of the number of 
transduced GFAP+ cells in rats (B) and mice (C). The grey bars depict the averages and each dot represents the 
mean value of one animal, a total of 4 animals were analysed for each condition. Statistical analysis was not 
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possible because two experimental groups have a mean value of zero transduced astrocytes. Lab journal 
reference: BN-18-23.  
 
 The number of transduced microglia was determined by counting the number of Iba1-
positive cells that expressed eGFP in the cerebral cortex that was transduced with AAVs. The 
AAV viral vector serotype 1 together with the promoters CMV, mPGK, sCAG and hSYN did 
not result in expression of eGFP in microglia (Fig. 21A).  No transduced microglia was 
observed in the investigated 16 rats (Fig. 21B) or 16 mice (Fig. 21C). 
 
 
 
Figure 21 – The recombinant AAVs serotype 1 and the selected four promoters did not have tropism for 
microglia. (A) Iba1 (red) and eGFP (green) staining in the cortex of AAV1-CMV-eGFP, AAV1-mPGK-eGFP, 
AAV1-sCAG-eGFP, and AAV1-hSYN-eGFP injected rats and mice. Quantification of the number of transduced 
Iba+ cells in rats (B) and mice (C). Each dot represents the mean value of one animal, a total of 4 animals were 
analysed for each condition. Lab journal reference: BN-18-14. 
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 The transduction of oligodendrocytes was also examined in this study. Staining for the 
oligodendrocyte lineage was performed by using anti-OliG2 and clone CC1 antibodies. We 
experienced that the CC1 antibody resulted in better visualization of matured 
oligodendrocytes in mice (Fig. 22 – right) than rats (Fig. 22 – left).  The CMV (Fig. 22A) 
and sCAG (Fig. 22C) promoters resulted in several eGFP positive cells in the corpus 
callosum that did co-label with the oligodendrocytes markers in rats and mice. The corpus 
callosum of animals transduced with AAV1-mPGK-eGFP consisted mainly of eGFP positive 
axons and very few transduced oligodendrocytes (Fig. 22B). No transduced oligodendrocytes 
were detected in the corpus callosum of AAV1-hSYN-eGFP injected animals, but clear 
bundles of eGFP+ axons were visible (Fig. 22D).  
 
Fig. 22. - next page - Expression of eGFP in the oligodendrocyte lineage with the AAV1 serotype and the 
promoters CMV, sCAG, and mPGK, but not with hSYN. The upper panels illustrate an overview of the right 
cerebral hemisphere that was injected with the rAAV viral vector serotype 1 and four different promoters 
expressing eGFP. The lower panels are magnification images of the box in the upper panel showing a portion of 
the corpus callosum. The 40 µm thick brain sections were stained for clone CC1 (red), Olig2 (blue) and eGFP 
(green) in both rats (left) and mice (right).  The experimental conditions were AAV1-CMV-eGFP (A), AAV-
mPGK-eGFP (B), AAV-sCAG-eGFP (C), and AAV-hSYN-eGFP (D) injected into the sensory-motor cortex of 
mice and rats. Lab journal reference: BN-18-29.  
	152	
 
 
 
 
 
 
 
	153	
(10) Co-transfection efficiency of two plasmids in cortical neurons in vitro 
 Co-transfection of plasmids is a common procedure for various cell culture 
experiments. Here, we determined the co-transfection rate of plasmids containing hSYN-
eGFP and hSYN-tdTomato in cultured cortical neurons by magnetofection. The plasmids 
hSYN-eGFP and hSYN-tdTomato were mixed in an equal amount and afterwards transfected 
in cortical neurons on 10 DIV. The number of neurons that expressed both fluorophores, or 
eGFP-, or tdTomato alone, was counted on 14 DIV. The co-transfection via magnetofection 
resulted only in neurons that were positive for both eGFP and tdTomato (Fig. 23A, B) and 
therefore the co-transfection efficiency was 100%. One control experiment was performed to 
confirm that the high co-transfection rate was not a result of fluorophores bleed through 
during image acquisition. Single vector plasmids were transfected into neurons as negative 
control and images were taken with identical confocal microscope settings. As expected, 
simultaneous transfection of hSYN-eGFP and hSYN-TdTomato resulted in both green and 
red fluorescence (Fig. 23C). Neurons that were transfected with hSYN-eGFP showed only 
green fluorescence (Fig. 23C), while transfection of hSYN-tdTomato resulted in red 
fluorescence only (Fig. 23C).  
 
 
Fig. 23. - next page -  Co-transfection of hSYN-eGFP and hSYN-tdTomato in cultured cortical neurons via 
magnetofection. Embryonic day 18 cortical neurons from rat were cultured and transfected on 10 DIV with a 
1:1 mixture of hSYN-eGFP and hSYN-tdTomato plasmids. (A) Representative image of 14 DIV neurons that 
were co-transfected. The tile-scan image was taken with a Leica DMi-8 inverted microscope with 20x objective. 
(B) Quantifications of the number of neurons that expressed eGFP/tdTomato, eGFP, or tdTomato following co-
transfection. A total of 100 transfected neurons were imaged with a confocal microscope and analyzed (n = 5, 20 
neurons per experiment) (C) Representative images of transfected neurons on 14 DIV. The cells were 
simultaneously transfected with 3.5 µg hSYN-eGFP and 3.5 µg hSYN-tdTomato, or 7 µg hSYN-eGFP, or 7 µg 
hSYN-tdTomato plasmid, respectively.  Images were taken with an SP5 confocal with 40x objective and 2.5 
digital zoom factor. Lab journal reference: BN-18-16. 
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(11) Co-transduction rate after injecting two viruses in the sensory-motor cortex in vivo 
 Two AAV1 vectors expressing either eGFP or tdTomato under the hSYN promoter 
were mixed and injected into the right sensory-motor cortex of rats and mice (see Fig. 2). 
AAV1-hSYN-eGFP and AAV-hSYN-tdTomato were titre matched and the mixed vector 
contained 1.68 E+11 genomic copies of each vector per ml. The aim was to quantify the 
proportion of double labelling in the corticospinal tract six weeks post-injection. Co-
expression of the eGFP and tdTomato fluorophores was observed in a small number of axons 
in the dorsal column of the spinal cord with this low titre (Fig 24). We observed that the 
eGFP fluorescence was brighter than the tdTomato signal in the axons, yet both had a 
relatively weak signal. Quantifications were not performed due to the low virus titre, and as a 
consequence only few neurons were transduced in the brain (not shown). However, this pilot 
experiment indicates that co-transduction of two viruses by direct mixing before injection is 
feasible.  
 
 
Fig. 24. Co-transduction of two low titre viruses in the corticospinal tract following direct injection in the 
right sensory-motor cortex. Representative confocal microscope images of one mouse dorsal spinal cord 
section showing that few axons were (co-) transduced. Lab journal reference: BN-18-28. 
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IV. DISCUSSION 
 `The aim of this study was to optimize AAV-mediated transgene expression in cortical 
spinal neurons of the rat and mouse. We studied the impact of the viral vector serotype and 
the promoter, two variables that are known to have a significant effect on transduction 
efficiency of AAV vectors. We first compared the transduction efficiency of AAV serotypes 1 
and 5 since these two serotypes have previously been identified as the best and second best 
for transduction of corticospinal neurons (Hutson et al.,  2012). We confirmed that AAV1 is 
the best serotype for corticospinal neurons. Subsequently, we examined the impact of the 
promoter by comparing AAV1 vectors harbouring CMV, mPGK, sCAG, or hSYN promoter. 
The results show that (1) the mPGK and hSYN promoters transduced significantly more 
neurons than the CMV and sCAG promoters, (2) mPGK and hSYN directed higher levels of 
transgene expression in individual neurons than the CMV and sCAG promoters, and (3) the 
hSYN promoter mediated neuron-specific transgene expression, whereas the CMV, sCAG 
and mPGK promoters directed transgene expression in neurons and non-neuronal cells. These 
results will be of use for the design of AAV-based gene transfer experiments in corticospinal 
projection neurons, which form a widely used fiber tract for studies on long-distance axon 
regeneration in the injured spinal cord.          
 
 (1) Comparison of promoters in cultured cortical neurons after transfection  
 The vector plasmids were transfected into cultured cortical neurons to validate that 
they were functional before making AAVs. This goal was achieved. We next decided to 
compare the efficiency of the selected four promoters in cultured cortical neurons after 
transfection (rather than viral transduction), because this method is commonly used in cell-
culture experiments. The time-point of transfection (10 DIV) and analysis (14 DIV) are 
typically chosen to study mature cortical neurons derived from embryonic day 18 embryos 
(Eva et al.,  2017; Koseki et al.,  2017; see also Chapter II and Chapter III).  It is important 
to note that the plasmid transfection is not a delivery method that is comparable to the AAV-
transduction in vivo; hence the results in vitro are not predictable for the efficiency in vivo.  
 The direct comparison between the plasmid containing the four promoters resulted in 
no differences in the mean eGFP intensity of the transfected cortical neurons. Four days post-
transfection resulted in eGFP intensities close to saturation levels in the soma, were the eGFP 
protein is synthesized. The soma is therefore not a suitable area to compare the efficiency of 
transgene expression by different promoters. There was also no difference found in the eGFP 
intensity in the initial parts of the neurites between the vector plasmids. There was a strong 
eGFP expression four days after transfection; this relatively long incubation period is the most 
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likely explanation for observing no differences in the cultured neurons.  The eGFP intensity in 
the distal part of the axon was not analysed, because the cultured neurons form neuronal 
networks on 14 DIV, which makes it difficult to analyse a single and non-branched 
transfected axon.  
 An alternative explanation for the identical eGFP intensities could be due to the fact 
that the cortical neurons are derived from embryonic rats. I would speculate that the young 
cortical neurons have a high rate of transcriptional activity that allows the activation of 
various promoters, while this may become more selective in adult cortical neurons. For 
instance, the adult cortical neurons may silence the expression of transgenes under non-
neuronal promoters.  
 The data suggest that the choice of promoter may not be important for in vitro 
transfection experiments in order to gain high expression levels. However, the experience 
from our laboratory is that some promoters e.g. CMV have a low transfection efficiency in 
cultured neurons when expressing large genes (such as integrins). The number of transduced 
neurons by each promoter was not determined in this in vitro experiment due to the indeed 
low transfection efficiency by magnetofection (less than 0.1%).  
   
(2) ImageJ macro for semi-automated analysis of NeuN+ and eGFP+ NeuN+ cells in 
AAV-transduced cortex 
 The cortex contains an orchestra/plethora of different cell types, including neurons, 
astrocytes, microglia cells, oligodendrocytes and endothelial cells. Quantifying the number of 
AAV transduced neurons along with the eGFP fluorescence intensity could therefore be a 
challenging task. Manual analysis of fluorescent images containing thousands of neurons is 
time-consuming and prone to human bias and inconsistency. We therefore decided to use a 
semi-automated quantification by employing a custom-made ImageJ macro, co-developed by 
a colleague in the lab.  
 The ImageJ macro automatically detects round cells that are present in the red channel 
of an image (e.g. NeuN+ cells) and then measures the fluorescent intensity of all marked cells 
in the green channel (e.g. eGFP). Afterwards, the user has to manually measure the eGFP 
intensity of three non-transduced cells to set as threshold for the background signal in non-
transduced neurons. In addition, the user has to measure a small area in between multiple 
transduced somata within the region of interest. Based on these background intensity 
measurements, the number of transduced neurons and the mean eGFP intensity per transduced 
neuron can be calculated in a Microsoft excel sheet (the excel sheet with automated 
calculations will be included as supplementary data in the paper). The ImageJ parameters to 
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detect round cells in the red channel (tresholding, watersheding, particle analysis) can be 
adjusted by the user to fit their experimental needs. For example, the macro can be adjusted to 
measure the green intensity in larger neuronal cells, including dorsal root ganglion cells or 
motor neurons.  
 The Macro was tested on cropped images, to ease and improve the accuracy of the 
manual counting of the total number of neurons and those that were eGFP-positive, before 
using the ImageJ macro on the large images from 32 animals. When the correct settings for 
the identification of round cells were determined, there was no statistically significant 
difference between the semi-automated and manual counting of neurons in the cropped 
images. After successful development of the code, the Image J macro was more time-efficient 
than the manual counting. The code can, therefore, be useful when a large quantity of images 
is investigated.   
 The ImageJ macro does have some limitations. The user has to set an arbitrary 
intensity ratio that will be used to determine whether a round cell is eGFP positive or not. 
This limit was set to 30% in this study (see Fig 3F). This arbitrary limit prevents that eGFP-
positive branches (e.g. dendrites or transduced astrocytes) that are overlapping with non-
transduced cells will be counted as separate eGFP positive neurons. Nevertheless, we cannot 
exclude and even deem it likely that transduced non-neuronal cells, especially under the 
condition of transduction with viruses that have a CMV or sCAG promoter, are incorrectly 
counted as eGFP-positive neurons (false positives).  However, this arbitrary limit allows the 
eGFP intensity in all transduced neurons above the threshold to be measured.  It, therefore, 
avoids cherry picking of a select number of cells (e.g. n=20 per condition) and manual 
measurement of the eGFP intensity. In addition, it is difficult for the human eye to identify 
whether two fluorescent colors do overlap (especially when they are coming from two 
different fluorescent channels, e.g. NeuN+ in red and eGFP in green), while the computer 
measures the intensity value consistently. The ImageJ macro is limited to detect round 
structures only (e.g. nuclear stains such as DAPI or NeuN), and can therefore not be applied 
to detect more complex morphologies such as microglia or astrocytes.  
 
(3) Comparison of the AAV1 and AAV5 serotypes for transduction of the corticospinal 
tract 
 We chose to first compare AAV1 and AAV5 because this were the best and second-
best serotypes in an earlier study that compared the transduction of corticospinal tract with 
seven AAV serotypes (AAV1 to AAV6, and AAV8) harbouring a CMV promoter driving 
eGFP expression (Hutson et al.,  2012).  
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 AAV1 is superior to AAV5 because it transduces almost twice as many corticospinal 
neurons compared to AAV5 in both mice and rats. This is consistent with the study in rats by 
Hutson and colleagues in 2012. The transduction efficiency of a specific cell type by an AAV 
vector is dependent on a number of steps, including interaction of the AAV vector with a cell 
surface receptor, cellular uptake and subsequent release from endosomes, trafficking to the 
nucleus and finally transcription and translation of the transgene. The differential transduction 
efficiency of AAV1 and AAV5 may be due to differential capsid protein – cell surface 
interactions resulting in more efficient entry of AAV1 in cortical neurons. Although both 
AAV1 and AAV5 (Kaludov et al.,  2001; Seiler et al.,  2006) bind to α2-3 and α2-6 N-linked 
sialic acids (Wu et al.,  2006; Mietzsch et al.,  2014) Kaludov:2001gv, Seiler:2006fk}, 
endocytosis may required additional cellular co-receptors. For instance, AAV1 and many 
other serotypes interact with integrins for efficient transduction while AAV5 does not 
(Kaminsky et al.,  2012). Instead AAV5 utilizes platelet-derived growth factor receptor 
(PDGFR) as co-receptor for transduction (Di Pasquale et al.,  2003). Furthermore, AAV1 and 
AAV5 bind to different domains of adeno-associated virus receptor (AAVR) on the cell 
surface to initiate transduction (Pillay et al.,  2017).  The different patterns of transduction 
could also be caused by differential endosomal processing of the viral vector particles inside 
the cell and differential de-capsidation and release of the viral genome into the cell nucleus 
(Bantel-Schaal, Hub, & Kartenbeck,  2002; Keiser et al.,  2011; Aschauer, Kreuz, & Rumpel,  
2013).  
 In contrast to the study of Hutson et al.,  2012, we observed that AAV1 directs a 
significant stronger expression of eGFP in individual neurons compared to AAV5. This 
difference may be caused by the entry of more copies of the AAV1 than the AAV5 vector 
into neurons or to the use of different promoters that exhibit different temporal patterns of 
transcriptional activity. Hutson et al used the viral CMV promoter, whereas we used the 
strong mammalian SYN promoter. In our hands the CMV promoter is a relatively weak 
transcriptional activator compared to the SYN promoter (see more discussion below).  
 The viral vector serotypes AAV1 and AAV5 with the synapsin promoter had both a 
relatively good spread in the cortex. We did not find a statically significant difference in virus 
spread between the two serotypes in rats, but the transduction area of AAV1 was slightly 
bigger in mice.  
 Other AAV serotypes not investigated by us or Hutson and colleagues, that are 
commonly used for transduction of CNS neurons are AAV7 (Van der Perren et al.,  2011; 
Gerits et al.,  2015) and AAV9 (Aschauer et al.,  2013; Schuster et al.,  2014; Jackson, 
Dayton, & Klein,  2015; Markel et al.,  2017). AAV7 and 9 have a different mechanism for 
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transduction compared to AAV1 and AAV5. AAV9 binds Galactose as glycan receptor (Shen 
et al.,  2011; Bell et al.,  2012) and is capable to pass the blood-brain-barrier. Interestingly, 
the receptor for transduction by AAV7 is unknown and was found not to bind in a glycan 
array that tested 611 different glycans (Mietzsch et al.,  2014). Having a widespread transgene 
expression in the brain, and possibly beyond the blood-brain barrier, can be considered 
negative for studies aiming to achieve axonal regeneration following an injury of the 
corticospinal tract.  In these particular studies, it is important to achieve a relatively focal 
expression pattern of regeneration-associated genes into the corticospinal tract only.  
 
(4) Comparison of four promoters for transgene expression in the corticospinal tract  
 The promoter is a major regulatory element in the viral vector genome that determines 
both the level and the cell-selectivity of the expression of the transgene in the transduced cell. 
The size constraints of AAV vectors obviate the need for the use of small promoters. Here we 
compared four compact promoters for their ability to drive transgene expression in 
corticospinal neurons. This study found that mPGK and hSYN promoter directed strong 
neuronal expression in which hSYN was also neuron-specific. The mPGK promoter mainly 
transduced neurons but also had a rare and weaker expression pattern in oligodendrocytes. 
The CMV and sCAG resulted in relatively weak transgene expression in neurons as well as 
non-neuronal cells.  
 The high levels of neuron-specific transgene expression observed with the human 
synapsin promoter corroborated previous studies with this promoter (Thiel, Greengard, & 
Südhof,  1991; Kügler, Kilic, & Bähr,  2003; McLean et al.,  2014). Other ubiquitous neuron-
specific promoters are the neural protein BM88 and neuronal nicotinic receptor b2 (CHRNβ2) 
(Pignataro et al.,  2017) promoters. The Ca2+/calmodulin-dependent protein kinase II 
(CaMKII) promoter drives preferably transgene expression in excitatory neurons (Nathanson 
et al.,  2009; Scheyltjens et al.,  2015) and the ‘5 tyrosine hydroxylase (TH) promoter is best 
for  dopaminergic neurons (Oh et al.,  2009; Stauffer et al.,  2016). To our knowledge, there is 
no promoter available that is specific for layer V pyramidal neurons.  Thus, the hSYN 
promoter is currently the promoter of choice to drive transgene expression in corticospinal 
neurons, because it is small (allowing large coding sequences to be inserted), strong and 
neuron specific.  
 Another important factor for AAV-mediated gene delivery is the size of the chosen 
promoter because of the approximately 4700 nucleotides packaging capacity of AAVs. All 
the promoters investigated in this study were relatively small in nucleotide length; sCAG, 860 
bp, CMV 670 bp; mPGK 610 bp; hSYN, 470 bp. These DNA regulatory units are therefore 
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interesting candidates for the delivery of large transgenes, such as regeneration-associated 
genes like integrins (Chapter I) and phosphoinositide 3-kinases (Chapter III) via AAV-
mediated transduction in vivo. However, it is important to note that not only neurons of the 
corticospinal tract are transduced. The AAV1 and AAV5 serotypes transduced neurons in 
multiple layers of the cortex. This, for instance, also resulted in axonal fibers crossing over at 
the corpus callosum. 
 
(5) AAV serotypes and transduction of non-neuronal cells in the cortex  
 We observed that AAV1 serotype with different promoters induces transgene 
expression in different cell types. The hSYN promoter was specific for neurons. The promoter 
mPGK did mainly transduce neurons and had poor cellular tropism for oligodendrocytes. The 
CMV and sCAG promoters transduced neurons, but also astrocytes and few oligodendrocytes. 
The transduction of non-neuronal cells can therefore be improved by using different viral 
serotypes and promoters.   
 Astrocytes are a common target of interest to be transduced by AAVs. The 
transduction of astrocytes by the AAV1 serotype with CMV or CAG promoter is not new, as 
it was previously observed by others (Burger et al.,  2004; Hutson et al.,  2012; Watakabe et 
al.,  2015). A study by Schober et al.,  2016 suggested that the AAV6 serotype (with CMV 
promoter) has a higher transduction efficiency for astrocytes in rat cortex.  One year later, 
another comparative study with AAV serotypes (with a CMV promoter) suggested that AAV8 
was superior to drive transgene expression in astrocytes in the cortex. Koh et al., 2017 utilised 
the AAV8 serotype combined with the ALDH1L1 promoter and achieved predominantly 
transduction of astrocytes, and a small number of neurons. Pignataro et al., 2017 also used 
AAV8, but combined this with truncated forms of the GFAP promoter and achieved high 
transduction rates of astrocytes, and observed a limited number of transduced 
oligodendrocytes. Lawlor et al., 2009 achieved targeted transduction of astrocytes in 
nonhuman primates by using the AAV8 serotype and the GFAP promoter.  
 Microglia have been proven to be more difficult to transduce with AAVs in vivo. The 
AAV1 serotype together with CMV, mPGK, sCAG, and hSYN, did not transduce microglia 
in our study. The first transduction of microglia was achieved by using AAV5 in combination 
with a promoter derived from the macrophage marker F4/80 gene (Cucchiarini et al.,  2003). 
Rosario et al., 2016 characterised that an amino acid optimized AAV6 capsid in combination 
with the F4/80 or CD68 promoter results in targeted transduction of microglia in the mice 
brain.  It will be interesting to see whether the addition of other microglia specific promoters, 
e.g. P2ry12 or Tmem119 (Hickman et al.,  2013; Bennett et al.,  2016b; Satoh et al.,  2016), 
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can improve microglia transduction in vivo.  
  Targeting of the oligodendrocyte lineages by AAVs could be useful for demyelinating 
disorder studies, among others. We observed that CMV and sCAG had the ability to 
transduced oligodendrocytes. Consistently, another study also observed that injection of 
AAV8 with CAG promoter transduces mainly neurons, astrocytes and a small number of 
oligodendrocytes (Pignataro et al.,  2017). In addition, systemic injection of AAV9 with a 
CMV promoter in the cerebrospinal fluid had been shown to transduce neurons and 
oligodendrocytes in cats (Bucher et al.,  2014). Our study observed that the mPGK promoter 
had rare transgene activation in oligodendrocytes in the corpus callosum. In general, the 
transduction of oligodendrocytes can be improved by injecting directly into the corpus 
callosum or striatum, rather than the injection coordinates that were used to transduce the 
sensory-motor cortex. The use of a different serotype can also aid the transduction of 
oligodendrocytes. Hutson and colleagues showed one image that hinted that AAV8 serotype 
with CMV promoter has a potential oligodendrocyte tropism (Hutson et al.,  2012). Another 
study compared the serotypes AAV1, AAV5, AAV9, and AAV-rh10 with a CMV promoter 
following intraspinal injection immediately after a spinal cord contusion injury, and found 
that the AAV-rh10 was most efficient to transduce oligodendrocytes and 
macrophages/microglia (Petrosyan et al.,  2014). An oligotrophic AAV vector called olig001 
has been shown to transduce a large proportion of oligodendrocytes in rats and rhesus 
macaques (Mandel et al.,  2017). Examples of promoters that have been implemented in 
rAAVs and are believed to be specific for the oligodendrocyte lineage are derived from the 
myelin-associated glycoprotein (MAG) (Jonquieres et al.,  2016) and myelin basic protein 
(MBP) gene (Lawlor et al.,  2009; Jonquieres et al.,  2013).   
 However, for overexpression of transgenes in layer V neurons, our study suggest to 
AAV1 with an hSYN promoter to achieve maximal neuronal targeting and expression.  
(6) Co-transduction of two plasmids in vitro and viruses in vivo 
 Some gene therapies are based on the combination of multiple genes (e.g. integrin and 
kindlin). This study examined the co-transfection efficiency of two plasmids in primary 
cortical neurons and the co-transduction rate of mixing two rAAVs prior to injection in the 
rat/mouse brain.  
 Our laboratory prefers the magnetofection method for in vitro experiments because of 
the low neuronal toxicity. Yet, we experience low transfection efficiency by using this 
method (e.g. 40-150 transduced cells per 200,000 cultured neurons). Magnetofection is a 
transfection method based on combining plasmid DNA with magnetic nanoparticles that bind 
	163	
to nucleic acids with high efficiency. The plasmid DNA and magnetic beat complexes are 
next endocytosed by primary cortical neurons, which have been placed above a magnetic 
field. We expected high co-transfection efficiency by using this method, but were surprised to 
find a 100% co-transfection rate (n=5 experiments).  We, therefore, speculate that magnetic 
nanoparticles always bind the DNA of two plasmids during the incubation step prior to the 
uptake of the molecular complex by the cells. However, the magnetic nanoparticles do not 
always uptake an even amount of the two plasmids that are mixed in the Eppendorf tube. For 
instance, when co-transfecting the hSYN-eGFP and hSYN-tdTomato, some neurons were 
more bright red fluorescent than green and vice versa (data not shown).  
 We attempted to determine co-transduction in vivo by mixing two rAAV viruses. The 
viral mixture consisted of 50% AAV1-hSYN-eGFP and 50% AAV1-hSYN-tdTomato. In 
contrast to the transfection methods in vitro, the two viral vectors don’t form a molecular 
complex and each viral vector can, therefore, transduce different cells in the brain.  Our 
expectation was that mixing viral vectors does not result in a perfect rate of co-transduction, 
but yet it remains important to determine how often co-transduction occurs. However, the 
viral titres that were injected (1.68 E+11 genomic copies per ml) in the brain were too low, 
and as a consequence only a few transduced axons were observed in the dorsal column of the 
spinal cord with weak fluorescent intensity. The titre of AAV-hSYN-tdTomato was low due 
to serum and cell culture issues during the AAV preparation. It is important to repeat this 
experiment with high enough viral titres, e.g. E+12 or E+13 gc/ml to properly transduce the 
corticospinal tract. A good co-transduction efficiency of two viral vectors will be crucial for 
combinatorial gene therapy approaches that aim to achieve axonal regeneration of this motor 
pathway.   
 
(7) Perspective for spinal cord injury research 
  It is important for any gene therapy that transgenes are delivered with high cell-
specificity and adequate expression levels. This also counts for research in spinal cord injury 
with loss of motor function; regeneration-associated-genes need to be efficiently delivered 
into the neurons of the corticospinal tract. High cell-specificity is also crucial because the 
introduction of regeneration-associated genes into glial cells could lead to unwanted side 
effects. Based on the data presented in this study, the AAV1 viral vector serotype and the 
hSYN promoter is the optimal combination for transgene delivery in the corticospinal tract of 
mice and rats. Viral transduction prior to an injury is common practice for axon regeneration 
experiments in vivo. In the nearby future, it will be interesting to explore whether the AAV1 
serotype and promoters will also be functional when applied after a spinal cord injury.   
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CHAPTER V – Summary and general discussion   
 
 Adult neurons of the central nervous system (CNS) have a poor capacity to regenerate 
their axon after injury. I also observed this in cortical neurons that were cultured for two 
weeks. Importantly, this dissertation shows that the axon regeneration capacity of CNS 
neurons can be enhanced using vectors containing phosphoinositide 3-kinases. Furthermore, 
this dissertation contributed to improved viral transduction of the corticospinal tract in mice 
and rats. Identification of the superior viral vector serotype and promoter for this motor 
pathway is crucial for any gene therapy that aims to promote axon regeneration of the CST. 
This doctoral thesis also investigated whether a novel dual-promoter viral vector containing 
CRISPR-Cas9 system is suitable for protein knockout in CNS neurons. This final chapter will 
briefly summarise the findings of this dissertation and place them in perspective to the field of 
axon regeneration.    
 Chapter I is a literature review (Nieuwenhuis et al.,  2018) highlighting that integrin 
receptors are an important component of axon regeneration. The review hypothesizes that the 
absence of integrins in the growth cone, and importantly the subsequent signalling and 
cytoskeleton changes, is one of the reasons for regenerative failure in adult CNS neurons. 
Targeting the trafficking of regeneration-associated receptors, such as integrins, TrkB, and 
IGFR, into the axon is therefore one strategy to promote axon regeneration in the CNS. 
Furthermore, manipulation of the activation state of receptors could be a promising strategy to 
promote axon regeneration.   
 Chapter II is based on the hypothesis that the axon initial segment (AIS) contributes 
to regenerative failure in adult CNS neurons by forming an axon transport barrier for 
regeneration-associated receptors such integrins. The aim of this chapter was to knockout 
cytoskeleton scaffolding protein Ankyrin-G (AnkG) in cortical neurons with the rationale to 
dismantle the AIS. Short hairpin RNA interference and an approach consisting of viral vector-
mediated delivery of CRISPR-associated endonuclease 9 from Staphylococcus aures (saCas9) 
targeting AnkG were made and tested in vitro. The data shows that the vector-mediated RNA 
interference results in cellular toxicity in cultured cortical neurons. Other studies also reported 
neuronal degeneration in CNS tissue after AAV-mediated delivery of scrambled-shRNA and 
targeting-shRNA in vivo (Ulusoy et al.,  2009; Ehlert et al.,  2010; Khodr et al.,  2011; Martin 
et al.,  2011). For the CRISPR-Cas9 approach, a novel dual promoter AAV viral vector 
construct was modified resulting in the neuron-specific promoter hSYN to drive the 
expression of SaCas9 protein and the RNA promoter hU6 to express a single guide RNA.  In 
contrast to shRNA interference, the CRISPR-Cas9 did not result in neuronal cell death in 
	166	
vitro.  The SaCas9 protein was found to localise in the soma and importantly knockout of 
AnkG and dismantling of the AIS was achieved in a small proportion of the cultured cortical 
neurons. The AnkG knockout efficiency can likely be improved by increasing the duration of 
the experiment to match the extremely stable half-live time of the AnkG protein (Hedstrom et 
al.,  2008).  It is important that future research tests the AAV vector-mediated delivery of 
SaCas9 in vivo. The research-question whether the AIS is a barrier for the entry of integrins in 
the axon of adult CNS neurons is unanswered. Yet, this chapter achieved the generation of 
genetic tool that will be useful for other scientist to knockout their protein of interests.   
 Chapter III explored whether overexpression of phosphoinositide 3-kinases (PI3Ks), 
which generates PtdIns-3,4,5-P3 (PIP3), could promote axon regeneration of CNS neurons. 
Immunohistochemistry for PIP3 confirmed the hypothesis that there is a decline of PIP3 levels 
in the axon in line with maturation. Expression of activated PI3Ks, but not wild type PI3K, in 
developing neurons resulted in increased axonal growth, and expression in maturing neurons 
enlarged the soma size and more complex dendritic morphology in vitro. Consistently, 
expression of constitutively activated PI3K enhanced PIP3 signalling in these neurons. 
Importantly, the success rate of axon regeneration was increased in cortical neurons that 
underwent in vitro laser axotomy after PI3K overexpression. This chapter highlights that 
enhancing axonal PIP3 signalling is an important target to promote axon regeneration. Indeed, 
follow-up experiments in the Keith Martin laboratory showed that AAV-vector mediated 
delivery of PI3Ks promote axon regeneration in the injured optic nerve in vivo. My future 
research will investigate whether elevated PIP3 signalling promotes transport of regeneration-
associated receptors into the axon as potential mechanism for the observed regeneration.  
 Chapter IV aimed to optimize AAV-mediated gene transfer to the corticospinal tract 
in vivo. This chapter compared the AAV1 and AAV5 serotypes and the transgene efficiency 
of four promoters: cytomegalovirus (CMV), mouse phosphoglycerate kinase (mPGK), short 
CMV early enhancer/chicken β actin (sCAG), and human synapsin (hSYN). The AAVs were 
injected into the sensorimotor cortex of rats and mice and the transduction was examined by 
histology after six weeks. Consistent with a previous study (Hutson et al.,  2012), we found 
that that AAV1 is superior to AAV5 to transduce the corticospinal tract. Our study found that 
the mPGK and hSYN promoters induce the strongest transgene expression in neurons.  The 
AAV1 serotype with the hSYN promoter resulted in neuron-specific expression, while this 
serotype combined with other promoters also activated transgenes in non-neuronal cells like 
astrocytes, microglia and oligodendrocytes. This chapter contributes to the optimisation of 
AAV-mediated delivery of transgenes into corticospinal tract and is therefore beneficial for 
spinal cord injury research using gene therapy. 
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 This dissertation was focused on axonal growth signalling in CNS neurons, although it 
is important to note that that intrinsic axon growth is a dynamic process (reviewed in Petrova 
& Eva,  2018; Fawcett & Verhaagen,  2018). The general discussion below briefly highlights 
that multiple interventions are possible to promote axon regeneration in the CNS.  
 Successful axon regeneration requires activation of regeneration-associated genes in 
the nucleus as well as effective growth machinery in the axon. Transcriptional reprogramming 
is essential in order to synthesize the growth-associated proteins for axon regeneration 
(reviewed in van Kesteren et al.,  2011; Fagoe et al.,  2014b). Genetic screenings estimated 
that approximately 1200 genes, including 50 transcription factors (TFs), are differently 
regulated in axons that do regenerate compared to adult CNS neurons (Smith & Skene,  1997; 
Stam et al.,  2007; Chandran et al.,  2016; Sekine et al.,  2018). Current approaches aim to 
deliver combinations of TFs or pharmaceutical drugs that are able to up-regulate clusters of 
genes in the regeneration-associated gene program. To date, AAV-mediated delivery of single 
growth-associated-TFs has lead to restricted axon regeneration in the corticospinal tract 
(Blackmore et al.,  2012; Lang et al.,  2013; Z. Wang et al.,  2015b). Another hypothesis 
contributing to regenerative failure is that epigenetic mechanisms block the accessibility of 
promoters from regeneration associated-genes in adult CNS neurons (Weng et al.,  2017; 
Venkatesh et al.,  2018; Oh et al.,  2018; reviewed in Danzi et al.,  2018). Improving 
chromatin accessibility is therefore another approach to stimulate axon regeneration in the 
CNS. Another area of research aims to enhance the intrinsic axon regeneration response by 
delivering neurotropic factors near the soma (Yu et al.,  2011) or near the site of injury 
(Anderson et al.,  2018; Eggers et al.,  2019).  
 In addition to factors within neurons, extrinsic factors play a crucial role in spinal cord 
injury and axon regeneration. Neuronal cell death, devascularisation, inflammation, 
demyelination, and astroglial scar formation can restrict axon regeneration. Only the neurons 
that survive the traumatic insult have the possibility to promote axonal regeneration, and 
therefore neuroprotective treatments are also important to indirectly stimulate axon 
regeneration (reviewed in Ulndreaj, Badner, & Fehlings,  2017). The upregulation of axon 
repulsive molecules at the site of injury are also detrimental for axon regeneration (see 
Chapter I Section V). Neutralization of myelin-associated growth inhibitors and specifically 
the inhibitory components of the glial scar are essential in order to permit axon regeneration 
through the injury site (Kucher et al.,  2018; Burnside et al.,  2018; reviewed in Quraishe, 
Forbes, & Andrews,  2018).  
 There are a number of considerations in order to establish combination therapies for 
spinal cord injury. It will important to select the most robust treatments to combine, consider 
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the possible side effects of each treatment, and importantly the combination of treatments 
should be applied following the progression of spinal cord injury e.g. optimized timing of 
individual treatments. I would speculate to apply neuroprotective treatments immediately 
after the injury, followed by anti-scarring and axon regeneration strategies at the sub-acute 
injury phase. During the more chronic stages, the treatment should consist of long-distance 
axon guidance and re-myelination treatments. The axons also need to connect and re-
innervate the target tissue, which may be aided by electrical stimulation and extensive 
rehabilitation. Above highlights that the molecular and cellular events after a spinal cord 
injury are complex and overcoming all these has proven to be difficult to achieve functional 
recovery. Yet, combination therapies are likely essential to establish long-range axon 
regeneration and functional recovery after spinal cord injury.  
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